Box Ambulance Market Size, Share & Trends Analysis by Application (Emergency Medical Services (EMS), Patient Transport, and Mobile Clinics), By End-User (Public Services, Private Services, and Non?Governmental Organizations (NGOs)), Forecast Period (2026-2035)
Published: Mar 2026
Box ambulance market was valued at $3,525.0 million in 2025 and is projected to reach $5,719.6 million by 2035, growing at a CAGR of 5.0% during the forecast Period (2026-2035). The market comprises specialized emergency vehicles designed to transport patients and medical equipment safely during emergencies. These vehicles are characterized by their box?shaped rear compartments, which provide space for advanced medical systems and care during transit. The market is experiencing steady growth driven by increasing demand for efficient emergency medical services, rising healthcare expenditure, and advancements in ambulance technology, such as real?time monitoring and telemedicine capabilities. Regional dynamics vary, with developed healthcare systems and infrastructure fueling demand in several major markets globally.
Teledermatology Market Size, Share & Trends Analysis Report by Technology (Store-and-Forward Teledermatology, Real-time Teledermatology, and Hybrid Teledermatology), by Services (Teleconsultation, Telemonitoring, Tele-education, and Others), and by End Use (Patients, and Providers), Forecast Period (2026-2035)
Published: Feb 2026
Global teledermatology market was valued at $13.96 billion in 2025 and is projected to reach $46.4 billion by 2035, growing at a CAGR of 12.8% during the forecast period (2026–2035). The global teledermatology market is experiencing rapid expansion as healthcare systems increasingly adopt remote dermatological care to bridge gaps in specialist access and meet rising demand for dermatology services. Key growth drivers include the escalating prevalence of skin diseases, the shortage of dermatologists in underserved regions, and the maturation of enabling technologies such as high-resolution imaging, mobile apps, and artificial intelligence. Teledermatology is a specialized field within telehealth that uses virtual communication technologies to provide remote dermatological care.
Mobile Intensive Care Ambulance Market Size, Share & Trends Analysis by Vehicle Type (Van-Based Ambulances, Truck-Based Ambulances, Bus or Multi-Patient Ambulances, and Others), By Equipment Type (Advanced Life Support Equipment, Diagnostic Equipment, Communication and Telemedicine Systems, and Others), and By End-Users (Hospitals, Emergency Medical Services, Government Emergency Services, Others) Forecast Period (2026-2035)
Published: Feb 2026
Mobile intensive care ambulance market was valued at $6.9 billion in 2025 and is projected to reach $12.8 billion by 2035, growing at a CAGR of 5.8% from 2026 to 2035. Mobile intensive care ambulance, also known as a mobile intensive care unit (MICU). These care units/ambulances are specialised ambulances equipped with advanced medical equipment. These ambulance facilities provide critical care to patients during transport. The growing population leads to urban congestion, delays hospital access, and increases demand for mobile intensive care ambulances. These intensive care ambulances have become essential for providing on-site stabilisation and safe patient transfer. The rising demand for advanced emergency medical services and critical care transport. For instance, in June 2024, Gleneagles BGS Hospital announced the introduction of a 5G-enabled ambulance service in Kengeri, Karnataka. The introduction of 5G-enabled ambulances aims to improve emergency medical response. It is claimed to be South India’s first 5G-enabled ambulance service.
Digital Health Tracking App Market Size, Share & Trends Analysis by Platform (iOS, Android, and Web-based), By Technology (Tele-healthcare, mHealth, Digital Health Systems, Healthcare Analytics, and Others), by Application (Fitness Tracking, Chronic Disease Management, Medication Management, Mental Health Monitoring, Diet/Nutrition Management, Women’s Health Management, and Others (Healthcare Analytics & Reporting)), and by End-Users (Patients, Healthcare Professionals, and Care Givers) Forecast Period (2025-2035)
Published: Feb 2026
Digital health tracking app market was valued at $17.8 billion in 2024 and is expected to reach $52.34 billion by 2032 and further expand to $78.90 billion by 2035, growing at a CAGR of 14.5% during 2025–2035. The digital health tracking app is a smartphone or wearable-based application that allows users or patients to monitor their health activities, such as diet, sleep, steps, and more. Consumers globally are becoming more responsive to their health and well-being, driven by the prevalence of chronic diseases and the influence of digital media. The rising trend of proactive health management rather than traditional treatment is pushing the market growth positively. These tools allow users to monitor vital signs, physical activity, sleep patterns, and nutrition in real time. For instance, the government of Punjab has launched AI-enabled screening devices that detect breast cancer, cervical cancer, and refractive errors at an early stage.
Telerehabilitation Market Size, Share & Trends Analysis Report by Component (Hardware and Software), by Therapy Type (Physical Therapy, Occupational Therapy, Speech Therapy, and Cognitive Behavioral Therapy), by Application (Orthopedic, Cardiovascular, Neurological, Cognitive, and Others), and by End-User (Hospitals & Clinics, Rehabilitation Centers and Homecare Settings) Forecast Period (2025-2035)
Published: Feb 2026
The telerehabilitation market was valued at $5,400 million in 2024 and is projected to reach $14,147 million in 2035, growing at a CAGR of 9.2% during the forecast period (2025-2035). The market is growing as more people are looking for home-based rehabilitation, wearable technology is being incorporated more frequently, AI-driven treatment platforms are more individualized and improve patient outcomes by offering individualized care, and telerehabilitation is enabling cognitive and behavioral therapy to treat mental health issues remotely.
Next-Generation Biomanufacturing Market Size, Share & Trends Analysis Report by Manufacturing Type (Upstream Manufacturing, and Downstream Manufacturing), by Product Type Biopharmaceuticals, Vaccines, Biofuels, Biopolymers, and Others (Recombinant Proteins, Monoclonal Antibodies)), and by End-User (Pharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Development and Manufacturing Organizations (CDMOs), and Others (Biotechnology Companies, Research and Academic Institutions) Forecast Period (2024-2031)
Published: Feb 2026
Next-generation biomanufacturing market is anticipated to grow at a CAGR of 10.4% during the forecast period (2024-2031). Next-generation biomanufacturing involves an advanced approach to producing biological products, including pharmaceuticals, biofuels, and other biotechnological products, leveraging cutting-edge technologies and innovation. Further, the market is expected to experience significant growth in the future attributed to the growing demand for biopharmaceuticals, a supportive regulatory environment for industry development, and the growing integration of AI (Artificial Intelligence), ML (Machine Learning), and digital technologies.
Pediatric Telehealth Market Size, Share & Trends Analysis Report by Product Type (Hardware, Software, and Services), by Delivery Mode (On-premises, Web-based, and Cloud-based), by End-User (Payers, Providers, and Patients), and by Disease Type (Psychiatry, Substance Use Disorder, Radiology, Dermatology, Neurological Medicine, ENT, Dental, and Others) Forecast Period (2024-2031)
Published: Feb 2026
Pediatric telehealth market is anticipated to grow at a CAGR of 26.6% during the forecast period (2024-2031). Pediatric telehealth leverages telecommunication and digital health technologies to deliver healthcare services tailored to children. It encompasses virtual consultations, remote monitoring, tele-diagnosis, and specialized telehealth services. Ongoing technological advancements, regulatory support, and evolving consumer preferences for convenient, integrated, and equitable healthcare for their babies are major factors driving the global market growth.
Medical Supply Delivery Service Market Size, Share & Trends Analysis Report by Application (Medical Supplies, Drug Supplies, Emergency Services, and Lab Specimens & Reports), by Mode Of Service (Courier Delivery, and Drone Delivery), and by End-User (Hospitals, Clinics, Laboratories, Pharmacies, Patients, and Others) Forecast Period (2024-2031)
Published: Feb 2026
Medical supply delivery service market is anticipated to grow at a CAGR of 9.4% during the forecast period (2024-2031). The medical supply delivery service market is influenced by various factors, including the growing geriatric population, technological advancements, and e-commerce growth. Technological advancements, such as real-time tracking and automated logistics systems, improve efficiency and have made a significant contribution to global market growth. Additionally, e-commerce and digital health platforms have revolutionized the delivery of medical supplies, with online pharmacies and telemedicine services driving the need for prompt delivery.
Digital Stethoscope Market Size, Share & Trends Analysis Report by Product Type (Amplifying Stethoscope, and Digitalization Stethoscope), by Technology (Integrated Chest-Piece System, Wireless Transmission System, and Integrated Receiver Head-Piece System), and by End User (Hospitals and Clinics, Ambulatory Surgery Centers, Diagnostic Centers, and Others), Forecast Period (2024-2031)
Published: Feb 2026
Digital stethoscope market is anticipated to grow at a CAGR of 5.7% during the forecast period (2024-2031). The growing prevalence of telemedicine, point-of-care diagnostics, the aging population, preventative healthcare, investments in healthcare infrastructure, advancing technology, and improvements in artificial intelligence and machine learning are all driving factors in the global market for digital stethoscopes. While telemedicine and AI-powered gadgets improve healthcare access and lower diagnostic errors, advanced digital stethoscopes improve sound quality, diagnostic capabilities, and recording.
Clinical Trial Management Services Market Size, Share & Trends Analysis Report By Type (Clinical Trial Monitoring, Regulatory Submissions, Clinical Trial Data Management, Medical Writing, Site Management & Monitoring, and Others), and by End User (Pharmaceutical and Biotechnology Companies, Medical Device Companies, Contract Research Organizations (CROs), and Others), Forecast Period (2024-2031)
Published: Feb 2026
Clinical trial management services market is anticipated to grow at a CAGR of 7.8% during the forecast period (2024-2031). The clinical trial management services (CTMS) market is fueled by the complexity of clinical trials, research growth, globalization, technological advancements, data quality, patient-centricity, and cost-effectiveness. Cloud-based solutions, artificial intelligence, machine learning, and mobile applications enhance efficiency, while cost-effective solutions focus on patient engagement and retention.
Cleanroom Technology Market Size, Share & Trends Analysis Report by Type (Standard Cleanrooms, Modular Cleanrooms (Hardwall Cleanrooms, and Softwall Cleanrooms), and Mobile Cleanrooms), and by End-User (Pharmaceutical Industry, Biotechnology Industry, Medical Device Manufacturers, and Hospitals), Forecast Period (2025-2035)
Published: Feb 2026
Cleanroom technology market was valued at $8.6 billion in 2024 and is projected to reach $17.2 billion by 2035, growing at a CAGR of 6.6% during the forecast period (2025-2035). The cleanroom technology market is witnessing notable growth owing to the rising demand across the medical, biotechnology, and semiconductor industries. Expanding administrative compliance for product quality and impurity control is driving the acceptance of the advanced cleanroom key solution. The rise in biologics and sterile manufacturing has further fueled market expansion. The expansion of healthcare systems in developing economies is fueling market growth, with increased capital investment in life sciences research and development driving additional demand for cleanroom products and supplies.
Equine Healthcare Market Size, Share & Trends Analysis Report by Indication (Musculoskeletal Disorders, Parasite Control, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus and Others), by Product (Vaccines, Pharmaceuticals (Parasiticides, Anti-infectives, Anti-inflammatory & Analgesics), Medicinal Feed Additives, Diagnostics, and Others), and by Distribution Channel (Veterinary hospital pharmacies and E-commerce) Forecast Period (2024-2031)
Published: Feb 2026
Equine healthcare market is anticipated to grow at a CAGR of 6.1% during the forecast period (2024-2031). The market growth is driven by the increasing animal health spending, accelerating prevalence of equine diseases, and increasing uptake of animal insurance. Additionally, the rise in demand for the use of horses for various purposes such as sports events, is also contributing significantly towards the market growth. The market will also grow owing to the rise in the equine population.
Animal Artificial Insemination Market Size, Share & Trends Analysis Report by Components (Equipment, Semen (Normal, Sexed), Kits and Reagent, and Service), by Animal (Bovine, Swine, Equine and Others), by Technique (Intracervical, Intrauterine and Intratubal) and by End-User (Hospital and Clinic) Forecast Period (2024-2031)
Published: Feb 2026
Animal artificial insemination market is anticipated to grow at a CAGR of 6.4% during the forecast period (2024-2031). Animal artificial insemination is a reproductive technique used in animal breeding to facilitate the process of fertilization without natural mating. It involves the collection of semen from a male animal, typically of superior genetics, and its deposition into the reproductive tract of a female animal using specialized instruments. AI is commonly employed in various livestock species such as cattle, sheep, goats, pigs, and horses. The market growth is driven by the growing animal and fishery industry and the increasing burden of sexually transmitted diseases, among the farm animals.
Revenue Cycle Management Market Size, Share & Trends Analysis Report by Structure (In-house and Outsourced), by Type (Software and Service) by Function (Claims & Denial Management, Medical Coding & Billing, Clinical Documentation Improvement (CDI) and Insurance), and by End-User (Hospitals, Physician’s Office, and Diagnostic Laboratories), Forecast Period (2024-2031)
Published: Feb 2026
Revenue cycle management (RCM) market is anticipated to grow at a CAGR of 9.4% during the forecast period (2024-2031). RCM refers to the process of managing the financial aspects of a healthcare organization's interactions with patients, payers, and other entities to generate revenue and ensure timely payment for services rendered. It encompasses various stages, including patient registration, insurance verification, coding, charge capture, claims submission, payment posting, denial management, and revenue analysis. The industry's transition towards value-based care models, alongside regulatory changes and the imperative for cost containment, further propels investment in RCM solutions.
Healthcare Creditor Insurance Market Size, Share & Trends Analysis Report by Age Group (Pediatric, Adult, and Geriatric), and by Distribution Channel (Direct Sales, Brokers and Individual Agents and Bankers), Forecast Period (2024-2031)
Published: Feb 2026
Healthcare creditor insurance market is anticipated to grow at a CAGR of 6.0% during the forecast period (2024-2031). Healthcare creditor insurance is a type of insurance coverage designed to protect healthcare providers such as hospitals, clinics, and medical practices, from financial losses resulting from unpaid patient debts. This insurance typically covers outstanding medical bills owed by patients unable or unwilling to pay due to financial hardship, bankruptcy, among other factors. Healthcare creditor insurance helps mitigate the risk of revenue loss for healthcare providers by reimbursing them for the unpaid balances owed by patients.
Digital Health For Cardiovascular Market Size, Share & Trends Analysis Report by Component (Hardware, Software, and Services), by End-User (Patients, Payers, Providers and Other) Forecast Period (2024-2031)
Published: Feb 2026
Digital health for cardiovascular market is anticipated to grow at a CAGR of 22.4% during the forecast period (2024-2031). Digital health for cardiovascular disorders is a field that uses technology to improve the prevention, diagnosis, and management of heart and blood vessel diseases. Tools and services include wearable devices, mobile health apps, telemedicine, and remote patient monitoring. Wearable devices monitor heart rate, blood pressure, and activity levels, while mobile health apps track symptoms, medications, and progress.
Hemoglobinopathies Market Size, Share & Trends Analysis Report by Type (Thalassemia, Sickle Cell Disease, and Others), by Therapy (Monoclonal Antibody Medication, ACE inhibitors, Hydroxyurea, and Others), and by Distribution Channel (Hospital Pharmacy, Online Providers, and Drug Stores and Retail Pharmacy), Forecast Period (2024-2031)
Published: Feb 2026
Hemoglobinopathies market is anticipated to grow at a CAGR of 7.9% during the forecast period (2024-2031). Hemoglobinopathies are caused by a mutation in the gene of DNA of hemoglobin molecule. Structural abnormalities in the hemoglobin molecule generate defective red blood cells, which is a root cause of sickle cell disease. Furthermore, the presence of hemoglobin-related diseases is higher in Asia and Africa region. According to the World Health Organization (WHO), 7.0% of the world’s population is affected by hemoglobinopathies. WHO also estimated that 30,000-40,000 newborn babies carry severe hemoglobinopathies from their parents as a genetic disorder.
Hypnotherapy Market Size, Share & Trends Analysis Report by Type (Body Healing, Mind Healing, Sensory Healing, and External Energy), by End-User (Online, and Offline) Forecast Period (2024-2031)
Published: Feb 2026
Hypnotherapy market is anticipated to grow at a CAGR of 30.4% during the forecast period (2024-2031). Hypnotherapy uses hypnosis to bring about positive changes in a client's thoughts, behaviors, or emotions. Therapists use frameworks like the Direct Model, Ericksonian Hypnosis, and Parts Therapy to tailor sessions to clients' specific needs and goals.
Oxygen Concentrators Market Size, Share & Trends Analysis Report by Type (Portable, and Fixed), by Technology (Continuous flow, and Pulse flow) by Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Respiratory Distress, and Others)), and by End-User(Hospitals & Clinics, Home Care Settings, and Ambulatory Surgical Centers & Physician Offices)) Forecast Period (2024-2031)
Published: Feb 2026
Oxygen concentrators market is anticipated to grow at a considerable CAGR of 8.5% during the forecast period (2024-2031).The global oxygen concentrators market is expanding owing to factors such as, respiratory disorders, aging population, technological advancements, home healthcare, COVID-19, healthcare expenditure, government initiatives, and increased awareness about oxygen therapy. These devices extract oxygen from air for higher concentrations.
Brain Mapping Instruments Market Size, Share & Trends Analysis Report by Product (Computed Axial Tomography (CAT), Position Emission Tomography, Electroencephalography (EEG), Functional Near-Infrared Spectroscopy (fNIRS), Functional Magnetic Resonance Imaging (fMRI), and Others), and by End User (Hospitals and Clinics, Diagnostic Centers, and Others), Forecast Period (2024-2031)
Published: Feb 2026
Brain mapping instruments Market is anticipated to grow at a considerable CAGR of 6.1% during the forecast period (2024-2031). The global brain mapping instruments market is fueled by advancements in neuroscience research, the increasing prevalence of neurological disorders, technological innovations, government, and private funding, clinical applications, increasing awareness and education, globalization, partnerships, and regulatory landscape.
Respiratory Disease Testing Market Size, Share & Trends Analysis Report by Product and Service (Instruments & Devices, Assays & Reagents, and Services & Software), by Test Type (Imaging Tests, Mechanical Tests, and In-vitro Diagnostic Tests), by Disease Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, and Others), and by End Users (Hospitals and Clinics, Diagnostics Laboratories, and Others), Forecast Period (2024-2031)
Published: Feb 2026
Respiratory disease testing market is anticipated to grow at a considerable CAGR of 6.3% during the forecast period (2024-2031). The primary driver propelling the market's expansion is the progressively increasing prevalence of respiratory diseases caused by rising air pollution levels. The growth has been prompted by the increasing rate of air pollution and the release of dangerous chemicals leading to lung ailments, such as chronic obstructive pulmonary disease (COPD), and other respiratory diseases globally.
Dietary Supplement Contract Manufacturing Market Size, Share & Trends Analysis Report by Product Type (Proteins and Amino Acid Supplements, Multivitamin, Multi-Mineral, and Antioxidant Supplements, Weight Management and Meal Replacer Supplements, Other Supplements), by Dosage Form(Tablets, Capsules, Liquid Oral, Powder In Sachet / Jar, Gummies), Forecast Period (2024-2031)
Published: Feb 2026
Dietary supplement contract manufacturing market is anticipated to grow at a significant CAGR of 12.4% during the forecast period (2024-2031). Dietary Supplement Contract Manufacturing (DSCM) is a business model in the dietary supplement industry, involving a partnership between a brand and a contract manufacturer. The brand develops, markets, and sells the supplement, while the contract manufacturer handles manufacturing, packaging, and labeling. The market growth is driven by convergence of technology, genomics, and nutrition enables a more personalized approach to dietary plans.
Arthroscopy Devices Market Size, Share & Trends Analysis Report by Type (Arthroscopes, Arthroscopic Implants, Fluid management systems, Radiofrequency systems, Visualization systems, and Powered Shavers), and by Application (Knee Arthroscopy, Hip arthroscopy, Spine Arthroscopy, and Shoulder and elbow arthroscopy), Forecast Period (2024-2031)
Published: Feb 2026
Arthroscopy devices market is anticipated to grow at a moderate CAGR of 4.9% during the forecast period (2024-2031). An arthroscope is a medical device used to visualize, examine, and execute therapeutic interventions inside the body joints, including the knee, hip, spine, shoulder, and elbow. Arthroscopy devices can examine bone joints for specific conditions, such as osteoarthritis, rheumatoid arthritis, tendinitis, and bone tumors. A major factor supporting the market growth is the increasing knee arthroscopy.
Smart Healthcare Market Size, Share & Trends Analysis Report by Product Type (Electronic Health Records (EHR) Systems, Telemedicine and Remote Monitoring Devices, M-Health, Healthcare Analytics and AI Solutions, Hospital Information Systems (HIS), Smart Hospital Infrastructure, and Others) and by End-User (Hospitals and Clinics, Healthcare Payers and Insurers, Pharmaceutical and Life Sciences Companies, Government Agencies and Regulatory Bodies, and Others), Forecast Period (2024-2031)
Published: Feb 2026
Smart healthcare market is anticipated to grow at a significant CAGR of 12.8% during the forecast period (2024-2031). Rising healthcare costs, aging populations, and chronic disease burdens influence the global smart healthcare market. Smart healthcare technologies like telemedicine, remote patient monitoring, and predictive analytics help optimize resource utilization and reduce healthcare expenditures. The aging population and chronic diseases also demand proactive disease management and personalized care delivery.
Oculoplastic Surgery Market Size, Share & Trends Analysis Report by Procedure (Eyelid Surgery, Face Lift, Brow Lift & Forehead Lift, Pediatric Oculoplastic surgery and Orbital Surgery), and by End User (Hospitals & clinics, Ambulatory surgical centers, Ophthalmology Clinics and Eye Research Institutes) Forecast Period (2024-2031)
Published: Feb 2026
Oculoplastic surgery market is anticipated to grow at a considerable CAGR of 5.7% during the forecast period (2024-2031). An oculoplastic procedure is a type of surgery done around the eyes. This procedure is done to correct a medical problem or for cosmetic reasons. Oculoplastic procedures are usually done by eye doctors (ophthalmologists) who have special training in plastic or reconstructive surgery. In some cases, procedures are performed by doctors who specialize in head and neck surgery.
Kidney Function Tests Market Size, Share & Trends Analysis Report by Product Type (Dipsticks, Reagents, and Disposables) by Test Type (Urine Test, and Blood Test) and by End Users (Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes, and Others) Forecast Period (2024-2031)
Published: Feb 2026
Kidney function tests market is anticipated to grow at a CAGR of 6.8% during the forecast period (2024-2031). Kidney function tests market is driven by the increasing prevalence of kidney diseases, such as chronic kidney disease, diabetic nephropathy, and glomerulonephritis, in addition to the diagnostic significance of these tests. Key players include diagnostic companies, laboratory equipment manufacturers, and healthcare institutions. Technological advancements, such as automation and molecular diagnostics, have improved the accuracy and accessibility of these tests.
Lung Cancer Screening Software Market Size, Share & Trends Analysis Report by Cancer Type (Non-small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer) by Diagnosis Type (Dose Spiral, CT Scan, and Chest X-ray) and by End-User (Hospitals & Clinics, and Diagnostic Centres) Forecast Period (2024-2031)
Published: Feb 2026
Lung cancer screening software market is anticipated to grow at a significant CAGR of 19.5% during the forecast period (2024-2031). Lung cancer is a leading cause of cancer-related deaths globally, driving the demand for advanced screening tools. Advancements in imaging technology, such as CT scanners, enable more accurate visualization of lung anatomy. Early detection is crucial for better treatment outcomes and increased survival rates. AI integration in screening software enhances image analysis, pattern recognition, and risk prediction.
Digital Health For Obesity Market Size, Share & Trends Analysis Report by Application (Mobile Health (mHealth) Apps, Telemedicine Platforms, Digital Therapeutics (DTx), and Wearable Devices). by Component (Software, and Services). and by End-User (Patients, Providers, Payers, and Others). Forecast Period (2024-2031).
Published: Feb 2026
Digital health for obesity market is anticipated to grow at an exponential CAGR of 28.6% during the forecast period (2024-2031). The global obesity prevalence is driving the digital health market for obesity management. Advancements in digital technologies, such as mobile applications, wearable devices, and artificial intelligence, have transformed the landscape of obesity management. These technologies offer personalized interventions, remote monitoring, and real-time feedback, enhancing weight management efforts.
Thyroid Function Testing Market Size, Share & Trends Analysis Report by Type (Thyroid Stimulating Hormone (TSH) Tests, T4 Tests, T3 Tests, and Others). and by End User (Hospitals and Clinics, Diagnostic Laboratories, and Research and Academic Institutes).Forecast Period (2024-2031).
Published: Feb 2026
Thyroid function testing market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2024-2031). The global thyroid function testing market is driven by the increasing prevalence of thyroid disorders, advancements in diagnostic technologies, growing awareness and screening programs, and the increasing incidence of autoimmune thyroid diseases. Lifestyle and environmental factors, such as diet, stress, and obesity, also influence thyroid function and contribute to thyroid disorders.
Digital Dose Inhaler Market Size, Share & Trends Analysis Report by Product (Dry Powder Inhalers, and Metered Dose Inhalers), by Application (Chronic Obstructive Pulmonary Disease, Asthma, and Others). by Type (Branded, and Generic). and by End Users (Hospitals, Homecare Settings, and Others). Forecast Period (2024-2031).
Published: Feb 2026
Digital dose inhaler market is anticipated to grow at a CAGR of 7.3% during the forecast period (2024-2031). Digital health technology has led to the development of digital dose inhalers, that offer features such as dose tracking and mobile app connectivity, improving medication adherence and patient outcomes. The increasing prevalence of respiratory diseases, patient-centric care, and government initiatives are driving investment in digital health technologies.
Health Information Exchange Market Size, Share & Trends Analysis Report by Setup Type (Private HIE, and Public HIE), by Implementation Model (Hybrid Models, Centralized Models, Decentralized/ Federated Models) by Type (Directed Exchange, Query-based Exchange, and Consumer-mediated Exchange) by Application (Web Portal Development, Workflow Management, Secure Messaging, Internal Interfacing, and Others) by Solution (Portal-centric Solutions, Messaging-centric Solutions, and Platform-centric Solutions) and by End User (Healthcare Providers, Healthcare Payers and Pharmacies) Forecast Period (2024-2031)
Published: Feb 2026
Health information exchange market is anticipated to grow at a significant CAGR of 15.8% during the forecast period (2024-2031). Government mandates and policies globally are driving the adoption of Health Information Exchange (HIE) solutions, contributing to market growth. Data-driven decision-making is growing the demand for HIE solutions, as healthcare organizations use data to improve patient care, and operational efficiency, and reduce costs.
Healthcare Analytical Testing Services Market Size, Share & Trends Analysis Report by Type (Bioanalytical Testing Services, Physical Characterization Services, Method Development & Validation Services, Raw Material Testing Services, Batch- Release Testing Services, and Others (Stability Testing Services, Genomics Testing Services).and by End-Users (Pharmaceuticals, Hospitals and Clinics and Forensic Lab). Forecast Period (2024-2031).
Published: Feb 2026
Healthcare analytical testing services market is anticipated to grow at a considerable CAGR of 13.1% during the forecast period (2024-2031).The growth of the healthcare analytical testing services market is attributed to increasing demand for electronic health records (EHRs), personal health records (PHRs), electronic prescription services (E-prescribing), patient portals, master patient indexes (MPI), with digital data collection globally driving the growth of the market.
Medication Management System Market Size, Share & Trends Analysis Report by Product Type (Computerized Physician Order Entry, Clinical Decision Support System Solutions, Electronic Medication Administration Record, Inventory Management Solutions, and Others). by Mode of Delivery (Web-based, Cloud-based, and On-premise). and by End-User (Pharmacies and Retail Drug Outlets, and Hospitals and Clinics). Forecast Period (2024-2031).
Published: Feb 2026
Medication management system market is anticipated to grow at a significant CAGR of 12.4% during the forecast period (2024-2031). The global medication management system market is driven by factors such as increasing medication errors, growing geriatric populations, and rising chronic disease burden. These factors drive the adoption of medication management systems to automate dispensing, administration, and monitoring processes, reduce adverse drug events, optimize treatment for elderly patients, and enhance patient outcomes.
Pregnancy Tracking and Postpartum Care Apps Market Size, Share & Trends Analysis Report by Type (prepartum, and Post-partum), by Device (Smartphones, Tablets, and Others), and by End-User (Android, and iOS) Forecast Period (2024-2031)
Published: Feb 2026
Pregnancy tracking and postpartum care apps market is anticipated to grow at a considerable CAGR of 5.3% during the forecast period (2024-2031). The global pregnancy tracking and postpartum care app market is expanding owing to increased digital health awareness, convenience, and technological advancements. The COVID-19 pandemic has accelerated adoption, with smartphones and internet connectivity making these apps more accessible and personalized.
Trocars Market Size, Share & Trends Analysis Report by Tip Type (Bladeless Trocars, Blunt Trocars, Bladed Trocars, and Optical Trocars), by Product Type (Disposable Trocars and Reusable Trocars), by Application (General Surgery, Gynecological Surgery, Urological Surgery, and Other (Pediatric Surgery and Laparoscopy Surgery)), and by End-User (Hospitals and Ambulatory Surgical Centers) Forecast Period (2024-2031)
Published: Feb 2026
Trocars market is anticipated to grow at a CAGR of 5.5% during the forecast period (2024-2031). Trocars are surgical instruments with a sharp, pointed tip attached to a hollow tube, often with a handle for manipulation. To make entrance sites through the body wall that permit the insertion of additional surgical equipment and devices into bodily cavities or spaces, they are used in minimally invasive surgical procedures.
Esoteric Testing Market Size, Share & Trends Analysis Report by Test Type (Infectious Disease Testing, Oncology Testing, Endocrinology Testing, Genetic Testing, Toxicology, Neurology Testing, and Others), By Technology (Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Mass Spectrometry, DNA Sequencing, Flow Cytometry, Others), and by End-User (Hospital-based Laboratories and Independent and Reference Laboratories) Forecast Period (2024-2031)
Published: Feb 2026
Esoteric testing market is anticipated to grow at a CAGR of 11.0% during the forecast period (2024-2031). Esoteric testing, which analyzes rare molecules or substances, can help diagnose conditions accurately, leading to early intervention, proper treatment, and improved patient outcomes. The esoteric testing market growth is driven by the increasing prevalence of cancer and infectious diseases along with the growing demand for diagnosis of rare diseases to identify complex medical conditions and guide personalized treatment.
Healthcare Distribution Market Size, Share & Trends Analysis Report by Type (Pharmaceutical Product Distribution Services, Biopharmaceutical Product Distribution Services, and Medical Device Distribution Services), and by End-User (Retail Pharmacies, Hospital Pharmacies, and Others) Forecast Period (2024-2031)
Published: Feb 2026
Healthcare distribution market is anticipated to grow at a CAGR of 6.7% during the forecast period (2024-2031). Post the COVID-19 pandemic, globally was an increase in demand for effective public health distribution systems. This is primarily due to the supply chain disruption.
Healthcare Digital Signage Market Size, Share & Trends Analysis Report by Component (Hardware, Services and Software), by Type (Video Walls, Transparent LED Screen, Video Screen, Kiosks and Digital Poster), and by Application (Wayfinding and Navigation, Advertising and Promotion and Information and Education) Forecast Period (2024-2031)
Published: Feb 2026
Healthcare Digital Signage market is anticipated to grow at a CAGR of 8.9% during the forecast period (2024-2031). Healthcare Digital Signage is a technology solution that uses digital displays to convey information, messages, and multimedia content within healthcare facilities and is also a versatile tool that can enhance communication, patient engagement, and overall efficiency in healthcare settings.
Menstrual Health Apps Market Size, Share & Trends Analysis Report by Application (Period Cycle Tracking, Fertility & Ovulation Management, Menstrual Health Management, and Others), and by Platform (Android, and iOS) Forecast Period (2024-2031)
Published: Feb 2026
Menstrual health apps market is anticipated to grow at a CAGR of 18.8% during the forecast period (2024-2031). The market expansion is driven by rising health awareness among women, digital literacy, smartphone usage, higher disposable income, improved internet connectivity, and the emergence of new market players.
Healthcare Quality Management Market Size, Share & Trends Analysis Report by Type (Business Intelligence and Data Analytics Solutions, Clinical Risk Management Solutions, Physician Quality Reporting Solutions, and Provider Performance Improvement Solutions), by Application (Data Management, Risk Management, and Others), by Deployment Mode (Cloud-Based, and On-Premises), and by End-User (Hospitals, Ambulatory Surgery Centers (ASCs), Nursing homes, and Others) Forecast Period (2024-2031)
Published: Feb 2026
Healthcare quality management market is anticipated to grow at a CAGR of 14.8% during the forecast period (2024-2031). In healthcare, quality management refers to the administration of systems design, policies, and processes that minimize, if not eliminate, harm while optimizing patient care and outcomes.
Healthcare Navigation Platform Market Size, Share & Trends Analysis Report by Deployment Model (Cloud-based, and On-premises), by Application (Clinical and Care Navigation, Insurance and benefits Navigation, Telehealth and Remote Care, and Financial Navigation), and by End User (Healthcare Providers, Health Plans/Insurance Companies, and Employers) Forecast Period (2025-2035)
Published: Feb 2026
Healthcare navigation platform market was valued at $11.1 billion in 2024 and is projected to reach $26.5 billion by 2035, growing at a CAGR of 8.3% during the forecast period (2025–2035). A healthcare navigation platform is a digital tool that helps individuals to recognise the healthcare system by offering real-time support, benefits, cost comparisons, provider options, and personalised services. Healthcare navigation platforms provide personalized support, cost transparency, and 24/7 access to information, optimizing wellness and reducing costs, using AI, machine learning, cloud hosting, EHR integration, and telehealth technologies.
AI in Patient Engagement Market Size, Share & Trends Analysis Report by Delivery Type (Cloud Based and On-Premises), by Application (Population Health Management, Outpatient Health Management, In-Patient Health Management, and Others), and by End-User (Hospitals and Clinics, Healthcare Providers, Healthcare Payers, and Others) Forecast Period (2024-2031)
Published: Feb 2026
AI in patient engagement market is anticipated to grow at a CAGR of 21.0% during the forecast period (2024-2031). The market is driven by demand for personalized healthcare plans and AI for data analytics. The AI improves patient engagement and care management by predicting health outcomes, identifying high-risk patients, and enhancing interaction between providers and patients.
Rapid Test Market Size, Share & Trends Analysis Report by Product (Laboratory Rapid Test and Over-the-counter (OTC) Rapid Test), by Technology (Immunoassay, Chromatography, Spectroscopy, and Polymerase Chain Reaction (PCR)), by Application (Infectious Disease, Pregnancy Test, Glucose Test, and Others), and by End-Users (Hospitals and Clinics, Diagnostic Laboratories, and Home Care), Forecast Period (2024-2031)
Published: Feb 2026
Rapid test market is anticipated to grow at a CAGR of 8.2% during the forecast period (2024-2031). The rising awareness regarding early and reliable diagnosis of disease, prevalence of infectious diseases, introduction of technologically advanced products and need for low cost as well as accurate diagnostic testing. Additionally, rapid tests provide accurate results in a short time and these benefits have led to a surge in adoption of rapid tests in point-of-care testing, wherein results are obtained on the same day which is boosting the market growth.
Prediabetes Market Size, Share & Trends Analysis Report by Drug Class (Biguanide (Metformin), Thiazolidinediones (TZDs), Glucagon-like Peptide-1 Agonists (GLP-1), SGLT2 Inhibitors, DPP-4 Inhibitors, and Others), by Route of Administration (Oral, and Injectable), and by Age Group (Children (12 to 18 Years), Adult (18 to 50 Years), and Elderly (Above 50 Years)) Forecast Period (2025-2035)
Published: Feb 2026
Prediabetes market was valued at $0.35 billion in 2024 and is projected to reach $1.1 billion by 2035, growing at a CAGR of 11.3 % during the forecast period (2025–2035). The market growth is fueled by the increasing incidence of prediabetes, growing awareness of early diagnosis and treatment, and the evolution of digital health solutions. The rising usage of continuous glucose monitoring (CGM) devices, wearables, and AI-based predictive analytics is substantially improving patient outcomes and disease prevention. Government public health programs, increasing insurance coverage for preventive services, investments in personalized medicine, and behavioral interventions are among the prime drivers of market growth. Another trend is the inclusion of telemedicine, mobile health apps, and digital therapeutics into pre-diabetes disease management models, which is revolutionizing disease management, patient engagement, and early intervention approaches.
Medical Document Management Systems Market Size, Share & Trends Analysis Report by Solutions (Standalone Medical Document Management Solutions, Document Scanning Software, Electronic Document Management Software, and Integrated Medical Document Management Solutions) by Services (Medical Record Scanning and Management Services, Product Support Services, Implementation & Integration Services, Maintenance, Support, and Optimization Services, and Training & Education Services) and by End-User (Hospitals and Clinics, Insurance Providers, and Others) Forecast Period (2024-2031)
Published: Feb 2026
Medical document management systems market is anticipated to grow at a CAGR of 11.9% during the forecast period (2024-2031). The market’s growth is attributed to the growing demand for use of medical document management systems to update obsolete processes and infrastructure, the healthcare sector occurs through a technological transition that can enhance patient outcomes.
Lab Automation in Genomics Market Size, Share & Trends Analysis Report by Equipment Type (Automated Liquid Handler, Automated Plate Handler, Robotic Arms, Automated Storage & Retrieval System, and Vision Systems) Forecast Period (2024-2031)
Published: Feb 2026
Lab automation in genomics market is anticipated to grow at a significant CAGR of 11.5% during the forecast period (2024-2031). The increasing advancements in genomic research, increasing prevalence of chronic disorders, and growing demand for lab automation are major factors driving the global market.
Healthcare Data Integration Market Size, Share & Trends Analysis Report by Component (Tools and Services), by Deployment (Cloud and On-premises), by Business Application (Marketing, Sales, Operations & Supply Chain, Finance and HR), and by End-User (Hospitals, Clinics, Laboratories and Others) Forecast Period (2024-2031)
Published: Feb 2026
Healthcare data integration market is anticipated to grow at a significant CAGR of 12.4% during the forecast period (2024-2031).The growing adoption of electronic health records and other healthcare IT solutions, favorable government policies, funding programs, and initiatives to deploy healthcare IT integration solutions are the key factors supporting the growth of the market globally.
Dental Practice Management Software Market Size, Share & Trends Analysis Report by Delivery Mode (On-Premises, Web-Based, and Cloud-Based), by Application (Patient Communication software, Invoice/Billing Software, Payment Processing Software, Insurance Management, and Others), and by End-User (Dental Clinics, Hospitals, and Others) Forecast Period (2024-2031)
Published: Feb 2026
Dental practice management software market is anticipated to grow at a CAGR of 10.60% during the forecast period (2024-2031). The market’s growth is attributed to the growing demand for effectiveness and automation across the globe. Software solutions that simplify administrative processes and improve overall efficiency have been adopted by dental clinics more and more.
Chromatography Software Market Size, Share & Trends Analysis Report by Deployment Mode (On-Premises, Web-Based, and Cloud-Based), by Application (Pharmaceutical Industry, Environmental Testing, Forensic Testing, Food & Beverage Industry, and Others), and by End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Environmental Testing Laboratories, and Clinical Research and Diagnostics) Forecast Period (2024-2031)
Published: Feb 2026
Chromatography software market is anticipated to grow at a CAGR of 8.5% during the forecast period (2024-2031). The market’s growth is attributed to the growing demand for efficiency and speed across the globe. The time and complexity involved in chromatographic separations are decreased by chromatography-free mass spectrometry devices, that simplify analytical processes. This effectiveness is a key motivator, particularly in applied market sectors where rapid and easy assessments are essential.
Population Health Management Market Size, Share & Trends Analysis Report by Component (Software and Services), by Mode of Delivery (On-Premises and Cloud-Based), and by End-User (Introduction, Healthcare Providers, Healthcare Payers, and Others) Forecast Period (2024-2031)
Published: Feb 2026
Population health management market is anticipated to grow at a CAGR of 13.5% during the forecast period (2024-2031). The market’s growth is attributed to the growing chronic illness among population and need for managing health of population is anticipated to drive the market. Furthermore growing policies and initiatives taken by the organization in the field of population health management is creating favourable condition for the growth of the market.
Hospital Bed Management Systems Market Size, Share & Trends Analysis Report by Type (Acute Care Bed, Critical Care Bed, Long-term Care Bed, and Others), by Deployment (Cloud & Web Based and On-premises), and by End-User (Hospitals, Clinics and Outpatient Centers, Government and Military Healthcare Facilities, and Others), Forecast Period (2024-2031)
Published: Feb 2026
Hospital bed management systems market is anticipated to grow at a CAGR of 9.3% during the forecast period (2024-2031). The market’s growth is attributed to the growing demand for patient-centered safety and care across the globe. Global adoption of advanced bed management systems is a result of the growing need for patient-centered care. These systems, that include elements such as weight control, non-disruptive turns monitoring, and movement-free X-rays, prioritize patient safety and well-being while additionally improving operating efficiency.
Burn Care Market Size, Share & Trends Analysis Report by Product (Foam Dressing, Collagen Dressing, Hydrogel Dressing, Hydrocolloid Dressing, Alginate Dressing, Wound Contact Layers, Film Dressing, and Others), by Depth of Wound (Full Thickness Burns, Partial Thickness Burns, and Minor Burns), and by End-User (Hospitals, Outpatient Facilities, Home Care, and Others), Forecast Period (2024-2031)
Published: Feb 2026
Burn care market is anticipated to grow at a CAGR of 7.4% during the forecast period (2024-2031). The rising incidence of burns owing to accidents, fire-related incidents, or medical conditions across the globe is projected to boost the market growth. According to the World Health Organization (WHO), burns are a global public health problem, accounting for an estimated 180,000 fatalities annually.
Portable X-ray Devices Market Size, Share & Trends Analysis Report by Technology (Computed Radiography, and Digital X-ray), by Application (Dental X-ray, Mammography, Chest X-ray, and Abdomen X-ray), by Modality (Handheld X-ray Devices, and Mobile X-ray Devices) and by End User (Hospitals and Clinics, Diagnostic Centers and Imaging Facilities, Military and Defense, and Others) Forecast Period (2025-2035)
Published: Feb 2026
Portable X-ray devices market was valued at $6.7 billion in 2024 and is projected to reach $16.2 billion by 2035, growing at a CAGR of 8.5% during the forecast period (2025-2035). Portable X-ray devices are experiencing rapid changes in healthcare delivery models toward flexibility, speed, and access. The more healthcare professionals move toward decentralized, patient-centered diagnostic services, the demand for mobile radiographic systems in numerous medical environments is on the rise. Portable X-ray devices are useful in that they offer real-time imaging in environments where moving a patient to a hospital-based radiology department is not practical or timely. Amid global attention on the need to improve diagnostic turnaround times and thus enhance the efficiency of the healthcare system, portable X-ray units are a more vital tool used in both high-acuity and outpatient facilities. Their compact size, ease of use, and ability to work in conjunction with digital imaging options in the marketplace make them suitable for rapid deployment systems in emergency care, rural outreach programs, and home healthcare.
Knee Replacement Market Size, Share & Trends Analysis Report by Product Type (Total Knee Replacement, Partial Knee Replacement, and Complex (Revision) Knee Replacement), by Material Type (Metal, Ceramic, and Plastic Component), by End-User (Hospitals, Specialized Orthopedic Clinics, and Ambulatory Surgical Centers), Forecast Period (2024-2031)
Published: Feb 2026
Knee replacement market is anticipated to grow at a considerable CAGR of 4.5% during the forecast period. The rising geriatric population along with the increasing prevalence of osteoporosis and, arthritis globally is a key factor driving the global market. According to the October 2021 report of the World Health Organization, the global population of people aged 60 years and more is expected to increase from 1 billion in 2020 to 2.1 billion by 2050, which is expected to have a significant impact on the demand for home healthcare software market as older people are more dependent upon others for their care and other needs.
Multiomics Market Size, Share & Trends Analysis Report by Product & Services (Product and Services), by Type (Single-cell Multiomics and Bulk Multiomics), by Application (Cell Biology, Oncology, Neurology, and Immunology), by End-User (Pharma & Biotech Companies, Academics & Research Organization, and Hospital & Diagnostic Laboratories), Forecast Period (2024-2031)
Published: Feb 2026
Multiomics market is anticipated to grow at a considerable CAGR of 16.5% during the forecast period (2024-2031). Advancements in multiomics technology along with its growing application in the treatment of several disorders is a key factor driving the growth of the global market. The discovery of new application areas of multiomics is further aiding the market growth.
Anesthesia Electronic Medical Record (EMR) Software Market Size, Share & Trends Analysis Report by Anesthesia Type (General Anesthesia, Regional Anesthesia, Cardiac Anesthesia, and Pediatric Anesthesia), by Deployment Type (Cloud and On-Premises), by Organization Size (Small and Medium Enterprises (SMEs), and Large Enterprises), and by End-User (Hospitals, Ambulatory Surgery Centers, and Clinics) Forecast Period (2023-2030)
Published: Feb 2026
Anesthesia EMR Software market is anticipated to grow at a CAGR of 7.8% during the forecast period (2023-2030). The widespread adoption of electronic medical records (EMRs) within the healthcare industry serves as a primary driving force behind the expanding anesthesia EMR software market. EMRs represent digital counterparts of a patient's medical chart, offering healthcare providers a multitude of benefits, including enhanced patient care, reduced costs, and improved efficiency.
Hepatitis E Diagnostic Tests Market Size, Share & Trends Analysis Report by Disease Type (Serology Tests, Molecular Tests, Immunoassays, and Point-of-Care Tests), by Technology (Enzyme-Linked Immunosorbent Assay, Rapid Diagnostic Tests, Next-Generation Sequencing, and Nucleic Acid Amplification Tests) and by End User (Hospitals and Clinics, Diagnostic Laboratories, and Public Health Agencies and Research Institutions), Forecast Period (2024-2031)
Published: Feb 2026
Hepatitis e diagnostic tests market is anticipated to grow at a CAGR of 7.40% during the forecast period (2024-2031). The market’s growth is attributed to the demand for global health concern. The global prevalence and significance of Hepatitis E as a major public health concern motivate continued growth and acceptance of diagnostic tests to effectively manage and minimize the disease's impact on public health.
New Drug Delivery Systems (NDDS) Market Size, Share & Trends Analysis Report by Route of Administration (Oral Drug Delivery Systems (DDS), Injectable Drug Delivery Systems (DDS), Pulmonary Drug Delivery Systems (DDS), Transdermal Drug Delivery Systems (DDS), and Others ), and by Mode of NDDS (Targeted Drug Delivery Systems, Controlled Drug Delivery Systems, Modulated Drug Delivery Systems, and Others) Forecast Period (2024-2031)
Published: Feb 2026
NDDS market is anticipated to grow at a CAGR of 21.6% during the forecast period (2024-2031). The market’s growth is attributed to the growing demand for targeted therapies. Based the increased risks associated with diabetes, there is rising demand for more specific and focused medicines for managing cardiovascular problems. NDDS provides a possibilities by allowing drugs to be delivered directly to afflicted locations, decreasing systemic side effects while increasing the effectiveness of therapy.
Hirsutism Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Medications, and Procedures), By Application, (Upper Lip, Chin, Chest, Arms, Others), by End-use (Hospitals, Dermatology Clinics, and Aesthetic Centers), Forecast Period (2024-2031)
Published: Feb 2026
Hirsutism treatment market is anticipated to grow at a considerable CAGR of 7.2% during the forecast period (2024-2031). The growth of this market is attributed to the increasing prevalence of hirsutism among women. According to the American Academy of Family Physicians, hirsutism affects around 8.0% of women, and it is associated with an estimated economic burden surpassing $600 million annually in the US. Cosmetic and psychological problems associated with unwanted hair and the increasing prevalence of polycystic ovary syndrome are major factors projected to fuel market growth during the forecast period.
Cyclotron Market Size, Share & Trends Analysis Report by Product (Cyclotron 10-12MeV, Cyclotron 16-18MeV, Cyclotron 19-24MeV, and Cyclotron above 24MeV), by Application (Medical, and Industrial), Forecast Period (2024-2031)
Published: Feb 2026
Cyclotron market is anticipated to grow at a CAGR of 11.2% during the forecast period (2023-2030). The market growth is attributed to factors such as the growing prevalence of cancer and the increasing use of diagnostic imaging procedures. According to the World Health Organization, cancer is a leading cause of death around the globe, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. In terms of new cases of cancer in 2020 included breast (2.26 million cases); lung (2.21 million cases); colon and rectum (1.93 million cases).
Optical Coherence Tomography Market Size, Share & Trends Analysis Report by Technology (Time Domain, Frequency Domain, Spatial Encoded Frequency Domain, and Fourier Domain), by Type (Catheter-based, Doppler, Handheld, and Tabletop), and by Application (Ophthalmology, Cardiovascular, Oncology, and Others) Forecast Period (2023-2030)
Published: Feb 2026
Optical coherence tomography (OCT) market is anticipated to grow at a CAGR of 12.2% during the forecast period (2023-2030). OCT is an imaging technique that uses light to create cross-sectional images of a material or object. It is analogous to ultrasound, which uses sound waves to create images. OCT is a non-invasive imaging technique, which means that it does not require any contact with the object being imaged. This makes it a valuable tool for imaging sensitive tissues, such as the retina of the eye.
Biomarker Clinical Phase Outsourcing Services Market Size, Share & Trends Analysis Report by Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers, and Surrogate Endpoints), by Therapeutic Area (Oncology, Cardiology, Neurology, and Autoimmune Diseases), and by End-Use (Pharmaceutical Companies and Biotechnology Companies), Forecast Period (2023-2030)
Published: Feb 2026
Biomarker clinical phase outsourcing services market is anticipated to grow at a CAGR of 21.3% during the forecast period (2023-2030). Significant factors including the increasing number of drug development processes, and the rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has led to an increased focus on biomarkers for early detection, disease monitoring, and treatment response assessment. World Health Organization (WHO) estimated 17.9 million lives every year.
Leadless Pacemakers Market Size, Share & Trends Analysis Report by Pacing Chamber (Single-chamber Pacemaker, Dual-chamber Pacemaker), By Product, (Micra Transcatheter Pacing System and Nanostim Leadless Pacemaker), by End-use (Hospitals, Ambulatory Surgical Centers, and Others), Forecast Period (2023-2030)
Published: Feb 2026
Leadless pacemakers market is anticipated to grow at a CAGR of 3.6% during the forecast period (2023-2030). One of the major factors are attributed to the market growth including the rising geriatric population, increasing prevalence of cardiovascular disease (CVDs), favorable government initiatives and policies, and the introduction of new and enhanced technological products. According to the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global mortalities.
Blood Processing Devices and Consumables Market Size, Share & Trends Analysis Report by Blood Processing Devices (Blood Bank Freezers, Blood Warmers, Blood Grouping Analyzers, Blood Bank Refrigerators, Hematocrit Centrifuges and Blood Cell Processors), and by Consumables (Blood Lancets, Vials, Microscopic Slides, Blood Bags, Blood Administration Sets, and Others), Forecast Period (2023-2030)
Published: Feb 2026
Blood processing devices and consumables market is anticipated to grow at a CAGR of 9.2% during the forecast period (2023-2030) owing to the rise burden of disorders requiring blood transfusion, increasing surgical procedures, as well as increasing geriatric population. The rising need for safe blood supply for surgeries or other transfusion procedures is shows market growth. To overcome the infections caused due to blood transfusions and blood donation, several blood processing machines and blood processing consumables are utilized to prevent infection.
Electrocardiography (ECG) Telemetry Devices Market Size, Share & Trends Analysis Report by Technology (Single Stage and Double Stage), by Absorber Type (Lithium Bromide and Ammonia), by Power Source (Direct Fired, Indirect Fired, and Water Driven), and by Application (Chemicals, Food & Beverages, Power, Paper & Pulp, power & energy and Others), Forecast Period (2025-2035)
Published: Feb 2026
Electrocardiography (ECG) telemetry devices market is anticipated to grow at a CAGR of 5.6% during the forecast period (2023-2030). The growing demand for technological advancements across the globe. The integration of ECG telemetry devices with IoT and mobile computing technology expands their reach and effectiveness, allowing for remote monitoring and data move in instantaneously. According to the MDPI, in February 2020, the World Health Organization (WHO) reported that cardiovascular diseases (
Whole Slide Imaging Market Size, Share & Trends Analysis Report by Technology (Scanners, IT Infrastructure, and ViewerImage Management System), by Application (Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others), and by End-User (Academic Institute, Hospitals and Healthcare Institutions, Pharmaceutical Research and Contract Research Organizations (CROs), and Others), Forecast Period (2023-2030)
Published: Feb 2026
Whole slide imaging market is anticipated to grow at a CAGR of 6.39 % during the forecast period (2023-2030). The market’s growth is attributed to the increased computer processing power across the globe. The development of powerful computers has made it possible to process and analyze enormous images generated by WSI scanners. Image analysis has grown more rapid and precise as a result of technology.
Telepsychiatry Market Size, Share & Trends Analysis Report by Product (In-Home Solutions, Forensic Solutions, Routine Solutions, and Crisis Solutions), by Age-Group (Pediatric, Adult, and Geriatric), by End-User (Community Mental Health Centers, Specialty Care Settings, Homecare, Operation Management, and Other (Skilled Nursing Facilities)) Forecast Period (2023-2030)
Published: Feb 2026
Telepsychiatry market is anticipated to grow at a considerable CAGR of 19.5% during the forecast period. The rising healthcare costs, technological innovations, increasing remote patient monitoring, and the rising mental disorders are driving the growth of the global market. According to the WHO, in 2019, 1 in every 8 people, or 970 million people around the world were living with a mental disorder, with anxiety and depressive disorders the most common.
Pupillometer Market Size, Share & Trends Analysis Report by Type (Digital, and Video), by Application (ophthalmology, neurology, oncology, and others) and by End User (Hospitals, Eye Clinics, and Others), Forecast Period (2023-2030)
Published: Feb 2026
Pupillometer market is anticipated to grow at a CAGR of 6.85% during the forecast period (2023-2030). The market’s growth is attributed to the growing demand in healthcare across the globe. In healthcare, it contains an increasing demand for reliable and efficient diagnostic tools, particularly in sectors such as ophthalmology, neurology, and critical care. The pupillometers are essential in diagnosing neurological diseases, brain traumas, and monitoring patients in critical care situations.
EConsent in Healthcare Market Size, Share & Trends Analysis Report by Enrollment Type (On-site, and Remote Consent), by Deployment Mode (Cloud-based, and Web-based) and by Form Type (General Consent, General Consent with Specific Denial(s), General Denial with Specific Consent(s), and General Denial), Forecast Period (2023-2030)
Published: Feb 2026
EConsent in Healthcare market is anticipated to grow at a CAGR of 9.90% during the forecast period (2023-2030). The market’s growth is attributed to the increased sponsor control. The addition of tiered license options and extra features in eConsent solutions offers sponsors more control and customization capabilities. This satisfies the desire for customized consent solutions based on the needs of the study.
Multiplex assays Market Size, Share & Trends Analysis Report by Type (Protein Multiplex Assays, Nucleic Acid-Based Multiplex Assays, and Cell-based Multiplex Assays), by Technology (Multiplex Real-Time PCR, Luminex Bead Technology, Flow Cytometry, and Others), and by End-User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations (CROs), Research and Academic Institutions, Others), Forecast Period (2023-2030)
Published: Feb 2026
Multiplex assays market is anticipated to grow at a CAGR of 14.8% during the forecast period (2023-2030). The market’s growth is attributed to the increasing advancements in immunotherapy. The increased use of immunotherapy, particularly chimeric antigen receptor (CAR) T cell therapy, for cancer treatment increases the need for accurate measurement and monitoring of CAR-T cells. Multiplex digital PCR assays satisfy the demand by delivering accurate, comprehensive analysis necessary for determining therapy success.
GMP Testing Service Market Size, Share & Trends Analysis Report by Technology (Single Stage and Double Stage), by Absorber Type (Lithium Bromide and Ammonia), by Power Source (Direct Fired, Indirect Fired, and Water Driven), and by Application (Chemicals, Food & Beverages, Power, Paper & Pulp, power & energy and Others), Forecast Period (2023-2030)
Published: Feb 2026
GMP testing service market is anticipated to grow at a CAGR of 6.7% during the forecast period (2023-2030). The market’s growth is attributed to growing healthcare preventive maintenance. GMP programs are a type of preventive healthcare that focuses on the early detection of growth problems in children. The requirement for GMP testing stems from the priority of ensuring the health and well-being of the next generation.
Autologous Wound Patches Market Size, Share & Trends Analysis Report by Type (Platelet Rich Plasma and Platelet Rich Fibrin), by Application (Acute Wound and Chronic Wound), and by End User (Hospitals, Clinics, and Ambulatory Surgical Centers), Forecast Period (2025-2035)
Published: Feb 2026
Autologous wound patches market was valued at $63.8 million in 2024 and is projected to reach $158.5 million by 2035, growing at a CAGR of 8.7% during the forecast period (2025-2035). Market expansion is primarily driven by growth and development in the increasing adoption of autologous remedies to increase regenerative therapy, individual wound care solutions, and treatment efficiency. Platelet-rich plasma (PRP) patches, bio-engineered skin options as substitutes, and stem cell-based dressing, such as demanding innovative wound care products to accelerate tissue regeneration, reducing the risk of infection. Certainly, integrating advanced biomaterials, point-of-care wound diagnostics, and AI-assisted wound monitoring systems is transforming the industry. These innovations help to solve major challenges, including chronic wound management, diabetes ulcers, and individual patient-specific treatments.
Patient Registry Software Market Size, Share & Trends Analysis Report by Type of Registry (Disease-Specific Registries, Health Service Registries, and Product Registries), by Type of Software (Stand-Alone Software, and Integrated Software), by Deployment (On-Premises, and Cloud), and by End-User (Hospitals and Health Systems, Government Organizations, and Third Party Administrators (TPAs), Pharmaceutical, Biotechnology, and Medical Device Companies, and Others) Forecast Period (2023-2030)
Published: Feb 2026
Patient registry software market is anticipated to grow at a CAGR of 8.6% during the forecast period (2023-2030). The market’s growth is attributed to patient-centered care across the globe. The inclusion of patient-reported outcome measures, in addition to the participation of patient advocacy groups, reflects an increasing tendency toward patient-centered care.
Legal Artificial intelligence (AI) Software Market Size, Share & Trends Analysis Report by Component (Solution and Services), by Deployment (On-Premise, and Cloud), by Application (Legal Research, Contract Review and Management, E-billing, E-discovery, Compliance, Case Prediction, and Others), and by End-User (Law Firms, Corporate Legal Departments, and Others), Forecast Period (2023-2030)
Published: Feb 2026
Legal AI software market is anticipated to grow at a CAGR of 36.8% during the forecast period (2023-2030). The market’s growth is attributed to balancing innovation and security. Copyright legislation has to strike a balance between supporting AI innovation and protecting content creators' rights. It needs to encourage AI development while maintaining creators' rights.
Healthcare Payer Services Market Size, Share & Trends Analysis Report by Services (Business Process Outsourcing (BPO) Services, Knowledge Process Outsourcing (KPO) Services, and Information Technology Outsourcing (ITO) Services), and by End-Use (Private Payers and Public Payers), Forecast Period (2023-2030)
Published: Feb 2026
Healthcare payer services market is anticipated to grow at a CAGR of 7.8% during the forecast period (2023-2030). The growth of this market is attributed to the rising need for cost-effective operations and the growth in demand for advanced supply chain management (SCM) practices, minimizing the overall cost of healthcare supply chain BPO services is likely to boost market growth during the forecast period.
Ostomy Care and Accessories Market Size, Share & Trends Analysis Report by Product (Bags and Accessories), by Surgery Type (Colostomy, Ileostomy, And Urostomy), by End-Use (Hospitals and Clinics, and Homecare), Forecast Period (2023-2030)
Published: Feb 2026
Ostomy care and accessories market is anticipated to grow at a CAGR of 6.3% during the forecast period (2023-2030). Pivotal factors attributed to market growth including the growing geriatric population, coupled with the increasing prevalence of colorectal cancer, high prevalence of bladder cancer, and technological advancements.
WealthTech Solutions Market Size, Share & Trends Analysis Report by Component (Solution, and Service), by Deployment Mode (On-Premise, and Cloud), by Enterprise Size (Large Enterprises, and Small and Medium-sized Enterprises), and by End-User (Banks, Wealth Management Firms, and Others), Forecast Period (2023-2030)
Published: Feb 2026
Wealthtech solutions market is anticipated to grow at a CAGR of 13.13% during the forecast period (2023-2030). The market’s growth is attributed to growing adoption of technology and digitization. India, such as several other countries, is experiencing rapid digitalization and technological adoption. Investors have been searching for digital solutions that enable easy access to wealth management services, that increases the demand for advanced digital platforms.
Cardiovascular Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, and Phase IV), by Study Design (Observational, Interventional, and Expanded Access), by Indication (Coronary Artery Disease, Acute Coronary Syndrome, Pulmonary Arterial Hypertension, Ischemic Heart Disease, Stroke, Heart Failure, and Others), Forecast Period (2023-2030)
Published: Feb 2026
Cardiovascular clinical trials market is anticipated to grow at a CAGR of 6.4% during the forecast period (2023-2030). Pivotal factors including the increasing prevalence of peripheral vascular diseases (PVDs) and coronary artery diseases (CAD). According to the World Health Organization, Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year.
Spinal Non-Fusion Technologies Market Size, Share & Trends Analysis Report by Product (Artificial Disc Replacement Device, Partial Disc (Nucleus) Replacement Device, Dynamic Stabilization Devices, Total Facet Replacement Devices, Annulus Repair Device, and Nuclear Arthroplasty Devices), and by End-user (Hospitals, Orthopedic Centers and Other), Forecast Period (2023-2030)
Published: Feb 2026
Spinal non-fusion technologies market is anticipated to grow at a CAGR of 7.2% during the forecast period (2023-2030). Spinal non-fusion technologies are a group of surgical and non-surgical procedures that are designed to treat spinal disorders without fusing the vertebrae. The market growth is driven by increasing cases of spinal injuries due to preventable causes such as road traffic crashes, falls or violence is creating demand for spinal non-fusion technologies.
Healthcare Claims Management Market Size, Share & Trends Analysis Report by Component (Software and Services), by Type (Integrated Solutions and Standalone Solutions), by Delivery mode (On-premise and Cloud-based), and End User (Healthcare Payers and Healthcare Providers) Forecast Period (2023-2030)
Published: Feb 2026
Healthcare Claims Management market is anticipated to grow at a CAGR of 5.2% during the forecast period (2023-2030). Healthcare claims management is the process of submitting and processing healthcare claims to payers, such as health insurance companies and government programs. Healthcare claims management solutions can help providers to streamline the claims process and improve their efficiency.
Paresthesia Treatment Market Size, Share & Trends Analysis Report by Type (Chronic Paresthesia, and Acute Paresthesia), by Treatment (Immunosuppressant, Anticonvulsants, Topical Creams, Antivirals, and Others), and by Distribution Channel (Online Retailers, Hospitals and Healthcare Facilities, Retail Pharmacy, and Others), Forecast Period (2023-2030)
Published: Feb 2026
Paresthesia treatment market is anticipated to grow at a CAGR of 3.6 % during the forecast period (2023-2030). The market’s growth is attributed to high rate of chronic pain across the globe. According to the Population Health Metrics, in November 2022, about 20.0% of individuals globally suffer from chronic pain that signify an enormous expense for the medical community. Numerous chronic pain conditions, including neuropathic pain linked to paresthesia, are prevalent in the aforementioned group.
High Level Disinfection Services Market Size, Share & Trends Analysis Report by Disease Type (Human immunodeficiency viruses (HIV), Tuberculosis (TB), Influenza, Hepatitis, Human papillomavirus (HPV) and Malaria), by End-Use (Hospitals, and Clinics), Forecast Period (2023-2030)
Published: Feb 2026
High level disinfection services market is anticipated to grow at a CAGR of 7.4% during the forecast period (2023-2030). Pivotal factors attributed to market growth including the increasing incidences of hospital-acquired infections (HAIs), the growing prevalence of infectious diseases, and the growing number of surgical procedures. HAIs are nosocomial infections that are more frequent in people undergoing long-term care, most notably surgical treatment. HAIs are most common in the elderly, infants, and patients with weakened immune systems. T
Healthcare Satellite Connectivity Market Size, Share & Trends Analysis Report, by Component (Medical Device, Software, and Research Diagnostic Analytic), by Application (Telemedicine, Clinical Operations, and Connected Imaging), by Connectivity (Mobile Satellite Research Diagnostic Analytic and Fixed Satellite Research Diagnostic Analytic), and by End-User (Clinical Research Organization (CRO), Hospitals & Clinics, and Research and Diagnostic Laboratories), Forecast Period (2023-2030)
Published: Feb 2026
Healthcare satellite connectivity market is anticipated to grow at a considerable CAGR of 6.5% during the forecast period. The cohesive government initiatives toward adopting healthcare satellite connectivity to drive the market growth. For instance, in March 2021, the Satellite telecommunications company and Luxembourg Government launched the second phase of the SATMED telemedicine project.
Geospatial Analytics Market Size, Share & Trends Analysis Report, by Type (Surface Analysis, Network Analysis, and Geo Visualization), and by End-User Industry (Agriculture, Utility and Communication, Defense and Intelligence, Government, and Natural Resources), Forecast Period (2023-2030)
Published: Feb 2026
Geospatial analytics market is anticipated to grow at a considerable CAGR of 8.5% during the forecast period. Geospatial analytics is used to add timing and location to traditional types of data and to build data visualizations. These visualizations can include maps, graphs, statistics and cartograms that show historical changes and current shifts. The ability of governments to utilize these analytics to map crime locations, issue alerts during natural disasters, and design effective disaster recovery mechanisms is a key factor driving the growth of the global market.
Bipolar Disorder Treatment Market Size, Share & Trends Analysis Report by Drug Class (Mood stabilizer, Anticonvulsant, Antipsychotic Drug, Antidepressant Drug, and Other), and by Distribution Channel (Hospitals and Clinics, Retail Pharmacies, and Online Pharmacies) Forecast Period (2023-2030)
Published: Feb 2026
Bipolar disorder treatment market is anticipated to grow at a CAGR of 2.6% during the forecast period owing to the rising prevalence of bipolar disorder, along with the rising awareness about mental health. Other factors, such as increased government initiatives and increased demand for innovative treatment choices, are likely to boost market expansion. Additionally, advancements in technology have also played a significant role in the growth of the bipolar disorder treatment market.
Healthcare Supply Chain Management Market Size, Share & Trends Analysis Report, by Component (Solution, and Services), by Deployment Model (On-Premises, and Cloud-Based), and by End-User (Healthcare Providers, Healthcare Manufacturers, and Other), Forecast Period (2023-2030)
Published: Feb 2026
Healthcare supply chain management market is anticipated to grow at a considerable CAGR of 8.5% during the forecast period. The increasing pressure faced by healthcare providers to improve operational profitability and efficiency along with the growing adoption of the GS1 system of standards in various countries is a key factor driving the growth of the global healthcare supply chain management market.
Dental Computer Aided Design (CAD) Market Size, Share & Trends Analysis Report, by Component (Scanners, Milling Machines, Software, and Other Components), and by Application (Dental Prosthesis and Dental Implants), Forecast Period (2023-2030)
Published: Feb 2026
Dental CAD market is anticipated to grow at a significant CAGR of 7.5% during the forecast period. The increasing burden of oral diseases and oral cancer, globally, is the major factor driving the growth of the dental CAD market. For instance, according to the World Health Organization (WHO) update in March 2022, 3.5 billion people are estimated to have oral diseases across the globe. In addition, rising product launches in the dental CAD industry are further expected to drive the market growth, due to the rise in adoption.
Mobile Clinics Market Size, Share & Trends Analysis Report by Clinic Type (Maternal Health, ICU and Surgery, Infant and Neonatal Health, Geriatric Care, Diagnostic/screening, and Others), by Vehicle Type (Mobile Medical Vans, Mobile Medical Bus, and Others), and by Design Layout (Single Exam Room, Double Exam Room, and Triple Exam Room), Forecast Period (2023-2030)
Published: Feb 2026
Mobile clinics market is anticipated to grow at a significant CAGR of 11.5% during the forecast period. The growing prevalence of chronic disorder, emerging demand for emergency care units, along with growing technological advancements in mobile clinics is a key factor driving the growth of the global mobile clinics market. The United Nations (UN) Sustainable Development Goal 3, or SDG 3, declared a universal health goal to “ensure healthy lives and promote well-being for all at all ages” by 2030.
Artificial Intelligence (AI) in Mental Health Market Size, Share & Trends Analysis Report by Technology (Machine Learning and Deep Learning, Natural Language Processing (NLP)), by Application (Conversational Interfaces, Patient Behavioral Pattern Recognition), and by Component (Software-as-a-Service (SaaS), Hardware), Forecast Period (2025-2035)
Published: Feb 2026
Artificial intelligence (AI) in mental health market was valued at $1.3 billion in 2024 and is projected to reach $15.1 billion by 2035, growing at a CAGR of 24.3% during the forecast period (2025-2035). Artificial Intelligence (AI) is leading the charge in mental health as it can improve diagnostics, tailor treatment, and increase accessibility. Chatbots and virtual therapists powered by AI offer instant help, lightening the load for healthcare professionals. Machine learning algorithms process patient data to identify early warning signs of mental illness, allowing intervention before it gets serious.
Healthcare Mobility Solutions Market Size, Share & Trends Analysis Report, by Products and Services (Enterprise Mobility Platforms, Mobile Applications, Mobile Devices), by Application (Enterprise Solutions, mHealth Applications), by End-User (Payers, Providers, Patients), Forecast Period (2023-2030)
Published: Feb 2026
Healthcare mobility solutions market is anticipated to grow at a significant CAGR of 21.0% during the forecast period. The increasing demand for quality care delivery in the healthcare system is a key factor driving the global market. The offered benefits of mobility solutions such as enhanced clinical collaborations and improved health outcomes are further driving the market growth.
Virtual Clinical Trials Market Size, Share & Trends Analysis Report by Study Design (Observational, Interventional, and Expanded Access), and by Indication (Cardiovascular Diseases (CVDs), Oncology, and Others) Forecast Period (2023-2030)
Published: Feb 2026
Virtual clinical trials market is anticipated to grow at a considerable CAGR of 8.5% during the forecast period. The rise in R&D activities, increasing healthcare digitization, as well as the adoption of telehealth are the key factors driving the growth of the global market. The alliances between clinical research organizations, pharmaceutical, and biotechnology companies as well as cohesive government initiatives are further contributing to the market development.
Hospice Services Market Size, Share & Trends Analysis Report by Services (Nursing Services, Medical Equipment and Supplies, Counseling Services, Short Term Inpatient Services, Physician Services, and Others), by Care Type (Acute Care and Respite Care), and by End-User (Home Settings, Hospitals, Specialty Nursing Homes, Hospice Care Centers, and others) Forecast Period (2023-2030)
Published: Feb 2026
Hospice services market is anticipated to grow at a CAGR of 9.10% during the forecast period (2023-2030). The market’s growth is attributed to number of chronic conditions seeking palliative care. Palliative care is necessary for a wide variety of chronic disorders and is additionally required for a limited number of diseases. Cardiovascular conditions, cancer, long-term respiratory conditions, HIV/ AIDS, diabetes, and other conditions can be among problems.
Digital Dentistry Market Size, Share & Trends Analysis Report by Type (Instruments, and Consumables), and by End-Users (Hospitals, Dental Clinics, and Dental Laboratories) Forecast Period (2023-2030)
Published: Feb 2026
Digital dentistry market is anticipated to grow at a significant CAGR of 8.5% during the forecast period. The increasing burden of oral diseases and oral cancer, globally, along with the rising integration of advanced technologies for its treatment is the major factor driving the growth of the digital dentistry market. For instance, according to the WHO update in March 2022, 3.5 billion people are estimated to have oral diseases across the globe.
Teleradiology Software Market Size, Share & Trends Analysis Report by Type (Radiology Information System, Picture Archive & Communication System, and Vendor Neutral Archive), and by Deployment Mode (On-Premise and Cloud-Based), Forecast Period (2023-2030)
Published: Feb 2026
Teleradiology software market is anticipated to grow at a significant CAGR of 7.5% during the forecast period. The increasing availability of more affordable and faster wireless data transfer, mass storage options, and broadband cellular technology has driven the growth of the global teleradiology software market. The rising prevalence of chronic disorders coupled with the rising healthcare expenditure has further increasing its adoption, globally.
Retinal Disorder Treatment Market Size, Share & Trends Analysis Report by Indication (Diabetic Retinopathy, Macular Degeneration, Retinal Detachment, Retinoblastoma and Other), by Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye Drops and Ointments), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Sales), Forecast Period (2023-2030)
Published: Feb 2026
Retinal disorder treatment market is anticipated to grow at a CAGR of 11.2% during the forecast period (2023-2030). Treating the main retinal diseases in the everlasting war against blindness and its associated morbidity has been growing steadily over the last two decades. The growing adoption of macular degeneration treatment for retinal disorder key factor supporting the growth of the market globally.
Computer Vision in Healthcare Market Size, Share & Trends Analysis Report by Type (Hardware, Software, and Services), by Application (Medical Imaging & Diagnostics, Surgeries, Patient Monitoring, and Others), and by End User (Healthcare Providers, Diagnostic Centers, Academic Research Institutes, and Others) Forecast Period (2023-2030)
Published: Feb 2026
Computer vision in the healthcare market is anticipated to grow at a CAGR of 43.2% during the forecast period (2023-2030). Computer vision has a wide range of applications in healthcare such as diagnostic imaging, pathology, surgical procedures, patient monitoring, drug discovery, and telemedicine, among others. Usage of computer vision reduces the chances of errors and improves speed, and accuracy of disease diagnosis, surgical interventions, and remote patient assessments, ultimately leading to enhanced healthcare outcomes.
Big Data in Healthcare Market Size, Share & Trends Analysis Report, by Portal (Integrated Big data in healthcare and Standalone Big data in healthcare), Deployment Mode (Cloud-based and Web-based), End-User (Hospitals and Clinics, Pharmacies), Forecast Period (2023-2030)
Published: Feb 2026
Big data in healthcare market is anticipated to grow at a significant CAGR of 15.5% during the forecast period. The rise in the number of healthcare facilities adopting big data in healthcare to generate revenues has driven the global market. Moreover, the increasing demand for Electronic Health Records (EHR) and mandatory federal norms are responsible for the increased usage of big data analytics in healthcares.
Surgical Dressing Market Size, Share & Trends Analysis Report by Type (Collagen Dressings, Transparent Film Dressings, Alginate Dressings, Foam Dressings, Gauze Dressings, Silver Dressings, and Others), by Application (Cardiovascular Diseases (CVD), Diabetes Based Surgeries, Transplant Sites, Ulcers, and Burns), and by End-User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Home Healthcare) Forecast Period (2023-2030)
Published: Feb 2026
Surgical dressing market is anticipated to grow at a CAGR of 6.4% during the forecast period (2023-2030). The prevalence of chronic wounds, such as venous leg ulcers, pressure ulcers, and diabetic foot ulcers, is increasing challenges to wound care professionals, having a considerable impact on the growth of the surgical dressing industry.
Healthcare Interoperability Market Size, Share & Trends Analysis Report, by Level (Foundational, Structural, and Semantic), Type (Solutions and Services), End-User (Healthcare Providers, Healthcare Payers, and Pharmacies), Forecast Period (2022-2030)
Published: Feb 2026
Healthcare interoperability market is anticipated to grow at a significant CAGR of 10.5% during the forecast period. The rise in the number of healthcare facilities adopting healthcare interoperability solutions has driving the global market. Also, increasing demand for Electronic Health Records (EHR) and mandatory federal norms are responsible for the increased usage of healthcare interoperability.
Nipah Virus Infection Testing Market Size, Share & Trends Analysis Report By Test (RT PCR Based Kits, and ELISA Kits), By Sample (Blood Serum or Plasma, Saliva and Throat Swabs, Urine, and Others), By End-User (Hospitals, Research Institutions, Diagnostic Centers, and Others), Forecast Period (2023-2030)
Published: Feb 2026
Nipah virus infection testing market is anticipated to grow at a CAGR of 4.8% during the forecast period (2023-2030). The market’s growth is attributed to the growing incidence of Nipah virus infection across the globe. NiV can be passed from infected animals (such as pigs or bats) or their bodily fluids to individuals through contact. It involves fluids including blood, urine, and saliva. According to the National Institute of Health, in March 2023, Encephalitis and NiV infection are connected (inflammation of the brain).
Healthcare Content Management System Market Size, Share & Trends Analysis Report, by Solution (Document Management, Web Content Management, Data Records, and Other (Social Media Management), by End-User (Hospitals & Clinics, Ambulatory Surgical Centers), Forecast Period (2022-2030)
Published: Feb 2026
Healthcare content management system market is anticipated to grow at a significant CAGR of 12.0% during the forecast period. The growing adoption of healthcare content management systems to manage a huge influx of data for efficient management of operational resources is a key factor driving the growth of the global market. The increasing investment from the life science & healthcare industry, exponential increase in healthcare data, and increasing emerging cloud and other solutions have been further contributing to the market growth.
Advanced Visualization Market Size, Share & Trends Analysis Report, by Product and Service (Hardware, Software, and Services), Solution Type (Enterprise and Standalone), Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, Nuclear Medicine, and Other Imaging Modalities), Clinical Application (Oncology, Orthopedics, Cardiovascular, Neurology, and Other Clinical Applications (Dental), Forecast Period (2025-2035)
Published: Feb 2026
Advanced visualization market was valued at $3.7 billion in 2024 and is projected to reach $11.8 billion by 2035, growing at a CAGR of 11.1% during the forecast period (2025-2035). The market growth is driven by increasing demand for healthcare and technology such as diagnostic imaging, surgical planning, and navigation, patient education and communication, drug discovery and development, &technology product design & engineering, & data analysis, business intelligence, virtual and augmented reality (VR/AR), scientific research, and geographic information systems (GIS).
Tele Intensive Care Unit (ICU) Market Size, Share & Trends Analysis Report by Component (Hardware, and Software and Services), by Management Type (Intensivist, Open, Co-managed, Open with Consultants, and Others) Forecast Period (2023-2030)
Published: Feb 2026
Tele ICU market is anticipated to grow at a significant CAGR of 18.5% during the forecast period. An increase in the volume of surgical procedures globally along with the increasing demand for remote patient monitoring are anticipated to drive market growth. The advantages offered by tele-ICU such as the low-cost method of connecting intensivists with hospitals, earlier interventions for critically ill patients, are further increasing their adoption.
Patient Portal Market Size, Share & Trends Analysis Report by Portal (Integrated Patient Portal and Standalone Patient Portal), by Deployment Mode (Cloud-Based and Web-Based), and by End-User (Hospitals & Clinics, and Pharmacies) Forecast Period (2023-2030)
Published: Feb 2026
Patient portal market is anticipated to grow at a significant CAGR of 18.5% during the forecast period. The rise in the number of healthcare facilities adopting patient portals has driving the global market. Also, increasing demand for Electronic Health Records (EHR) and mandatory federal norms are responsible for the increased usage of patient portals.
Medical Devices Connectivity Market Size, Share & Trends Analysis Report, By Component (Solution, Services) By Technology (Wired, Wireless, Hybrid), By End-User (Hospitals, Ambulatory Care Centers, Other), Forecast Period (2022-2030)
Published: Feb 2026
Medical devices connectivity market is anticipated to grow at a significant CAGR of 18.5% during the forecast period. The growing digitalization of healthcare infrastructure, high integration of IoT medical devices in healthcare settings, and high demand for connected medical devices is a key factor driving the growth of the global medical devices connectivity market. The rising implementation of EHRs and health information exchange systems along with the high demand for telemedicine technologies is further contributing to the market growth.
Medical Automation Market Size, Share & Trends Analysis Report by Application Diagnosis & Monitoring Automation, Therapeutic Automation, Lab & Pharmacy Automation and Medical Logistics & Training), by End Users (Hospitals, Diagnostic Centers, Pharmacies, Research Labs and Institutes, Ambulatory Surgical Centers and Others), Forecast Period (2023-2030)
Published: Feb 2026
Medical automation market is anticipated to grow at a CAGR of 13.7% during the forecast period (2023-2030). Medical automation helps improve patient outcomes by supporting technological advancements, making processes more efficient and effective. The key factors driving the market are the adoption of automated instruments by drug discovery departments of pharmaceutical companies, the rise in need for miniaturization, and technological advancements coupled with the rise in demand for robot-assisted surgeries.
Virtual Reality (VR) in Healthcare Market Size, Share, and Trends Analysis Report By Component (Hardware, Software, and Services), By Application (Training and Education, Surgery, Diagnostics, Pain management, Mental health), and by end-user (Hospitals and Clinics, Research institutions and others (Medical Schools and Universities, Pharmaceutical Companies), Forecast Period (2023-2030)
Published: Feb 2026
Virtual Reality (VR) market in healthcare is anticipated to grow at a CAGR of 35.3% during the forecast period (2023-2030). Growing regulatory support, increasing adoption of VR-based medical education and training, rapid technological advancements in VR technology, and growing affordability and access to healthcare are driving market demand for VR in the healthcare sector.
5G in Healthcare Market Size, Share & Trends Analysis Report by Component (Hardware, and Services), and by Application (Connected Medical Devices, Remote Patient Monitoring, Augmented Reality (AR)/ Virtual Reality (VR), Connected Ambulance, and Asset Tracking), Forecast Period (2024-2035)
Published: Feb 2026
5G in healthcare market is anticipated to grow at a CAGR of 52.2% during the forecast period (2024-2035). The market growth is driven by greater usage of robotic surgery and telemedicine, as well as advancements in communications and 5G technologies. Healthcare firms are increasingly adopting 5G technology, owing to the development of 5G-enabled wearable medical devices, faster transfer of large patient data files over 5G, and the availability of reasonably priced sensors. Furthermore, the increase is being driven by partnerships between governments and big business players to integrate 5G in healthcare after the impact of COVID-19. Mr. Alo Libang, the Health Minister of Itanagar, India, launched the 5G applications in the Northeast Region (NER) in June 2023, with its hub in Guwahati (Assam), at the Government College of Nursing (GCN), Bakin Pertin General Hospital (BPGH), and the College of Agriculture (CoA) in Pasighat, East Siang.
Newborn Screening Market Size, Share & Trends Analysis Report by Technology (Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry (LC-MS/MS), Pulse Oximetry, DNA Microarrays and Next-Generation Sequencing (NGS), Enzyme Based Assays, and Others), by Test Type (Blood Spot Screening, Hearing Screening, Pulse Oximetry Screening, Critical Congenital Heart Defect (CCHD), and Others), and by End-User (Hospitals and Birthing Centers, Neonatal Intensive Care Units (NICUs), Diagnostic Centers, Researchers and Scientists, and Others) Forecast Period (2023-2030)
Published: Feb 2026
Newborn screening market is anticipated to grow at a CAGR of 7.8% during the forecast period (2023-2030). The market’s growth is attributed to early intervention. Early intervention has become more and more essential in healthcare to enhance patient outcomes. Modern technologies help to achieve the essential goal of newborn screening. Accordingly, market players are coming up with new products to cater to the demand for new screening devices.
Internet-of-Things (IoT) in Healthcare Market Size, Share & Trends Analysis Report by Component (Medical Devices, Software & Solutions, and Services), by Application (Inpatient Monitoring, Telemedicine, Connected Imaging, and Drug Development), and by End-User (Healthcare Providers, and Research Laboratories) Forecast Period (2023-2030)
Published: Feb 2026
IoT in healthcare market is anticipated to grow at a considerable CAGR of 24.3% during the forecast period. The growth of the market is attributed to factors such as the rapidly growing penetration of smartphones, growing internet penetration, rising demand for remote patient monitoring, fueling the growth of IoT in healthcare market. According to the International Telecommunication Union (ITU) estimated that approximately 5.4 billion people or 67% of the world’s population are using the Internet in 2023.
Microbiology Testing Market Size, Share & Trends Analysis Report by Product (Equipment, Reagents, and Others), by Test Type (Bacterial, Viral, and Fungal), and by Application (Pharmaceutical, Diagnostic, Food and Beverage Testing, Environmental, Cosmetic, and Others), Forecast Period (2025-2035)
Published: Feb 2026
Microbiology testing market was valued at $18.5 billion in 2024 and is projected to reach $44.5 billion by 2035, growing at a CAGR of 8.4% during the forecast period (2025-2035). Increased awareness of infectious diseases and food regulations is driving up demand in the microbiology testing industry. Improved diagnostic techniques with faster and more accurate testing are taking place. Pharmaceutical companies are investing more in microbiological quality control as a result of tighter sterile manufacturing and microbiological standards. Routine microbial testing is more necessary owing to the increase in hospital-acquired infections. In agriculture, testing is being used to identify pathogens and assess the crop fit for produce.
Healthcare Predictive Analytics Market Size, Share & Trends Analysis Report, By Component (Software, Services), By Deployment Model (Cloud Based, On-premises), By Application (Clinical Data Analytics, Financial Data Analytics, Research Data Analytics, Operations Management, and Others), Forecast Period (2023-2030)
Published: Feb 2026
Healthcare predictive analytics market is anticipated to grow at a significant CAGR of 25.5% during the forecast period. Healthcare predictive analytics support healthcare organizations, hospitals, and doctors to access, analyze, and process patient data to provide data-based quality care, accurate diagnosis, and personalized treatments. In August 2023, a survey conducted by the Healthcare Information and Management Systems Society (HIMSS) and healthcare data analytics company Arcadia about the current state of healthcare analytics platforms demonstrates that less than 60 percent of health systems’ data is used to inform intelligent business decisions.
Medical Imaging Workstation Market Size, Share & Trends Analysis Report, By Component (Visualization Software, Display Units, Others) By Modality (Computed Tomography (CT), Magnetic Resonance Imaging, Ultrasound, Mammography, Others), By Usage Mode (Thick Client Workstation, Thin Client Workstation), Forecast Period (2022-2030)
Published: Feb 2026
Medical imaging workstation market is anticipated to grow at a CAGR of 5.5% during the forecast period. The ongoing technological advancements in imaging systems that require sophisticated operating units and workstations for smooth operation are key factors driving the growth of the global medical imaging workstation market. The rising prevalence of chronic disorders coupled with the rising healthcare expenditure is driving the global market.
Preclinical Imaging Market Size, Share & Trends Analysis Report by Product (MicroCT (Micro Computed Tomography), MRI (Magnetic Resonance Imaging), PET (Positron Emission Tomography), Ultrasound Imaging, Optical Imaging, Photoacoustic Imaging, and Others), by Application (Pharma and Biotech Companies, Research and Development, Neurology and Neuroscience, and Others), and by End-User (Pharma and Biotech Companies, Academic and Research Institutions, Hospitals and Medical Centers, Government Research Agencies, and Others) Forecast Period (2023-2030)
Published: Feb 2026
Preclinical imaging market is anticipated to grow at a CAGR of 6.82% during the forecast period (2023-2030). The market’s growth is attributed to enhancement of sensitivity and resolution. High-field MRI systems improve the sensitivity and resolution of scans, enabling researchers to detect and analyze delicate structural and functional modifications in animal models. This higher level of sensitivity and resolution is important for accurately modeling diseases and evaluating potential drug candidates. Accordingly market players are coming up with new products to cater the demand for new MRI devices.
Cannabidiol oil Market Size, Share & Trends Analysis Report Market, By Product Type (Marijuana Based, Hemp Based), By Application (Multiple Sclerosis, Depression and Sleep Disorders, Neurological Pain, Other Application) Forecast Period (2023-2030)
Published: Feb 2026
Cannabidiol oil market is anticipated to grow at a considerable CAGR of 16.3% during the forecast period. The increased awareness about the benefits of cannabidiol and its medicinal properties has driven its demand; which in turn driving the growth of the global cannabidiol oil. Additional, the high adoption of hemp oil in pharmaceutical industries as it reduces the body pain is a positive sign is further contributing to the market growth.
Animal Wound Care Market Size, Share & Trends Analysis by Product Type (Surgical, Advanced, Traditional, and Other Products), and by Animal Type (Companion Animals, and Livestock) Forecast Period (2025-2035)
Published: Feb 2026
Animal wound care market is projected to grow at a CAGR of 6.0% during the predicted period (2025-2035). The market for animal wound care covers the production, distribution, and application of wound care products, that are used after an animal is stabilized from trauma or shock. Rising awareness among pet owners about the importance of proper medical care has significantly boosted demand for these products, thereby driving market growth. Also, government programs and initiatives by animal welfare agencies to enhance animal healthcare have been prominent drivers of the growth in the global animal wound care market. Further, increasing adoption rates and increasing focus on veterinary care further reinforce market growth. Awareness campaigns have expanded marketing opportunities for companies by boosting adoption rates, prompting innovation in veterinary products, and intensifying competition to provide superior animal care solutions.
Scanning Electron Microscopes Market Size, Share & Trends Analysis Report by Type (Scanning Electron Microscope (SEM), Transmission Electron Microscope (TEM), Variable Pressure SEM, and Environmental SEM (ESEM)), by Application (Material Science, Nanotechnology, Life Science, Semiconductors, and Others), and by End-User (Industrial and Manufacturing Sector, Healthcare, Research Institute, and Others) Forecast Period (2023-2030)
Published: Feb 2026
Scanning electron microscopes market is anticipated to grow at a CAGR of 8.3% during the forecast period (2023-2030). The market’s growth is attributed to rise in research activities across the globe. The need for SEMs has been driven by expanding research initiatives across a range of sciences. For their studies, scientists and researchers demand superior imaging and analytic equipment. Accordingly market players are coming up with new products to cater the demand for scanning electron microscope.
Salmonella Testing and Treatment Market Size, Share & Trends Analysis Report by Testing Method (Culture-based Methods, Molecular-based Methods, and Immunoassays), by Sample Type (Food, Water, and Environmental Surfaces), and by Application (Clinical Diagnostics, Food Safety Testing, and Veterinary Diagnostics) Forecast Period (2023-2030)
Published: Feb 2026
Salmonella testing and treatment market is anticipated to grow at a CAGR of 7.5% during the forecast period (2023-2030). Salmonella is a bacterial disease that affects the intestinal tract. Salmonella bacteria typically live in animal and human intestines and are shed through stool (feces). Humans become infected most frequently through polluted water or food. The increasing number of patients suffering from food infection is the primary factor supporting the market growth. According to the Department of Agriculture, Environment and Rural Affairs, over 2,500 strains (serovars) of Salmonella are known most of which rarely cause disease.
Healthcare IT Solution Market Size, Share & Trends Analysis Report by Solution (Clinical Solutions (Electronic Health Records (EHR), Population Health Management Solutions, Mobile Health Applications, Telehealth Solutions, Laboratory Information System, Computerized Physician Order Entry (CPOE) Systems, and Others), and Non-Clinical Solutions (Revenue Cycle Management, Customer Relationship Management Solutions, Healthcare Interoperability Solutions, Supply Chain Management Solutions, and Others)), and by End-User (Healthcare Providers (Hospitals & ASCs, Diagnostic Imaging Centers, Pharmacies, and Others), and Healthcare Payers (Private Payers, and Public Payers) Forecast Period (2025-2035)
Published: Feb 2026
Healthcare IT solution market was valued at $380 billion in 2024 and is projected to reach $1,791 billion by 2035, growing at a CAGR of 15.1% during the forecast period (2025- 2035). The global healthcare IT solutions market is growing rapidly, led by companies such as Cerner and Epic Systems that are helping hospitals and clinics to shift toward digital platforms such as EHR, telemedicine, and cloud analytics. Central to this transformation are advanced tools, including real-time AI for clinical decision support, device-to-record connectivity, and advanced data-sharing systems designed to improve care quality and operational efficiency. Increasingly, healthcare organizations are seeking secure cloud infrastructure and seamless integration to support remote monitoring, mobile health apps, and patient engagement solutions, aligning with the rising wave of digital health demand. The strongest growth opportunities lie in telehealth, which is experiencing unprecedented adoption, as well as in high-adoption regions such as North America and Asia-Pacific. Overall, the market is moving steadily toward a more connected, personalized, and data-driven healthcare ecosystem that empowers providers to deliver improved outcomes to an increasingly tech-savvy population.
Cervical Dystonia Treatment Market Size, Share & Trends Analysis Report Market by Drug Type (Botulinum toxin, Anticholinergic agents, Dopaminergic agents, and others), by Application (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), and by End-User (Hospitals, Clinics, and Others) Forecast Period (2023-2030)
Published: Feb 2026
Cervical dystonia treatment market is anticipated to grow at a considerable CAGR of 7.8% during the forecast period. Cervical dystonia is a neurological disorder that causes the muscles in the neck to contract involuntarily. This can cause the head to lean or twist to one side, or the chin to pull up, down, forward, or backward. Primary factor propelling the market growth includes the increasing prevalence of cervical dystonia.
Apheresis Market Size, Share & Trends Analysis Report by Product (Apheresis Disposables, Apheresis Devices), by Procedure (Automated blood collection, Therapeutic Apheresis), and by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) Forecast Period (2025-2035)
Published: Feb 2026
Apheresis market is projected to grow by a CAGR of 8.6%. The market is growing owing to the unexpected rise in the demand for plasma-derived products. As the prevalence of chronic disorders increases, the advancement in healthcare technology increases, this advancement boosts the market opportunities and growth. Diseases such as sickle cell anemia and other hemoglobinopathies can be treated with the aid of these technologies. Additionally, as apheresis helps with blood filtration and purification, it has been utilized in a variety of medical treatments for ailments such as cancer, diabetes, arthritis, and renal diseases. Accordingly, market players are coming up with new products to cater to the demand for automated red blood cell exchange treatment.
Multi-Wall Carbon Nanotube Market Size, Share & Trends Analysis Report Market by Application (Electronics, Energy, Materials, and Others) Forecast Period (2023-2030)
Published: Feb 2026
Multi-wall carbon nanotube market is anticipated to grow at a considerable CAGR of 12.2% during the forecast period. Multi-walled carbon nanotubes (MWCNTs) are a composite structure of concentrically layered carbon nanotubes nested in each other. They are made up of two or more nested single-wall carbon nanotubes. MWCNTs are used in a variety of energy applications, such as batteries, solar cells, and fuel cells. MWCNTs can be used to develop more efficient and durable energy storage and conversion devices.
Surgical Sutures Market Size, Share & Trends Analysis Report by Product Type (Absorbable Sutures, Natural Sutures, Synthetic Sutures, Non-absorbable Sutures, Nylon, Prolene, and Others), by Application (Ophthalmic Surgery, Cardiovascular Surgery, Orthopedic Surgery, Neurology Surgery, and Others), and by End-User (Hospitals and Clinics, Ambulatory Surgical Centers, and Clinics and Physician Offices), Forecast Period (2023-2030)
Published: Feb 2026
Surgical Sutures market is anticipated to grow at a CAGR of 5.8% during the forecast period (2023-2030). Doctors use sutures to treat wounds and lacerations. The market’s growth is attributed to growing demand for technological advancements such as suture anchor system, and citregenTM. Suture anchor systems are employed during orthopedic and soft tissue procedures, especially when a secure and reliable bond amongst the soft tissue and the bone is required.
Superabsorbent Dressings Market Size, Share & Trends Analysis Report by Type (Non-Adhering Dressings, and Self-Adhering Dressings), and by Application (Hospitals, Clinics, Homecare, and Others), Forecast Period (2023-2030)
Published: Feb 2026
Superabsorbent Dressings market is anticipated to grow at a CAGR of 4.5% during the forecast period (2023-2030). The growth of the market is attributed to growing demand for advancements in wond care technology across the globe. The system can contain innovative superabsorbent dressings or wound dressings with unique capabilities to speed up healing and efficiently manage exudate. In March 2023, Vaporox received clearance from the US Food and Drug Administration for its next-generation VHT-200 medical device system for healing chronic wounds, which are wounds that do not respond to conventional wound treatment.
Mental Health Service Market Size, Share & Trends Analysis Report by Disorder (Schizophrenia, Alcohol Use Disorders, Bipolar Disorder, Depression, Anxiety, Post-Traumatic Stress Disorder, and Others), by Service (Emergency Mental Health Services, Outpatient Counselling, Home-Based Treatment Services, Inpatient Hospital Treatment Services and Other Services), and by Age Group (Pediatric, Adult and Geriatric), Forecast Period (2023-2030)
Published: Feb 2026
Mental health service market is anticipated to grow at a CAGR of 7.5% during the forecast period (2023-2030). Rising utilization of mental health service apps owing to their benefits in improving treatment outcomes and lifestyle and increasing awareness regarding mental health as a significant health condition are some of the major factors boosting the market growth. Mental health disorders are usually associated with distress or impairment in important areas of functioning.
Orthopedic Implants Market Size, Share & Trends Analysis Report by Product Type (Reconstructive Joint Replacements, Spinal Implants, Dental Implants, Trauma, Orthobiologics, and Others), by Biomaterial (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, and Others), and by Type (Knee, Hip, Wrist and Shoulder, Dental, Spine, and Others) Forecast Period (2023-2030)
Published: Feb 2026
Orthopedic implants market is anticipated to grow at a considerable CAGR of 5.0% during the forecast period. The growth of the market is attributed to factors such as an increasing aging population, rising prevalence of orthopedic conditions, advancements in medical technologies, and a growing number of orthopedic surgeries. Further, the demand for better quality of life and the adoption of minimally invasive surgical procedures are some of the factors anticipated to fuel the demand for Orthopedic Implants.
Dental Polishing Machine Market Size, Share & Trends Analysis Report by Filling Material (Instrument Polishers, Disposable Polishers, and Paste Polishers), and by End-User (Hospitals, Dental Clinics, and Academic & Research Institutes), Forecast Period (2023-2030)
Published: Feb 2026
Dental polishing machine market is anticipated to grow at a CAGR of 5.3% during the forecast period (2023-2030). The growth of the market’s is attributed to growing demand for new technological advances such as, dental laboratories that need to automate their polishing processes for a very low investment and obtain high-quality, consistent results in a single 20-minute phase can employ such a small solution.
RFID in Healthcare Market Size, Share & Trends Analysis Report by Product (Systems and Software, Tags), by Application (Blood Tracking, Patient Tracking, Pharmaceutical Tracking, Asset Tracking), and by End-Users (Hospitals and Clinics, Pharmaceutical), Forecast Period (2023-2030)
Published: Feb 2026
RFID in healthcare market is anticipated to grow at a CAGR of 15.2% during the forecast period (2023-2030). Inventory management in pharmacies, hospitals, and biotech firms and also improved patient security by healthcare providers are the driving factor for the growth of Improvement RFID in the Healthcare market. According to the UPS Healthcare Supply Chain Vital Signs US Hospitals Study, The operating room accounts for between 40.0% to 60.0% percent of a hospital's overall supply spending.
Eyelid Surgery Market Size, Share & Trends Analysis Report by Procedure Type (Upper Eyelid Surgery, Lower Eyelid Surgery) and by End User (Clinics & Surgery Centers, Hospitals) Forecast Period (2023-2030)
Published: Feb 2026
Eyelid surgery market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period. The growth of the market is attributed to factors such as the increasing aesthetic concerns, rising demand for cosmetic procedures, and advancements in surgical techniques. Further, the aging population and growing awareness about the benefits of eyelid surgery are some of the factors anticipated to fuel the demand for Eyelid Surgery.
X-ray Machine Manufacturing Market Size, Share & Trends Analysis Report by Product Type (Stationery, and Portable), by Technology (Analog, and Digital), and by End-User (Healthcare, Transportation and logistics, Governments, and Others), Forecast Period (2023-2030)
Published: Feb 2026
X-ray machine manufacturing market is anticipated to grow at a CAGR of 2.3% during the forecast period (2023-2030). The market’s growth is attributed to growing demand for point-of-care imaging. Rapid diagnostic point-of-care imaging systems are in higher demand. By implementing imaging capabilities right next to the patient, mobile X-Ray devices satisfy the requirements. Accordingly market players are coming up with new products to cater the demand for mobile x-ray systems.
Tumor Tracking Systems Market Size, Share & Trends Analysis Report by Application (Prostate Cancer, Gastric Cancer, Lung Cancer, Breast Cancer, and Others), and by End User (Hospitals, Radiotherapy Centers, Cancer Research Institutes, and Others), Forecast Period (2023-2030)
Published: Feb 2026
Tumor tracking systems market is anticipated to grow at a CAGR of 4.9% during the forecast period (2023–2030). The growth of the market is attributed to the growing development of digital pathology. Modern healthcare is incorporating more digital pathology technologies, such as sophisticated staining platforms such as Benchmark Ultra Plus. They enhance the overall diagnostic process by enabling remote cooperation, data storage, and analysis.
Orthopedic biomaterial Market Size, Share & Trends Analysis Report, By Material Type (Polymers, Ceramics & Bioactive Glasses, Calcium Phosphate Cements, Metal, Others), By Application (Orthobiologics, Joint Replacement/Reconstruction, Viscosupplementation, Orthopedic Implants, Others) Forecast Period (2022-2030)
Published: Feb 2026
Orthopedic biomaterial market is anticipated to grow at a considerable CAGR of 7.2% during the forecast period. The growth of the market is attributed to factors such as the increasing prevalence of orthopedic conditions, a rise in the number of orthopedic surgeries, advancements in technology, and the growing geriatric population. Further, factors such as the demand for minimally invasive procedures, the adoption of robotic-assisted surgeries, and the availability of advanced orthopedic biomaterial are expected to fuel the demand for orthopedic biomaterial market.
Digital Payment in Healthcare Market Size, Share & Trends Analysis Report by Component Solution (Solution and Service), by Deployment (On-Premises and Cloud), and by Organization Size (Small and Medium-Sized Enterprises (SMEs) and Large Enterprises), Forecast Period (2023-2030)
Published: Feb 2026
Digital payment in healthcare market is anticipated to grow at a considerable CAGR of 20.2% during the forecast period. The digital payment in healthcare market is experiencing significant growth and transformation due to factors such as the rising technology adoption, consumer preference for convenience, regulatory support, security and fraud prevention, integration with healthcare systems, and the impact of the COVID-19 pandemic.
Silicone Foam Dressings Market Size, Share & Trends Analysis Report by Type (Adhesive Border and Non-Adhesive Border), by Wound Type (Surgical Wounds, Ulcers, Burns, and Others), and by End-User (Hospitals & Clinics and Ambulatory Surgical Centers), Forecast Period (2023-2030)
Published: Feb 2026
Silicone foam dressings market is anticipated to grow at a CAGR of 5.2% during the forecast period (2023-2030). The main factor driving the expansion of the silicone foam dressings market is the rise in acceptance of advanced foam dressings among people all over the globe. Key companies in foam dressing are also anticipated to develop new products and innovate existing ones, resulting in an acceleration of market expansion.
Maternal Health Market Size, Share & Trends Analysis Report by Type (Intrauterine, Ectopic, Tubal, and Others), by Complication (Miscarriage, Premature Labor & Birth, Preeclampsia, Gestational Diabetes, Placenta Previa, and Others), and by care (Prenatal Care, and Postnatal Care), Forecast Period (2023-2030)
Published: Feb 2026
Maternal Health market is anticipated to grow at a CAGR of 9.0% during the forecast period (2023–2030). The growth of the market is attributed to the growing demand for adopting evidence-based best practices that can lead to better maternal and infant health outcomes. Nowadays, hospitals that have adopted the highest standards in terms of patient care quality, safety, and accessibility for pregnant and postpartum patients have been awarded a certification that informs consumers about the establishments.
Clinical Diagnostics Market Size, Share & Trends Analysis Report by Test (Lipid Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, and Others), by Product (Instruments, Reagents, and Others), and by End-User (Hospital Laboratory, Diagnostic Laboratory, and Point-of-Care Testing), Forecast Period (2023-2030)
Published: Feb 2026
Clinical diagnostics market is anticipated to grow at a CAGR of 6.3% during the forecast period (2023–2030). The market expansion is attributed to the ongoing modernization of innovative diagnostic tests. Technological advancements, such as next-generation sequencing (NGS), molecular diagnostics, and new imaging techniques, have substantially enhanced the precision and efficacy of diagnostic tests.
Dental 3D Printing Market Size, Share & Trends Analysis Report by Technology (VAT Photopolymerization, Fused Deposition, Model Selective Laser Sintering (SLS), and Polyjet Printing), by Application (Prosthodontics, Orthodontics, and Implantology), and by End-User (Dental Laboratories, Dental Hospitals & Clinics, and Dental Academic & Research Institutes), Forecast Period (2023-2030)
Published: Feb 2026
Dental 3D printing market is anticipated to grow at a CAGR of 29.9% during the forecast period (2023-2030). The market’s growth is attributed to the growing integration of advanced digital technologies such as artificial intelligence (AI), machine learning (ML), 3D printing, and others in several industries including healthcare and others. The printing speed, resolution, and material selections have all improved as a result of the ongoing developments in 3D printing technology.
Syphilis Testing Market Size, Share & Trends Analysis Report by Type (Primary and Secondary Syphilis, Latent and Tertiary Syphilis), by Location of Testing (Laboratory Testing, Point-of-Care (POC) Testing), and by Technology (Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Nucleic Acid Amplification Test (NAAT), and Others), by End User (Hospitals, Diagnostic Labs, Home Care), Forecast Period (2023-2030)
Published: Feb 2026
Syphilis testing market is anticipated to grow at a CAGR of 6.2% during the forecast period (2023–2030). Treponema palladium is the bacterium that causes the sexually transmitted disease syphilis. During the first two phases, it is most contagious. The initial stage of syphilis is the concealed, or latent, stage, during which the patient is not harmed. Although there are no symptoms, the disease is still vital. The second stage of the disease, referred to as tertiary syphilis, is the most harmful to health.
Lower Respiratory Tract Disease Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Condition (Pneumonia, Bronchitis, Tuberculosis, and Others), by Diagnosis (Mucus Samples, Blood Tests, Chest X-Rays, and Pulse Oximetry), and by Treatment (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics and, Antipyretic Drugs, Bronchodilator Inhaler and Others), and by Category (Over-the-Counter (OTC) and Prescription), Forecast Period (2023-2030)
Published: Feb 2026
Lower respiratory tract disease diagnosis and treatment market is anticipated to grow at a CAGR of 7.4% during the forecast period (2023-2030). The lower respiratory tract disease diagnosis and treatment market is driven by the rising incidence of lower respiratory tract diseases, the aging population, increased awareness and diagnosis, government initiatives and healthcare policies, environmental variables (such as air pollution, climate change, and allergens), and innovations in technology.
Transitional Care Management (TCM) Services Market Size, Share & Trends Analysis Report by Service (Patient TCM Services, Healthcare TCM Services, Billing TCM Services, and Documenting TCM Services), by Disease Type (Chronic Diseases, Cardiovascular Diseases, Orthopedic Conditions, Oncology, Pediatric Conditions, and Others), and by End-User (Hospitals and Healthcare Systems, Physician Practices, Home Health Agencies, and Accountable Care Organizations (ACOs) and Managed Care Organizations (MCOs)) Forecast Period (2023-2030)
Published: Feb 2026
Transitional care management (TCM) services market is anticipated to grow at a CAGR of 17.4% during the forecast period. TCM refers to a collection of services that assists patients in transitioning from one healthcare environment to another, such as from a hospital to a primary care physician. These services are used to guarantee continuity of treatment, minimize avoidable bad outcomes, and limit possibly avoidable readmissions and medical mistakes in the 30 days following discharge from the acute care environment.
Pediatric Neuroblastoma Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Chemotherapy, Immunotherapy, Radiation Therapy, and Others), and by End-User (Hospitals, Specialty Clinics and Others) Forecast Period (2023-2030)
Published: Feb 2026
Pediatric neuroblastoma treatment market is anticipated to grow at a CAGR of 10.3% during the forecast period. Pediatric neuroblastoma treatment refers to a kind of treatment for cancer or a tumor that affects the nervous system in children. The rising number of new cases of pediatric neuroblastoma is expected to propel the growth of the pediatric neuroblastoma treatment market over the forecast period.
Animal Operating Table Market Size, Share & Trends Analysis Report by Type (Electric, Hydraulic, and Manual), and by Application (Large Animals, Medium Animals, and Small Animals) Forecast Period (2023-2030)
Published: Feb 2026
Animal operating table market is anticipated to grow at a CAGR of 4.2% during the forecast period. The growing number of pet owners around the globe has increased demand for veterinary services and equipment, such as animal operating tables. The market for animal operating tables is growing considerably owing to the technological advancement, rising awareness, inclination towards adopting pet animals around the globe.
Anti-Venom Market Size, Share & Trends Analysis Report by Species (Snake, Scorpion, Spider, and Others), by Anti-Venom Type (Polyvalent Anti-Venom and Monovalent Anti-Venom), by Mode of Action (Cytotoxic, Neurotoxic, Haemotoxic, Cardiotoxic, Myotoxic, and Others), by End-User (Hospitals, Clinics, and Ambulatory Surgical Centers), Forecast Period (2025-2035)
Published: Feb 2026
Anti-venom market was valued at $1.2 billion in 2024 and is projected to reach $3.2 billion by 2035, growing at a CAGR of 8.9% during the forecast period (2025-2035). Anti-venom, often referred to as venom antiserum, is a type of drug used to treat the symptoms of venomous bites or stings from animals, such as snakes, spiders, scorpions, and some marine species, such as jellyfish or cone snails. According to the World Health Organization (WHO), in September 2023, an estimated 5.4 million people globally are bitten by snakes each year, with 1.8 to 2.7 million cases of envenoming.
Scanning Tunneling Microscopes Market Size, Share & Trends Analysis Report by Type (Constant-Current Mode and Constant-Height Mode), by Application (Semiconductors, Microelectronics, DNA Molecules, and Others), and by End User (Research Institutions, Life Sciences, and Electronics Industry) Forecast Period (2023-2030)
Published: Feb 2026
Scanning tunneling microscopes market is expected to grow at a CAGR of 5.8% during the forecast period. The market is majorly driven by various factors, including the increasing demand for high-resolution imaging across several industries such as semiconductors and microelectronics. Additionally, advancements in nanotechnology research and applications, coupled with growing demand for scanning tunneling microscope is anticipated to propel the growth of the market.
Solid Tumor Cancer Treatment Market Size, Share & Trends Analysis Report by Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, and Cervical Cancer), by Drug Type (Carboplatin, Cisplatin, Gemcitabine, Paclitaxel, Doxorubicin, Bevacizumab, Erlotinib, Sunitinib, and Everolimusa), by Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, and Surgical Procedures), and by End-User (Hospitals, Specialty Clinics, Research Institutes, and Homecare) Forecast Period (2023-2030)
Published: Feb 2026
Solid tumor cancer treatment market is anticipated to grow at a CAGR of 12.5% during the forecast period. Solid tumor cancer treatment refers to a treatment of an aberrant mass of tissue that does not generally contain cysts or liquid regions. Solid tumors include cancers of the brain, ovary, breast, colon, and other organs. The majority of the tumor's cells are created by cancer stem cells through division.
Autism Spectrum Disorders (ASD) Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Stimulants, Sleep Medications, and Others), by Application (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, and Others), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) Forecast Period (2023-2030)
Published: Feb 2026
ASD market is anticipated to grow at a considerable CAGR of 5.1% during the forecast period. The growth of the market is attributed to factors such as the increasing prevalence of autism and the development of innovative treatment options. For instance, in Jun 2019, Q BioMed Inc. founded two novel biomarkers for pediatric nonverbal autism, reportedly marking the first time a company has identified biomarkers that hold the potential to stratify an autism spectrum disorder subset of children as young as 18 months. Such discovery contribute to effective treatment for children destined with little or no ability to speak.
Pulmonary Function Testing Market Size, Share & Trends Analysis Report by Device Type (Handheld, and Tabletop), by Product Type (Spirometry, Lung Volume Testing, Arterial Blood Gas Testing, Pulse Oximetey, and Others (Maximal Voluntary Ventilation)), by Application (Respiratory Infections, Asthma, Asbestosis, Tumors, Sarcoidosis, and Others (chest surgery), and by End User (Hospitals, Clinical Laboratories, and Diagnostics Laboratories) Forecast Period (2023-2030)
Published: Feb 2026
Pulmonary function testing market is anticipated to grow at a considerable CAGR of 8.3% during the forecast period. Global pulmonary function testing systems market demand is fueled by the rising incidence of lung-related disorders, technological advancements in pulmonary function testing systems and occupational lung diseases. For instance, in April 2023, Asan Medical Center (AMC) developed an artificial intelligence lung testing device that predicts lung function based on computed tomography (CT) test results with an accurate rate of 90% or higher. This algorithm is capable of identifying patients with decreased lung function based on CT scans.
Orthopedic Surgery Software Market Size, Share & Trends Analysis Report by Product (Orthopedic Electronic Health Record (EHR), Orthopedic Practice Management, Orthopedic Picture Archiving and Communication Systems (PACS), Orthopedic Revenue Cycle Management, and Others), by Application (Orthopedic Surgery, Preoperative, Postoperative, Intraoperative, Fracture Management, Joint Replacement, and Pediatric Assessment), by End User (Hospitals, Orthopedic Clinics, and Ambulatory Surgical Centers), and by Deployment Mode (On-Premises, and Cloud) Forecast Period (2022-2030)
Published: Feb 2026
Orthopedic surgery software market is anticipated to grow at a considerable CAGR of 7.9% during the forecast period. The growth of the market can primarily be attributed to the growing prevalence of different types of orthopedic disorders, such as arthritis, osteoarthritis, fibromyalgia, fractures, osteoporosis, and soft-tissue injuries among others, and there rises the need for different orthopedic software to treat these disorders.
Digital Mental Health Market Size, Share & Trends Analysis Report by Component (Software and Services), by Type (Teletherapy, Tracking & Self-Help Apps, Meditation Apps, and Digital Therapeutics), by Disorder Type (Anxiety Disorder, Bipolar Disorders, Post-traumatic Stress Disorder (PSTD), and Others (depression, and eating disorders)), by End-User (Hospitals, Mental Healthcare Centers, and Research Institutes) Forecast Period (2022-2030)
Published: Feb 2026
Digital mental health market is anticipated to grow at a considerable CAGR of 20.3% during the forecast period. The increasing demand for behavioural health treatment and mental health services paves the way for a growing digital mental health market. In addition, the rising use of mental health apps, coupled with an upsurge in the number of neurology diseases, drives the market growth.
Artificial Womb Facility Market Size, Share & Trends Analysis Report by Technology (Bioreactors, Extrauterin Support Devices, and Other Advanced Technologies), By Application (Prenatal Care and Neonatal Care), and by End-User (Super-Specialty Hospitals, Neonatal Care Centers, Research Centers, and In-Vitro Fertilization Centers (IVF)), Forecast Period (2022-2030)
Published: Feb 2026
Artificial womb facility market is anticipated to grow at a considerable CAGR of 8.9% during the forecast period. The key factor fueling the market growth include the increasing prevalence of preterm births, which can result in long-term health problems for the infant. Artificial womb facilities offer the potential to improve outcomes for premature infants by providing a more controlled and supportive environment for their development. According to the Centers for Disease Control and Prevention (CDC), the preterm birth rate rose 4% in 2021, from 10.1% in 2020 to 10.5% in 2021 in the US.
Augmented Reality (AR) in Healthcare Market Size, Share & Trends Analysis Report By Technology (Head Mounted Devices and Handheld Devices), by Application (Surgical Application, Rehabilitation, and Training & Medical Education), and by End-User (Hospitals and Clinics, Research Laboratories, and Others), Forecast Period (2025-2035)
Published: Feb 2026
Augmented Reality (AR) in healthcare market was valued at $2.3 billion in 2024 and is projected to grow at a CAGR of 25.8% during the forecast period. The market growth is attributed to the adoption of augmented reality (AR) and virtual reality (VR) technologies in the healthcare sector, including technological advancements and digitalization in healthcare, favorable government initiatives, rising healthcare expenditures, growing usage in surgical procedures, and medical training. By immediately incorporating digital content—such as sounds, images, or text—into real perspective, augmented reality improves the vision of the outside. This makes interactive encounters possible and makes it possible to visualize difficult ideas in a concrete setting. This makes it possible to interact in a virtual environment, providing a completely different experience from the real one. In several fields, these technologies play a key role in increasing user engagement and comprehension.
Multiple Myeloma Market Size, Share & Trends Analysis Report by Drug Class (Immunomodulators, Proteasome Inhibitors, Anti-CD38 Monoclonal Antibody, Alkylating Agents, and Others), by Type (Hyperdiploid, and Non-Hyperdiploid or Hypodiploid), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies) Forecast Period (2023-2030)
Published: Feb 2026
Multiple myeloma market is anticipated to grow at a considerable CAGR of 4.8% during the forecast period. The growth of the market is attributed to factors such as the increasing prevalence of multiple myeloma and advancements in diagnostic and treatment technologies. For instance, according to the University of California, in 2020, nearly 176,404 or 95% new cases of multiple myeloma were reported globally. Moreover, according to the Canadian Cancer Society, the number of new myeloma cases diagnosed in 2022 was 4,000, among them 2,400 males and 1,550 females, and nearly 11 people are diagnosed with myeloma each day.
Artificial Kidney Market Size, Share & Trends Analysis Report by Device Type (Wearable Artificial Kidney and Implantable Artificial Kidney), by Dialysis Type (Hemodialysis and Peritoneal Dialysis), and by End-User (Dialysis Centers, Specialty Clinics, and Hospitals), Forecast Period (2025-2035)
Published: Feb 2026
Artificial kidney market is anticipated to grow at a considerable CAGR of 15.0% during the forecast period. The market is growing owing to the rising incidence of chronic kidney diseases, a shortage of donors, and advancements in artificial kidney technology. The increasing global number of people suffering from diseases such as Acquired Cystic Kidney Disease, Glomerular Diseases, Diabetes Insipidus, and others is driving market expansion. Furthermore, the scarcity of kidney donors is a major driver accelerating market growth. For instance, in June 2021, the US Department of Health and Human Services (HHS) collaborated with the American Society of Nephrology (ASN) to drive innovation in kidney disease prevention, diagnosis, and treatment. Currently, these groups are collaborating to develop waterless, dialysate-free technology, which will aid in the creation of the first implantable prosthetic kidney by 2026.
Hematology Analyzer Market Size, Share & Trends Analysis Report by Product & Service (Instruments, Reagent & Consumables, and Services), by Type (Fully-Automated and Semi-Automated), and by End User (Hospitals, Clinical Laboratories, Research Institutes, and Others) Forecast Period (2023-2030)
Published: Feb 2026
Hematology analyzer market size was valued at $7.3 billion in 2022, and is projected to reach $11.5 billion by 2030, registering a CAGR of 6.6% during the forecast period (2023-2030). Hematology analyzers are computerized, highly specialized machines that count the number of different types of red and white blood cells, blood platelets, hemoglobin, and hematocrit levels in a blood sample.
Digital Innovation in Insurance Market Size, Share & Trends Analysis Report by Insurance Type (Health Insurance, Motor Insurance, Home insurance, Travel Insurance, Commercial Insurance, and Others) and by Technology (Cloud Computing, Internet of Things, Advanced Analytics, Telematics, and Others) Forecast Period (2023-2030)
Published: Feb 2026
Digital innovation in insurance market is anticipated to grow at a considerable CAGR of 12.2% during the forecast period. The insurance industry has long been held back by manual processes, difficult-to-digitize workflows, and restrictive custom software for submitting, tracking, and paying out claims. Large insurance companies entrenched in legacy technology have historically found it hard to take advantage of advancements in technology without major changes to their business processes and underlying systems.
Neurological Biomarkers Market Size, Share & Trends Analysis Report by Biomarker Type (Imaging Biomarkers, Metabolomics Biomarkers, Proteomic Biomarkers, and Genomics Biomarkers), by Application (Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Autism Spectrum Disorders, and Others), and by End Users (Hospital, Clinical Diagnostic Centers, Research Organizations) Forecast Period (2023-2030)
Published: Feb 2026
Neurological biomarkers market is anticipated to grow at a significant CAGR of 12.4% during the forecast period. The increase in the prevalence of neurological diseases such as motor neuron disease (MND), Parkinson’s disease (PD), stroke, Alzheimer’s disease (AD), and Huntington’s disease (HD), and the increase in biobanks for addressing unmet requirements in oncology, neuroscience, and cardiovascular disease (CVDs) to accelerate the market growth.
Urology Robotic Surgery Market Size, Share & Trends Analysis Report by Component (Robotic Surgery Systems, Instruments, Accessories, and Services), by Type (Robot Machines, Navigation Systems, Planners, Simulators, and Others), and by Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), Forecast Period (2023-2030)
Published: Feb 2026
Urology robotic surgery market is anticipated to grow at a considerable CAGR of 11.5% during the forecast period. The growth of the market is attributed to factors such as technological advancements in robotic surgery systems, increasing prevalence of urological disorders, and rising adoption of robotic surgery by healthcare providers. As a result of all these factors, the market players are focusing on adopting new strategies such as partnerships and other to stay competitive in the market by offering updated medical facilities.
Acute Respiratory Distress Syndrome (ARDS) Therapeutics Market Size, Share &Trends Analysis Report by Drug Class (Vasoconstrictor, Steroids and Antibiotics, Sedative and Paralytic, Surfactant, Bronchodilators, and Others), and by End-User (Hospital/ Clinics and Others) Forecast Period (2023-2029)
Published: Feb 2026
Acute respiratory distress syndrome (ARDS) therapeutics market is anticipated to grow at a considerable CAGR of 7.2% during the forecast period. The market for acute respiratory distress syndrome (ARDS) is being driven by factors such as the rising prevalence and incidence of acute lung injury, a wide range of ARDS risk factors, and an increase in the number of patients who have ARDS.
High-Throughput Screening Market Size, Share & Trends Analysis Report by Product and Services (Consumables, Instruments, Services, and Software), by Technology (Cell-Based Assays, Lab-on-a-Chip Technology, and Label-Free Technology), and by Application (Drug Discovery, Biochemical Screening, Life Sciences Research, and Other) Forecast Period, (2026-2035)
Published: May 2026
High-throughput screening market valued at $7,200.6 million in 2025 and is projected to reach $12,922.7 million by 2035, growing at a CAGR of 6.1% during the forecast period (2026-2035). The global high-throughput screening market is advancing steadily as pharmaceutical and biotechnology companies intensify efforts to accelerate early-stage drug discovery and optimize compound evaluation processes. Market growth is being reinforced by rising demand for automated screening platforms capable of analyzing thousands to millions of compounds with speed and precision. Increasing integration of robotics, miniaturized assay formats, and data analytics tools is streamlining target validation and hit identification workflows. Additionally, the expanding pipeline of biologics and personalized therapies is driving the need for scalable, high-efficiency screening systems. As organizations prioritize cost-effective and time-efficient discovery strategies, high-throughput screening (HTS) technologies are becoming central to modern research infrastructure.
Glucagon Market Size, Share & Trends Analysis Report by Product Type (Injectable and Nasal), by Application (Emergency Kits, General Use, Diagnostics & Motility, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) Forecast Period, (2026-2035)
Published: May 2026
Glucagon market was valued at $350.8 million in 2025 and is projected to reach $616.4 million by 2035, growing at a CAGR of 5.9% during the forecast period (2026-2035). Rising awareness regarding the management of severe hypoglycemia is supporting steady demand for glucagon products across clinical and home care settings. The introduction of user-friendly delivery formats, including nasal and ready-to-use injectable options, is improving treatment accessibility and adherence. Increasing diagnosis rates of diabetes and expanded patient education initiatives are contributing to higher prescription volumes. Healthcare providers are prioritizing rapid emergency response solutions, which is reinforcing product adoption in both hospital and outpatient environments. Continued product innovation and broader pharmacy availability are expected to sustain market expansion over the forecast period.
GI Stool Testing Market Size, Share & Trends Analysis by Product Type (Instruments, and Consumables), By Test Type (Occult Blood Tests, Ova & Parasites Tests, Bacteria Tests, Fecal Biomarkers Tests, and Others), By Technology (Immunoassay Tests, Molecular Diagnostic Tests, Chromatography-Based Tests, Microbiological Culture Tests, Microscopy / Ova & Parasite Tests, and Enzyme-Linked Immunosorbent Assays (ELISA)), By End-User (Hospitals & Clinics, Diagnostic Laboratories, Point of Care Settings, Home Testing / Homecare, Research Centers & Academic Institutions, and Others), Forecast Period (2026-2035)
Published: Mar 2026
GI stool testing market was valued at $620 million in 2025 and is projected to reach $955.3 million by 2035, growing at a CAGR of 4.5% during the forecast Period (2026-2035). The market focuses on diagnostic tests that analyze stool samples to detect gastrointestinal disorders, including colorectal cancer, inflammatory bowel disease, and infections. The market is driven by the rising prevalence of GI diseases, increasing awareness of preventive healthcare, and growing demand for non-invasive, patient-friendly diagnostic solutions. Technological advancements in molecular diagnostics, immunoassays, and at-home testing kits are enhancing test accuracy and accessibility, supporting adoption across hospitals, diagnostic laboratories, and home healthcare settings globally.
Teleradiology Market Size, Share & Trends Analysis by Component (Hardware, Software, and Services), By Imaging Technique (X?Ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound, Mammography, Nuclear Imaging (PET/SPECT), and Others), and By End-User (Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Physician Clinics / Private Practices, and Others), Forecast Period (2026-2035)
Published: Mar 2026
Teleradiology market was valued at $7.5 billion in 2025 and is projected to reach $27.7 billion by 2035, growing at a CAGR of 14% during the forecast Period (2026-2035). The market is experiencing significant growth due to increasing demand for remote diagnostic services, advancements in imaging technologies, and the rising prevalence of chronic diseases. Teleradiology enables healthcare providers to share and interpret medical images remotely, improving accessibility and reducing turnaround times, especially in underserved regions. Adoption is supported by AI-assisted analysis, cloud-based platforms, and favorable telemedicine regulations. The market spans hardware, software, and service components, with services being the primary growth driver, reflecting the shift toward outsourced and scalable radiology solutions.
Cell Lysis Market Size, Share & Trends Analysis Report by Product Type (Instruments, and Reagents & Consumables), by Cell Type (Mammalian Cells, Microbial Cells, and Plant Cells), by Application (Protein Isolation, Downstream Processing, Cell Organelle Isolation, and Nucleic Acid Isolation) and by End-User (Hospital & Diagnostic Labs, Academic and Research Institutes, and Pharmaceutical and Biotechnology Companies), Forecast Period (2026-2035)
Published: Mar 2026
Cell lysis market was valued at $4.7 billion in 2025 and is projected to reach $11.0 billion by 2035, growing at a CAGR of 8.8% from 2026 to 2035. The global market is experiencing steady expansion, supported by sustained investment across key industries and increasing demand for advanced solutions. Evolving regulatory frameworks and quality standards are encouraging organizations to adopt more efficient and compliant products. Continuous technological refinement is improving product performance, reliability, and cost-effectiveness, further strengthening adoption rates. Growing research activity and commercial development initiatives across both developed and emerging economies are also contributing to higher procurement volumes. In addition, strategic capacity expansions and distribution network enhancements are improving product accessibility worldwide. Collectively, these factors are reinforcing consistent revenue growth across the international marketplace.
Wearable Injectors Market Size, Share & Trends Analysis Report by Type (On Body, And Off Body), by Technology (Electronic Injector, Mechanical Injector, and Others), by Mechanism of Injection (Motor Driven, Spring Driven, Expanding Battery, Rotary Pump, Collapsible Reservoir, And Pressurized Gas), by Application (Oncology, Infectious Disease, Autoimmune Disease, Cardiovascular Disease, Blood Disorder, And Others) by and End-User (Hospital, Lab And Diagnostics Clinics, Homecare Settings, and Others), Forecast Period (2026-2035)
Published: May 2026
Global wearable injectors market was valued at $12.3 billion in 2025 and is projected to reach $59.7 billion by 2035, growing at a CAGR of 17.1% from 2026 to 2035. The global market is expanding as healthcare systems increasingly adopt advanced drug?delivery technologies that improve treatment efficiency and patient adherence. Growing demand for convenient and minimally invasive therapeutic administration has encouraged the adoption of innovative delivery platforms designed for controlled and precise dosing. Additionally, the rising prevalence of chronic diseases has accelerated the need for solutions that enable reliable and user?friendly medication administration outside traditional clinical environments. Technological progress in device engineering has also enhanced the safety, accuracy, and functionality of modern delivery systems. Furthermore, pharmaceutical companies are prioritizing integrated delivery approaches that support complex biologic therapies. These factors collectively contribute to the sustained expansion of the global market.
Teledentistry Market Size, Share & Trends Analysis Report by Component (Software & Services, and Hardware), by Delivery Mode (Web-based, and Cloud-based), by Application (Tele-consultation, Remote Patient Monitoring, and Education & Training), and by End-User (Providers, Patients, and Others), Forecast Period (2026-2035)
Published: May 2026
Global teledentistry market was valued at $2.4 billion in 2025 and is projected to reach $10.3 billion by 2035, growing at a CAGR of 15.5% from 2026 to 2035. The global market is expanding as dental care providers increasingly incorporate digital platforms that enable remote consultation, diagnosis, and follow-up care. Advancements in cloud-based clinical systems and connected imaging technologies are improving the efficiency of virtual dental assessments. In addition, growing patient preference for convenient access to professional dental guidance without frequent in-clinic visits is contributing to wider adoption. Regulatory support for telehealth services in several regions has also encouraged providers to integrate remote care solutions into routine practice. Furthermore, the integration of digital monitoring tools allows clinicians to track treatment progress more effectively between appointments. Collectively, these developments are supporting the steady growth of the global market.
Lab Automation Market Size, Share & Trends Analysis Report by Product Type (Automated Workstations, Microplate Readers, Automated ELISA Systems, and Automated Nucleic Acid Purification Systems), by Application (Drug Discovery, Diagnostics, Genomics Solutions, Proteomics Solutions, Microbiology, and Other) and by End-User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Research and Academic Institutes, Forensic Laboratories, Environmental Testing Laboratories, and Food & Beverage Industry) Forecast Period (2025-2035)
Published: Feb 2026
Lab automation market is anticipated to grow at a significant CAGR of 7.9% during the forecast period. The key factors contributing to the market growth include increasing investments and funding activities by key players and the government for the implementation, integration, and development of new technology in lab automation. For instance, in February 2022, Automata raised funding of $50 million to automate entire lab processes from start to finish in $7.4 million was focused on developing and deploying its Eva robotic arm.
Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, and Phase IV), by Study Design (Interventional, Observational, and Expanded Access), by Therapeutic Area (Autoimmune Disease, Oncology, Cardiology, Infectious Disease, Dermatology, Ophthalmology, and Others) and by Sponsor Outlook (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Others) Forecast Period 2026-2035
Published: Feb 2026
Clinical trials market is anticipated to grow at a significant CAGR of 5.3% during the forecast period. The key factors contributing to the market growth include increasing advancement in products by the addition of various technologies in a product such as new software, system to monitor clinical trials that take fewer times and attributed to the demand for the various new technologies and growing and also adoption is increasing that in turn contributing in the positive growth of the market.
Intraoperative Imaging Market Size, Share & Trends Analysis Report by Product (iCT, iUltrasound, iMRI, and C-arm system), by Component (System, Software, and Services), by Application (Neurosurgery, Orthopedic & Trauma surgery, ENT surgery, Oncology surgery, Cardiovascular Surgery, and Others), and End-User (Hospitals & Clinics, Ambulatory Surgical Centers and Diagnostic Centers, and Research Laboratories & Academic Institutes) Forecast Period (2026-2035)
Published: May 2026
Global intraoperative imaging market was valued at $5.1 billion in 2025 and is projected to reach $9.8 billion by 2035, growing at a CAGR of 6.7% from 2026 to 2035. The global market is experiencing steady expansion driven by increasing technological advancements and the continuous introduction of innovative solutions across industries. Organizations are progressively adopting modern systems to improve operational efficiency, enhance service delivery, and support data-driven decision-making. In addition, rising investments from both public and private sectors are encouraging the development and deployment of advanced infrastructure and digital platforms. Growing demand for integrated and intelligent solutions is also influencing market growth as enterprises seek to optimize performance and remain competitive. Furthermore, supportive regulatory frameworks and strategic collaborations among industry participants are fostering a favorable environment for market development. Collectively, these factors are contributing to the sustained growth and evolution of the global market.
Dental Simulator Market Size, Share & Trends Analysis Report by Component (Hardware and Software), by Product (Workstation and Upper body), by Application (Dental Training & Education, and Treatment Planning), and by End-User (Dental Schools and Hospitals & Clinics) Forecast Period, (2026-2035)
Published: May 2026
Dental simulator market valued at $435.2 million in 2025 and is projected to reach $1,032.4 million by 2035, growing at a CAGR of 9.1% during the forecast period (2026-2035). The global dental simulator market is gaining momentum as dental education and training institutions increasingly integrate advanced simulation technologies to enhance clinical skill development. Growth is being driven by the rising emphasis on competency-based dental education, where realistic simulation environments allow students to practice procedures safely before treating patients. The adoption of virtual reality (VR), augmented reality (AR), and haptic feedback systems is improving the accuracy and effectiveness of training by replicating real-life dental procedures. Demand is also expanding as universities and dental training centers invest in digital learning infrastructure to modernize curricula and improve training outcomes. As institutions focus on improving clinical preparedness and reducing procedural errors, dental simulators are becoming an essential component of modern dental education ecosystems.
Sports Mouth Guard Market Size, Share & Trends Analysis Report by Product (Stock Mouth Guard, Boil & Bite Mouth Guard, Custom-made Mouth Guard, and Others), by Material (Acrylic Resins, Ethylene Vinyl Acetate (EVA), Natural Rubber, and Others), and by Distribution Channel (Offline and Online) Forecast Period, (2026-2035)
Published: May 2026
Sports mouth guard market valued at $920.6 million in 2025 and is projected to reach $1,502.8 million by 2035, growing at a CAGR of 5.1% during the forecast period (2026-2035). The global sports mouth guard market is evolving steadily as participation in contact and high-impact sports continues to rise across both professional and amateur levels. Increasing awareness regarding the prevention of dental trauma, jaw injuries, and concussion risks is encouraging athletes, parents, and sports organizations to prioritize protective gear. Growth is further supported by the introduction of advanced materials such as thermoforming polymers and shock-absorbing multilayer designs that enhance comfort, durability, and performance. Additionally, the growing popularity of customized and dentist-fitted mouth guards is expanding the market, as athletes seek better fit and improved protection during training and competition. As sports safety standards become more structured across leagues and educational institutions, mouth guards are becoming a critical component of athletic protective equipment globally.
Genomics Market Size, Share & Trends Analysis Report by Deliverable (Products and Service), by Technology (Sequencing, PCR, Nucleic Acid Extraction & Purification, Microarray, CRISPR and Other), by Application (Drug Discovery & Development, Diagnostics, Agriculture & Animal Research, Precision Medicine and Other), and by End-User (Hospitals & Clinics, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Clinical, Research Organizations (CROs) and Other), Forecast Period (2026-2035)
Published: May 2026
Genomics market was valued at $29.5 billion in 2025 and is projected to reach $84.4 billion by 2035, growing at a CAGR of 11.2% during the forecast period (2026-2035). The genomics market is experiencing steady expansion, driven by the increasing use of genomic technologies in medical research and clinical diagnostics. Advances in sequencing technologies and molecular analysis tools have significantly improved the speed and accuracy of genetic data generation. Growing investment in drug discovery and personalized medicine is further encouraging the adoption of genomics-based approaches across pharmaceutical and biotechnology companies. In addition, rising demand for early disease detection and genetic testing is supporting the integration of genomics in healthcare systems. Research institutions and clinical laboratories are also expanding their genomic capabilities to support complex biological studies. Continuous technological innovation and broader application of genomics across healthcare and agricultural research are expected to sustain market growth in the coming years.
Laboratory Mixer Market Size, Share & Trends Analysis Report by Product (Shakers, Magnetic Stirrers, Vortex Mixers, Conical Mixers, Overhead Stirrers and Accessories), by Platform (Digital and Analog), by Operability (Gyratory Movement, Linear Movement, Rocking/Tilting Movement and Orbital Movement), and by End-User (Research Laboratories and Institutes, Pharmaceutical and, Biotechnology Companies, Clinical Research Organizations, Environmental Testing Laboratories, Food Testing Laboratories, Diagnostic and Pathology Laboratories and Other) Forecast Period (2026-2035)
Published: May 2026
Laboratory mixer market was valued at $1.4 billion in 2025 and is projected to reach $2.1 billion by 2035, growing at a CAGR of 4.2% during the forecast period (2026-2035). The global laboratory mixer market is experiencing steady growth driven by the expanding activities in pharmaceutical and biotechnology research. Increasing demand for precise and efficient sample preparation in clinical and analytical laboratories is contributing significantly to market expansion. Advancements in laboratory technologies, including digital and automated mixing systems, are further supporting product adoption. Growing investments in life sciences research and development across both developed and emerging economies are also influencing market growth. In addition, the rising number of diagnostic laboratories and academic research institutions has increased the need for reliable laboratory mixing equipment. Continuous innovation by manufacturers to improve performance, accuracy, and operational efficiency is expected to sustain the market’s upward trajectory.
Medical Tubing Market Size, Share & Trends Analysis Report by Material (Plastics, Rubbers, Specialty Polymers, Silicone, and Polyolefins), and by Application (Bulk Disposable Tubing, Catheters, and Cannulas, Drug Delivery Systems, and Other Applications), Forecast Period (2026-2035)
Published: May 2026
Global medical tubing market was valued at $13.2 billion in 2025 and is projected to reach $29.5 billion by 2035, growing at a CAGR of 8.4% from 2026 to 2035. The global medical tubing market is experiencing significant growth driven by rising demand for minimally invasive procedures and advanced drug delivery systems. Increasing adoption of innovative materials, such as specialty polymers and medical-grade silicones, is enhancing product performance and broadening applications. Growing investment in healthcare infrastructure across emerging economies is further expanding the need for reliable tubing solutions. Additionally, the shift toward outpatient care and home healthcare is fueling demand for flexible and disposable tubing products. Technological advancements in catheter and cannula design are also contributing to market expansion. Regulatory emphasis on patient safety and quality standards is encouraging manufacturers to develop higher-precision tubing, supporting overall industry growth.
Urgent Care Center Market Size, Share & Trends Analysis Report by Services (Trauma/Injury Services, Vaccination Services, Acute Illness Treatment Solutions, Diagnostic Services, and Other), and by Ownership (Corporate Owned, Hospital Owned, Physician Owned, and Others) Forecast Period (2022-2028)
Published: Feb 2026
Urgent care center market is anticipated to grow at a significant CAGR of 4.3% during the forecast period. The key factors contributing to the market growth include an increase in the prevalence of various chronic diseases such as strokes, diabetes, among others, and sports-related injuries, as this requires immediate medical assistance. For instance, according to the data by World Health Organization (WHO), in April 2021, approximately 17.9 million people annually lead to death followed by cancers (9.3 million), and diabetes (1.5 million).
Topical Drug Delivery Market Size, Share & Trends Analysis Report by Dosage Form (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products), by Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, and Nasal Drug Delivery), by Application (Prescription, and Over-The-Counter Products), and by End-User (Pharmaceutical, Cosmetic and Personal Care, and Other), Forecast Period (2025-2035)
Published: Feb 2026
Topical drug delivery market was valued at $243.3 billion in 2024 and is projected to reach $610.1 billion by 2035, growing at a CAGR of 8.8% during the forecast period (2025-2035). The topical drug delivery market is experiencing significant traction owing to the increasing demand for localized treatment with limited systemic exposure. Advancements in formulation science have facilitated the creation of many stable and effective topical treatments. Rising patient acceptance of non-invasive treatments is shaping prescribers to choose topical solutions and other therapeutic categories. The increase in chronic skin conditions and demand for targeted pain management options is opening up new areas of opportunity. In addition, regulatory support for new delivery systems allows for product innovation.
Telehealth Services Market Size, Share & Trends Analysis Report by Services Type (Remote Patient Monitoring, Real Time Interactions, Video/ Audio Consultations, Appointment Scheduling, and Other Telehealth Services), by Application (Tele-radiology, Tele-psychiatry, Tele-cardiology, and Others), and by Deployment Mode (Web-Based, Cloud-Based) Forecast Period (2022-2028)
Published: Feb 2026
Telehealth services market is anticipated to grow at a significant CAGR of 24.2% during the forecast period. Owing to the rising shortage of healthcare facilities and increased risk of infection drove medical centers and healthcare workers to include virtual care technologies which are boosting the demand for telehealth services across the globe. According to the World Health Organization (WHO) data, there will be a shortfall of 15 million health workers by 2030, mostly in low- and lower-middle-income countries.
Mobile Imaging Services Market Size, Share & Trends Analysis Report by Product (X-ray, Computed Tomography (CT), Ultrasound, Magnetic Resonance Imaging (MRI), Mammography, and Others), and by End-User (Hospitals & Private Clinics, Home Healthcare, and Others), Forecast Period (2022-2028)
Published: Feb 2026
Mobile imaging services market is anticipated to grow at a significant CAGR of 4.3% during the forecast period. The major factors which are driving the market growth include the increased adoption of mobile imaging services throughout the COVID-19 pandemic and various key players in the market supported via product launches to fight COVID-19. For instance, the data provided by the Journal of Medical Radiation Sciences in June 2022, stated there was a peak in the adoption of mobile imaging rate per month in non?routine body regions.
Surgical Retractors Market Size, Share & Trends Analysis Report by Type (Hand Retractor, Self-Retaining Retractors, and Others), by Application (Orthopedic Retractors, Abdominal Retractors, Cardiothoracic Retractors, and Obstetric or Gynecological Retractors), and by End-User (Hospitals and Ambulatory Surgical Centers) Forecast Period (2022-2028)
Published: Feb 2026
Surgical retractors market is anticipated to grow at a significant CAGR of 6.3% during the forecast period. The increasing number of cases of trauma injuries, and hip and knee replacement procedures are the key factor driving market growth across the globe. For instance, in 2020, as per the report published by American Joint Replacement Registry (AJRR), approximately 2 million hip and knee procedures were performed in the US. T
Dental Imaging Market Size, Share & Trends Analysis Report by Method (Extraoral Imaging Systems, and Intraoral Imaging Systems), by Technology (Dental Cone-beam Computed Tomography (CBCT), General X-ray Imaging Systems, Intraoral Cameras, and Dental Optic Imaging), by Application (Endodontics, Orthodontics, Implantology, Oral & Maxillofacial Surgery, and Other), and by End-User (Hospitals, Dental Clinics, Diagnostic Centers, and Academic & Research Institutes), Forecast Period (2022-2028)
Published: Feb 2026
Dental imaging market is anticipated to grow at a significant CAGR of 8.3% during the forecast period. The key factors contributing to the market growth include the growing incidence of dental and oral health illnesses and a growing aging population that is more prone to develop the disease at an early stage. For instance, according to the data provided by World Health Organization (WHO) in March 2022, it stated that an estimated number of 3.5 billion people are affected by oral diseases which is the most common health condition as per the Global Burden of Disease 2019.
Digital Genome Market Size, Share & Trends Analysis Report by Product (Sequencing & Analyzer Instruments, DNA/RNA Analysis Kits, Sequencing & Analysis Software, And Sample Preparation Instruments), by Application (Microbiology, Reproductive & Genetic, Transplantation and Agriculture, Forensics, and Research and Development), and by End-User (Academic Research Institutes, Diagnostics & Forensic Labs, Hospitals, and Bio-pharmaceutical Companies) Forecast Period (2022-2028)
Published: Feb 2026
Digital genome market is anticipated to grow at a significant CAGR of 8.7% during the forecast period. The factors contributing to the digital genome market growth are the growing number of drug discoveries, the raising biotechnology sector, and the growing variants of the presenilin gene that leads to an increased number of Alzheimer's disease cases. For instance, as per the data by Alzheimer's Association approximately 6 million Americans are living with Alzheimer and by 2050 this number is projected to rise to nearly 13 million. Alzheimer's diseases cost $321 billion annually and which will increase by $1 trillion by 2050.
Dental Implants Market Size, Share & Trends Analysis Report by Product (Tapered Implants and Parallel-walled Implants), by Material (Titanium and Zirconium), and by End-User (Hospitals and Dental Clinics) Forecast Period (2026-2035)
Published: Mar 2026
Dental implants market is anticipated to grow at a significant CAGR of 7.5% during the forecast period. The major factor contributing to the market growth includes the rising incidence of tooth loss, high demand for aesthetic dentistry, and the growing per capita healthcare spending. Further, the development and launches of innovative and new technology-based products by key players operating in the market to expand product portfolio is another factor spurring the market growth.
Cell-based Assays Market Size, Share & Trends Analysis Report by Product (Consumable, Instruments, and Software & Services), by Application (Drug Discovery, Basic Research, ADME Studies, and Predictive Toxicology), and by End-User (Contract Research Organizations, Academic and Government Institutions, and Pharmaceutical and Biotechnology Companies) Forecast Period (2022-2028)
Published: Feb 2026
Cell-based assay market is anticipated to grow at a significant CAGR of 7.7% during the forecast period. The increasing number of chronic diseases such as cancer, diabetes, hypertension, and others owing to increasing chronic diseases that are raising demand growth for cell-based assays for new drug discoveries, is a key factor driving the market. For instance, according to the data by World Health Organization (WHO), in April 2021, approximately 17.9 million people annually lead to death which is followed by cancers (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million).
Bone and Joint Health Supplements Market Size, Share & Trends Analysis Report by Form (Soft Gels/Pills, Powder, and Liquid), by Ingredients (Vitamin D, Vitamin K, Calcium, Collagen, Magnesium, Omega-3, Glucosamine, and Others), and by Application (Men, Women, and Senior Citizen) Forecast Period (2022-2028)
Published: Feb 2026
Bone and joint health supplements market is anticipated to grow at a considerable CAGR of 8.3% during the forecast period. The rising number of patients with osteoporosis and rheumatoid arthritis is becoming a pressing concern for an increasing number of consumers. Furthermore, the growing aging population is leading to a substantial push to the market. Arthritis is no longer just a problem for elderly people as the number of sufferers of the disease among members of younger generations has grown gradually in recent years.
Image-guided Therapy Systems Market Size, Share & Trends Analysis Report by Product (Endoscopes, Ultrasound Systems, Computed Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), and Others), by Application (Neurosurgery, Cardiac Surgery, Urology, Orthopedic Surgery, Oncology Surgery, and Others), and by End-User (Hospitals, Ambulatory Surgery Centers, and Specialty Clinics) and Forecast Period (2022-2028)
Published: Feb 2026
Image-guided therapy systems market is anticipated to grow at a significant CAGR of 5.4% during the forecast period. The increasing use of radiotherapy to treat patients with cancer and the increasing several initiatives that are undertaken to promote cancer radiotherapy are factors that are contributing to the positive growth of the image-guided therapy systems market.
Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report by Product & Solution (Consumables, Instruments, and Software & Services), by Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing and Next-Generation Sequencing (NGS), DNA Microarray Technology, and Other Technologies) by Disease Type (Hepatitis, Human Immunodeficiency Virus (HIV), Hospital-Acquired Infections (HAIS), Human, Papillomavirus (HPV), Tuberculosis (TB), Influenza and Other Diseases) and by End-User (Hospital/Clinical Laboratories, Reference Laboratories, Academics/Research Institutes, and Others) Forecast Period (2022-2028)
Published: Feb 2026
Infectious disease diagnostics market is anticipated to grow at a significant CAGR of 5.9% during the forecast period. Infectious diseases are diseases caused by microscopic organisms including bacteria, viruses, parasites, and fungi. The organisms enter the body, multiply and cause symptoms ranging from mild to severe, including death. According to WHO, At least 169 severe hepatitis cases have been identified in children in an outbreak that involves 12 countries. Further in July 2022, WHO declared monkeypox a global health emergency.
Track and Trace Solutions Market Size, Share & Trends Analysis Report by Product (Hardware Systems and Software Solutions), by Technology (Barcode and RFID), by Application (Serialization Solutions and Aggregation Solutions), and by End-User (Pharmaceutical & Biotechnology Companies, Medical Device Companies, and Others) Forecast Period (2022-2028)
Published: Feb 2026
Track and trace solutions market is anticipated to grow at a significant CAGR of 16.5% during the forecast period. The key factors that are contributing to the market growth include favorable government intervention and stringent regulations and criteria for serialization implementation. Governments across the globe are working on various amendments and to approve specific laws for the implementation of serialization to ensure supply chain efficiency.
Femtech Market Size, Share & Trends Analysis Report by Type (Products, and Software), by Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, and General Healthcare & Wellness), and by End-User (Direct to Customer, Hospitals, Fertility Clinics, Surgical Centers, and Diagnostic Centers), Forecast Period (2022-2028)
Published: Feb 2026
Femtech market is anticipated to grow at a significant CAGR of 8.5% during the forecast period. The key factors that are attributed to the growth of the market are the increased burden of lifestyle diseases and increased access to remote areas are driving the market growth. Across the globe, women are facing various condition that includes reproductive disease coupled with a high risk of developing metabolic syndrome, changing lifestyle habits, mental health, and various other chronic diseases has increased concern of health conditions.
Dental Diamond Burs Market Size, Share, and Trends Analysis Report, By Type (Tungsten Carbide, Stainless Steel, and Ceramic), By Technology (Electrolytic Co-Deposition, Micro Brazing, Chemical Vapor Deposition, Sintering, and Others), By Application (Hospitals, Clinics, and Others), Forecast (2022-2028)
Published: Feb 2026
Dental diamond burs market is anticipated to grow at a CAGR of 7.5% during the forecast period. The market growth is being driven by major factors such as the rising prevalence of dental diseases, the rising geriatric population, and advancements in dental treatment. The most prevalent oral diseases include caries and periodontal disease which are mainly caused by poor oral hygiene, especially in the geriatric population. The Global Burden of Disease Study 2019 estimated that oral diseases affect close to 3.5 billion people globally, with caries of permanent teeth being the most common condition.
Bioprocess Container Market Size, Share & Trends Analysis Report, By Type (2D Bioprocess Containers, 3D Bioprocess Containers, and Other Containers and Accessories), By Type (Upstream Processes, Downstream, Processes, and Process Development), By End-User (Pharmaceutical & Biopharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes), Forecast Period (2022-2028)
Published: Feb 2026
Bioprocess container market is anticipated to grow at a CAGR of 14.0% during the forecast period. Bioprocess containers are containers utilized for critical sterile liquid-handling applications in the biopharmaceutical industry. The volume capacity of bioprocess containers available on the market can range from 50mL to 10,000L. Large volume flexible container systems are often used as alternatives to traditional stainless steel bioprocessing systems. Small volume flexible containers are increasingly used as a replacement for glass or rigid plastic containers which are widely used for applications such as sampling and storage.
Stem Cell Therapy Market Size, Share & Trends Analysis Report, By Type (Allogeneic and Autologous), By Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, and Autoimmune & Inflammatory), By Cell Source (Adipose Tissues, Bone Marrow, and Placenta/Umbilical Cord), Forecast Period (2022-2028)
Published: Feb 2026
Stem cell therapy market is anticipated to grow at a CAGR of 15.8% during the forecast period. The rising stem cell research activities and increasing approvals of GMP-certified facilities to manufacture stem cells are key factors driving the market. The rise in the demand for induced pluripotent stem cells (iPSCs) as an alternative to embryonic stem cells (ESCs) and the growing demand for cell & gene therapies are further expected to promote market growth. Stem cell therapy is a form of regenerative medicine designed to repair damaged cells within the body by reducing inflammation and modulating the immune system.
Bioanalytical Testing Services Market Size, Share & Trends Analysis Report, By Molecule (Large Molecule and Small Molecule), By Test (Pharmacokinetic Test, Pharmacodynamic Test, Bioequivalence Test, Bioavailability Test, and ADME Test), By Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology, and Others), By End-User (Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, Contract Research Organizations, and Others), Forecast Period (2022-2028)
Published: Feb 2026
Bioanalytical testing services market is anticipated to grow at a CAGR of 10.6% during the forecast period. Bioanalytics is an important tool in drug discovery and development for analysing the concentration of drugs and their metabolites as well as various pharmacodynamic biomarkers in biological fluids. Bioanalytical testing services are used to measure the levels of various biomolecules in the sample. These tests are often used to diagnose and monitor diseases, and to evaluate the effectiveness of treatments.
Enteric Disease Testing Market Size, Share & Trends Analysis Report, By Pathogen Tested (E. coli, Salmonella, Campylobacter, and Listeria), By Technology (Traditional, Rapid, Polymerase chain reaction (PCR), Immunoassay, and Chromatography & Spectrometry), By End-User (Water and Food), Forecast Period (2022-2028)
Published: Feb 2026
Enteric disease testing market is anticipated to grow at a CAGR of 3.2% during the forecast period. Enteric diseases are caused by micro-organisms such as bacteria, viruses, and parasites that cause intestinal illness. These are caused mainly by consuming contaminated food or water or by contact with animals or their environments. The rising incidence of enteric diseases across the globe is resulting increasing demand for enteric disease testing. For instance, according to World Health Organisation (WHO), each year around 1.3 to 4 million peoples gets cholera and around 21,000 to 143,000 peoples die due to cholera across the globe, it is an acute diarrhoeal disease that can kill within hours if left untreated.
Central Nervous System Therapeutic Market Size, Share and Trends Analysis Report, By Indication (Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases, and Cancer), By Application (Hospital and Clinic, Homecare, and Others), By Drug Class (Immunomodulatory Drugs, Interferons, Decarboxylase Inhibitors, Dopamine Agonists, Antidepressants, and Others), Forecast Period (2022-2028)
Published: Feb 2026
Central nervous system therapeutic (CNS) market is anticipated to grow at a CAGR of 7.5% during the forecast period. Central nervous system disorder is a neurological disease that directly affects the functioning of the brain or spinal cord and other body parts. Stroke, Alzheimer's Disease, spinal cord disorders, and Parkinson's disease are some common central nervous system disorders. The rising prevalence of Parkinson’s disease across the globe is contributing to the growth of the global central nervous system therapeutics market.
Rabies Immunoglobulin Market Size, Share & Trends Analysis Report by Type (Human Rabies Immune Globulin (HRIG) and Equine Rabies Immuno Globulin (ERIG)) Forecast Period (2022-2028)
Published: Feb 2026
Rabies immunoglobulin market is anticipated to grow at a significant CAGR of 6.1 % during the forecast period. Rabies is a fatal disease although preventable viral disease. It can spread to people and pets if they are bitten or scratched by a rabid animal. In the US, rabies is mostly found in wild animals such as bats, raccoons, skunks, and foxes. However, in many other countries dogs still carry rabies, and most rabies deaths in people across the globe are caused by dog bites. The increasing prevalence of rabies is expected to drive the rabies immunoglobulin market during the forecast period.
Emergency Medical Services Market Size, Share & Trends Analysis Report by Product Type (Life Support and Emergency Resuscitation Systems, Patient Monitoring Systems, Wound Care Consumables, Personal Protection Equipment, and Others), by Application (Cardiac Care, Trauma Injuries, Respiratory Care, Oncology, and Other), and by End-User (Hospitals and Trauma Centers, and Ambulatory Surgical Centers), Forecast Period (2022-2028)
Published: Feb 2026
Emergency medical services market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period. The key factor contributing to the growth of the market is an increase in healthcare expenditure and a growth in several hospitals. With an increasing number of road accidents across the globe coupled with the urgency of treating patients, the demand for emergency medical services market has gained traction. For instance, in June 2022, as per the report published by World Health Organization (WHO), each year approximately 1.3 million people die as a result of a road traffic crash.
Blood Glucose Monitoring Systems Market Size, Share & Trends Analysis Report, By Product (Self-Monitoring Blood Glucose Systems (Blood Glucose Meters, Testing Strips, and Lancets), Continuous Glucose Monitoring Systems (Sensors, Transmitters, and Receivers)), By Application (Type 1 Diabetes and Type 2 diabetes), By End-User (Hospital, Home Care, and Diagnostics Center), Forecast Period (2022-2028)
Published: Feb 2026
blood glucose monitoring systems market is expected to grow at a CAGR of 6.5% during the forecast period. According to the World Health Organization (WHO), nearly 422 million people are suffering from diabetes across the globe. Diabetes is a chronic disease characterized by elevated levels of blood glucose, which leads over time to serious damage to the heart, blood vessels, eyes, kidneys and nerves. The blood glucose monitoring system allows patients to monitor the effects of medicines and identify the range of blood sugar level.
Global Menstrual Cup Market Size, Share, and Trends Analysis Report, by Product (Reusable, and Disposable), by Material Type (Latex, Thermoplastic, Natural Rubber, and Medical-Grade Silicone), and by End-User (Online Stores, Pharmacies, and Others) Forecast Period (2022-2028)
Published: Feb 2026
The global menstrual cup market is anticipated to grow at a significant CAGR of 6.5% during the forecast period. The key factors that are contributing to the market growth are as pads and tampons generate a lot of waste and these pads and tampons are not inaccessible and unaffordable for many individuals which in turn is creating demand for the menstrual cups market. Moreover, menstrual cups are made up of medical silicone, and they last up to 10 years on one-time purchase owing to their longer life span they are not much costly also.
Global Ambulatory EHR Market Size, Share & Trends Analysis Report by Delivery Mode(Cloud-Based and On-Premises), by Application(Practice Management, Population Health Management, E-Prescription, Health Analytics, and Referral Management), and by Practice Size(Large Practices, Small-to-Medium Practices, and Solo Practices) Forecast Period (2022-2028)
Published: Feb 2026
The global ambulatory EHR market is anticipated to grow at a significant CAGR of 5.5% during the forecast period. Ambulatory electronic health records is a software designed for storing and managing outpatient history. The software assists healthcare professionals to access patients' complete medical history and storing confidential information related to demographics, immunizations, and laboratory data. According to National Center for Chronic Disease Prevention and Healthcare, 6 in 10 Americans live with at least one chronic disease, such as heart disease, stroke, cancer, or diabetes.
Global Healthcare Technology Management Market Size, Share & Trends Analysis Report by Technology Type (Artificial Intelligence, Cloud, Blockchain, Internet of Things, Machine Learning, and Other), By Application (Electronic Health Records, Electronic Prescribing Systems, Tele-Healthcare, Medical Billing Software, Others), and by End-User (Healthcare Providers and Healthcare Payers), Forecast Period (2022-2028)
Published: Feb 2026
The global healthcare technology management market is anticipated to grow at a significant CAGR of 28.3% during the forecast period. Healthcare technology management (HTM) is the field responsible for managing the selection, maintenance, and safe use of all health technology and medical equipment found in healthcare. The growing trend of digitalization and home-based services/care in healthcare and the demand for preventive healthcare is significantly growing the healthcare technology management market across the globe.
Cleanroom Technologies Market Size, Share & Trends Analysis Report by Product (Fan Filter Units, HVAC, Vacuum Systems, and Disinfectants) and by Application (Pharmaceutical, Biotechnology, and Medical Device Manufacturers) Forecast Period (2024-2031)
Published: Feb 2026
Cleanroom technologies market is anticipated to grow at a significant CAGR of 8.2% during the forecast period (2024-2031). The market growth is attributed to the growing demand for cleanroom technologies in manufacturing facilities across a range of industries. It is anticipated that cleanroom technology will be more widely used to ensure the sterility of both the finished goods and the entire manufacturing process driving the growth of the market. According to the International Society for Pharmaceutical Engineering (ISPE), Pharmaceutical cleanrooms can consume up to 15 times more energy than commercial building systems, with more than 50.0% of electricity being consumed by plant HVAC cleanroom systems. This level of energy consumption is driven by the high air change rates required to ensure the air quality of pharmaceutical production.
Nasal Drug Delivery Market Size, Share & Trends Analysis Report by Dosage Form (Gels, Sprays, Drops and Liquids, and Others), by Containers (Non-Pressurized Containers, and Pressurized Containers) by Therapeutic Application (Rhinitis, Nasal Congestion, Asthma, and Others) and by End-User (Hospitals, and Home Health Care) Forecast Period (2024-2031)
Published: Feb 2026
Nasal drug delivery market is anticipated to grow at a CAGR of 7.8% during the forecast period (2024-2031). Nasal drug delivery is gaining popularity owing to its various advantages such as rapid onset of action, easy administration, and avoidance of first-pass metabolism. This method has been particularly highlighted during the COVID-19 pandemic for its potential to deliver vaccines and respiratory treatments. Ongoing research and development efforts are focused on improving delivery efficiency and addressing unmet medical needs in this field.
Global Mental Health Apps Market Size, Share & Trends Analysis Report by Type (Free Apps and Paid Apps), by Platform Type (iOS, Android, and Others), and by Application (Depression and Anxiety Management, Meditation Management, Stress Management, Wellness Management, and Others) Forecast Period (2022-2028)
Published: Feb 2026
The global mental health apps market is anticipated to grow at a significant CAGR of 8.5% during the forecast period. The market growth is driven by the major factors which include increasing demand for mental health apps due toincreased incidence of mental health conditions among population especially among youngsters, rise in stress levels in society, increasing drug addiction. Apart from thisinternational awareness programs being promoted by the World Health Organization (WHO), each year on mental health day and other WHO also give 24x7 support on the online platform. Moreover, changing lifestyles and rising stress levels have deteriorated health among people. Mental health apps have gained increased popularity to help individuals cope with the limitations of personal treatment, particularly during COVID-19. In addition, several companies nowadays offer employees insurance benefits under this they usually include subscriptions to top mental health apps.
Global Healthcare Information System Market Size, Share & Trends Analysis Report by Deployment Type (On-Premises and Cloud-Based), by Application (Hospital Information system, Laboratory Information system, Pharmacy Information System, and Radiology Information System), and by End-User (Hospitals and Diagnostic Centers) Forecast Period (2022-2028)
Published: Feb 2026
The global healthcare information system market is anticipated to grow at a CAGR of 10% during the forecast period. The market growth is attributed to the increasing government initiatives and spending for providing better healthcare services. Further, growing investment by healthcare IT companies gives a boost to the growth of the healthcare information system industry. Healthcare Information System is an approach to managing information and communication systems and technology that facilitate quality patient care, innovative research, and progressive medical education.
Healthcare Cloud Computing Market Size, Share & Trends Analysis Report by Deployment (Private Cloud, Hybrid Cloud, and Public Cloud), Service Model (Software-as-a-service, Platform-as-a-service, and Infrastructure-as-a-service), Application (Clinical Information Systems (CIS), and Non-clinical Information Systems (NCIS)) and End-User (Healthcare Providers, Insurance Companies, Pharmaceutical Companies, and Research Institutes) Forecast Period (2025-2035)
Published: Feb 2026
Healthcare cloud computing market valued at $51.3 billion in 2024, is forecasted to grow at a 12.8% CAGR, reaching $190.4 billion in 2035. Healthcare cloud computing solutions are gaining widespread traction across the healthcare sector based on a growing region-level focus on developing digitized healthcare ecosystems, increasing deployment of cloud-based software by end-user organizations, and regulatory frameworks promoting digital record management and data transparency, among others. Further, the rising utilization of healthcare cloud solutions by virtual healthcare providers is projected to be a key contributor to healthcare cloud computing market expansion.
Healthcare Facility Management Market Size, Share & Trends Analysis Report by Location (On-Site Facility Management and Off-Site Facility Management), by Service (Hard Service, Construction Services, and Energy Services), and by Settings (Acute, Post-Acute and Non-Acute), Forecast Period (2025-2035)
Published: Feb 2026
Healthcare facility management market is valued at $102,763 million in 2024 and is projected to reach $203,834 million by 2035, growing at a CAGR of 6.5% during the forecast period (2025–2035). This expansion is fueled by the mounting complexity of healthcare facilities, heightened concern for patient experience, and the necessity for simplified operations. Healthcare facilities are outsourcing more facility management to specialized companies to maximize efficiency and lower costs. The market is characterized by a wide variety of services, ranging from cleaning, catering, and waste management to security, maintenance, and energy management, all designed to meet the specific needs of healthcare environments.
Ostomy Deodorant Market Size, Share & Trends Analysis Report by Product (Liquid, Tablets, and Others), by Application (Hospitals, Clinics, and Others), Forecast Period (2026–2035)
Published: Mar 2026
Ostomy deodorant market was valued at $210.05 million in 2025 and is projected to reach $315.12 million by 2035, growing at a CAGR of 4.2% during the forecast period (2026-2035). The Global Ostomy Deodorant Market is growing due to the steady increase in ostomy procedures worldwide, driven by rising incidences of colorectal cancer, inflammatory bowel diseases, and urological disorders. Growing awareness around post-operative stoma care and patient hygiene is supporting consistent demand across healthcare settings. Continuous product improvements aimed at better odor control, skin compatibility, and ease of use are enhancing patient acceptance and repeat usage. Expansion of home care and outpatient treatment models is further contributing to sustained consumption beyond hospital settings. In addition, improving access to ostomy care products through pharmacies, distributors, and online channels is strengthening market penetration across both developed and emerging regions.
Global Soft Filler Market Size, Share & Trends Analysis Report By Application (Face-Lift, Lip Enhancement, Facial Line Correction Treatment, and Others), By Type (Collagen Fillers, Poly-L-Lactic Acid (PLLA), Hyaluronic Acid (HA), Calcium Hydroxylapatite (CaHA), and Others, and By End-Users (Dermatology Clinics, and Hospitals) Forecast 2022-2028
Published: Feb 2026
The global soft filler market is anticipated to grow at a significant CAGR of 9.7% during the forecast period. During the forecast period, the soft filler market will progress due to an expanding network of healthcare facilities offering advanced aesthetic treatments and improved infrastructure. In recent years, both developed and developing countries have seen a significant increase in the number of facilities such as clinics, medical spas, and rejuvenation centers. Thus, the rapid adoption of various non-invasive treatments provided by these facilities will propel industry growth due to benefits such as cost-effectiveness and shorter treatment duration. Furthermore, an increasing number of skilled professionals such as dermatologists and plastic surgeons will contribute to the industry's growth.
Disabled Fitness Platform Market Size, Share & Trends Analysis Report by Application (Exercise & Weight Loss, Diet & Nutrition, and Activity Tracking), by Operating System (Android and IOS), and by Device (Smartphones, Tablets, and Wearables) Forecast Period (2026-2035)
Published: Mar 2026
Global disabled fitness platform market was valued at $3.3 billion in 2025 and is projected to reach $24.6 billion by 2035, growing at a CAGR of 22.3% from 2026 to 2035.
Pyrogen Testing Market Size, Share & Trends Analysis Report by Product & Services (Assays, Kits & Reagents, Instruments, and Services), By Test Type (LAL, Monocyte Activation, Chromogenic, Turbidimetric, Gel Clot, In Vitro, Rabbit, and Others), By End-User (Pharmaceutical companies, Biotechnology Companies, Medical Device Companies and, Others), Forecast Period (2026-2035)
Published: Mar 2026
Global pyrogen testing market was valued at $1.5 billion in 2025 and is projected to reach $5.8 billion by 2035, growing at a CAGR of 10.7% from 2026 to 2035.
Automatic Pill Dispenser Market Size, Share & Trends Analysis Report by Product (Vertical Carousel Automated Dispensing Systems, Robots/Robotic Automated Dispensing Systems, and Decentralized Automated Dispensing Systems), and by Application (Hospital Pharmacy, Retail Pharmacy, and Home Healthcare) Forecast Period, (2026-2035)
Published: Mar 2026
Automatic pill dispenser market was valued at $3.30 billion in 2025 and is projected to reach $6.51 billion by 2035, growing at a CAGR of 7.1% during the forecast period (2026-2035). The global automatic pill dispenser market is growing due to rising medication complexity across hospital, retail pharmacy, and home healthcare settings, which increases the need for accurate, automated dispensing solutions. Healthcare providers are adopting vertical carousel and robotic automated dispensing systems to improve workflow efficiency, reduce manual handling, and support centralized pharmacy operations. In parallel, decentralized automated dispensing systems are gaining traction as hospitals seek point-of-care medication access while maintaining inventory control and traceability. Growth in home healthcare services is further supporting demand for automated pill dispensers that enable adherence monitoring and scheduled dosing outside institutional settings.
Digital Healthcare Market Size, Share & Trends Analysis Report by Technology (Telehealthcare, mHealth, Apps, and Health Analytics), and by Components (Hardware, Software, and Services) Forecast Period, (2026-2035)
Published: Mar 2026
Digital healthcare market was valued at $434.3 billion in 2025 and is projected to reach $1,791.5 billion by 2035, growing at a CAGR of 15.3% during the forecast period (2026-2035). The global digital healthcare market is progressing steadily as healthcare providers, payers, life sciences companies, and public health systems intensify their focus on improving care accessibility, clinical outcomes, and operational efficiency through data-driven and technology-enabled models. Growth is being reinforced by the expanding adoption of tele healthcare platforms, mobile health (mHealth) solutions, healthcare applications, and health analytics, which enable continuous patient monitoring, remote consultations, personalized care delivery, and real-time clinical decision support across the care continuum. The integration of artificial intelligence, machine learning, cloud computing, and interoperable health data platforms is further enhancing digital healthcare capabilities by enabling early disease detection, predictive risk stratification, workflow automation, and population health management. Demand is additionally supported by rising digital transformation initiatives across hospitals, diagnostic centers, pharmaceutical companies, and public health agencies, where digital solutions help reduce care delivery costs, address workforce shortages, improve patient engagement, and expand healthcare access in both urban and remote settings.
Gastrointestinal Stent Market Size, Share & Trends Analysis Report by Product Type (Biliary Stent, Duodenal Stent, Colonic Stent, Pancreatic Stent, Esophageal Stent), By Technology Type (Anti Migratory Stent, Drug Eluting Stent, Radioactive Stent, Anti Reflux Stent, and Shape Modified Stent), By Material (Plastic Stent, Self-Expanding Metal Stent, Covered Self Expandable Metallic Stent, Biodegradable or Drug Eluting Stent) And By End-User (Hospital, Specialty Clinic and Ambulatory Surgical Center), Forecast Period (2026-2035)
Published: Mar 2026
Gastrointestinal stent market was valued at $540.2 billion in 2025 and is projected to reach $892.3 billion by 2035, growing at a CAGR of 5.2% during the forecast period (2026-2035). The global gastrointestinal stent market is experiencing consistent growth, driven by the increasing incidence of gastrointestinal disorders, including malignant and benign obstructions. Rising preference for minimally invasive procedures has led to greater utilization of gastrointestinal stents across hospitals and specialty clinics. Continuous advancements in stent technologies, such as improved material composition and enhanced anti-migratory features, have strengthened clinical outcomes and procedural efficiency. The growing elderly population, which is more prone to gastrointestinal complications, has further contributed to sustained market demand. Expansion of healthcare infrastructure and improved access to advanced endoscopic treatments in developing regions are also supporting market growth. Additionally, heightened awareness among healthcare professionals regarding early intervention and effective disease management continues to positively influence the market outlook during the forecast period.
Botanical Drug Market Size, Share & Trends Analysis Report by Source (Plant, Algae, and Macroscopic Fungi), by Dosage Form (Tablets, Injections, and Pills), by Therapeutic Application (Central Nervous System Disorders, Cardiovascular Diseases, Respiratory Diseases, and Others), Forecast Period (2026–2035)
Published: Mar 2026
Botanical drug market size was valued at $23.2 billion in 2025 and is projected to reach $46.0 billion by 2035, growing at a CAGR of 7.1% during the forecast period (2026-2035). The botanical drug market is expanding due to increasing acceptance of plant-derived therapies within regulated pharmaceutical frameworks. The rising incidence of chronic and lifestyle-related disorders has supported demand for treatments with well-documented safety profiles. Greater investment in clinical validation and standardization of botanical formulations has improved physician confidence and prescription uptake. Supportive regulatory pathways in several regions have enabled faster approvals for evidence-based botanical drugs. Advancements in extraction, purification, and quality control technologies have further strengthened commercial viability and scalability.
Adaptogen Market Size, Share & Trends Analysis Report by Nature (Natural and Synthetic), By Source (Ashwagandha, Ginseng, Astragalus, Turmeric and Others (Cordyceps & Holy Basil), and By Application (Food and Beverages, Pharmaceuticals, Nutraceuticals, Cosmetics & Personal Care and Animal Feed) By Distribution Channel (Online and Offline) Forecast Period (2026-2035)
Published: Mar 2026
Adaptogen market was valued at $3,895.0 million in 2025 and is projected to reach $8,253.2 million by 2035, growing at a CAGR of 7.9% during the forecast period (2026-2035). The global adaptogen market is expanding as organizations place greater emphasis on maintaining cleaner and safer environments. Many industries are adopting these coatings to help manage surface contamination and support long-term hygiene standards. Manufacturers are responding with improved formulations that offer reliable protection without altering routine maintenance practices. This has encouraged broader use across healthcare, transportation, food facilities, and commercial buildings. As expectations around safety continue to evolve, businesses are increasingly relying on coatings that add an extra layer of assurance. These factors together are contributing to steady market growth globally.
Global 3D Printing In Healthcare Market Size, Share and Trends Analysis Report, By Technology (Stereo Lithography, Deposition Modeling, Electron Beam Melting, Laser Sintering, Jetting Technology, Laminated Object Manufacturing, and Others), By Application (Medical Implants, Prosthetics, Wearable Devices, Tissue Engineering, and Others), By Material (Metal and Alloy, Polymer, and Others), Forecast (2022-2028)
Published: Feb 2026
The global 3D printing in the healthcare market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). 3D printing is also known as additive manufacturing. It is a process of making dimensional solid objects in healthcare industries. The creation of a 3D printed object is achieved using additive processes and is created by laying down successive layers of material until the object is created.
Global Anti-Aging Cosmetics Market Size, Share & Trends Analysis Report By Product Type (Skin Care, Hair Care, Eye Care, and Others) By Product Foam (Cream, Lotion, Serum, and Others) By Distribution Channel (Supermarkets & Hypermarkets, Convenience Stores, Online Stores, and Others) Forecast 2022-2028
Published: Feb 2026
The global Anti-Aging Cosmetics market is anticipated to grow at a considerable CAGR during the forecast period. The factor which can be seen as a driving pull to the growing demand for these anti-aging cosmetics is that the consumers are aware about skin problems which occur by growing age such as wrinkles, fine lines and dullness of skin. Apart from this reasons, growing pollution and bad lifestyle are causing a threat to skin care. Alcohol consumption deteriorates natural glow of the skin. Exposure to air pollution and UV rays make skin texture dull which ultimately leads to bad skin health. Market players in this segment are providing a variety of skin care options through which consumers can get professional medical treatment for skin rejuvenation.
Tendonitis Treatment Market Size, Share & Trends Analysis Report by Condition (Achilles Tendonitis, Epicondylitis Treatment, Others) By Treatment (Medicines/Drug Therapy, Surgical Treatment, Physical therapy, Shockwave Therapy, and Others) Forecast Period, (2026-2035)
Published: Mar 2026
Tendonitis treatment market was valued at $3,445 million in 2025 and is projected to reach $8,837.2 million by 2035, growing at a CAGR of 7.9% during the forecast period (2026-2035). The tendonitis treatment market is expanding due to the rising incidence of musculoskeletal disorders associated with occupational strain and sports-related activities. Increased preference for early, non-invasive management has led to higher utilization of physical therapy and shockwave-based interventions. Advancements in diagnostic accuracy have enabled the timely identification of tendon injuries, supporting consistent treatment adoption. Growing awareness among patients and clinicians regarding long-term functional outcomes has strengthened adherence to structured treatment protocols. In addition, incremental improvements in therapeutic devices and pharmacological formulations continue to support sustained market demand.
Global Weight Reduction Medicine Market Size, Share & Trends Analysis Report By Product Type (Prescription And Over The Counter), By Application (Appetite Suppression, Fat Blocking, And Others), And By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies And Online Pharmacies) Forecast 2022-2028
Published: Feb 2026
The weight reduction medicine market is anticipated to grow from rate of growth during the forecast period. Weight reduction medicine market is anticipated to grow in the coming years as people are facing obesity issues which is an alarming situation for them. According to WHO, 39% of people in the world above the age of 18 are overweight. Obesity is leading to further health issues like high blood pressure, diabetes, hypertension, and cardiac diseases. It is seen that consumers are getting conscious about their health and are focusing on maintaining a healthy diet chart and getting rid of obesity, which is turn creating a significant scope for the weight reduction medicines.
Global Halquinol Market Size, Share and Trends Analysis Report, By Type (95% Content, and < 95% Content), By Application (Veterinary Medicine, Feed, and Others), Forecast (2022-2028)
Published: Feb 2026
The global halquinol market is anticipated to grow at a significant CAGR 7.7% during the forecast period (2022-2028). Halquinol is an antimicrobial compound. It belongs to the hydroxyl-quinolines group which is a combination of 5-Chloro-8-hydroxyquinoline, 5,7-Dichloro-8-hydroxyquinoline. 7-Chloro-8-hydroxyquinoline. Additionally, it exerts its antibacterial activity in the digestive tract when taken orally. The major factor driving the demand for the global halquinol market during the forecast period is the increasing adoption of halquinol over conventional antibiotics. across the globe.
Global Glycosylated Hemoglobin And C Peptide Market Size, Share & Trends Analysis Report By Product (Tablet, Capsules, Injectable, and Others), By Application (Oncology, Blood Disorder, Diabetes, and Other) Forecast 2022-2028
Published: Feb 2026
The global glycosylated hemoglobin and c peptide market is anticipated to grow at a considerable CAGR during the forecast period. Glycosylated hemoglobin is used to evaluate the recent blood glucose level in patients who are suffering from diabetes. It is not used to measure the fluctuation of blood glucose in patients. An increase in the blood glucose level of people who have diabetes is directly related to the decline of islet function. In the case of type 1 diabetes, the fluctuation in blood glucose level can be seen by the GA/HBA1C ratio and it is considered much more convenient than MAGE. For patients who have a low C peptide level, their GA/HBA1 C ratio is high than those patients who have their C peptide level high.
Global Stem Cell Source Market Size, Share & Trends Analysis Report by Type (Allogeneic, and Autologous), and by Application (Research, Therapeutics, Oncology, Musculoskeletal Disorder, Blood Disorder, Autoimmune Disease, and Others) Forecast 2022-2028
Published: Feb 2026
The global stem cell source market is anticipated to grow at a significant CAGR of 15.5% during the forecast period. The increasing prevalence of chronic diseases aided the growth of the stem cell therapy market. Long working hours, insufficient physical activity, and unhealthy eating and drinking habits all contributes to the prevalence of chronic diseases, driving the need for stem cell therapy. According to a United Nations article, the proportion of global deaths caused by chronic diseases is expected to rise to 70% of total deaths by 2030. The global burden of chronic diseases is expected to be around 60% in upcoming years.
Global Soft Tissue Fillers Market Size, Share & Trends Analysis Report, By Type (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid (PLLA), and Polymethylmethacrylate Beads), By Application (Micro-Plastic and Cosmetic, Anti-Aging, and Others), Forecast (2022-2028)
Published: Feb 2026
The global soft tissue fillers market is expected to grow at a significant CAGR 7.7% during the forecast period (2022-2028). Soft tissue fillers are substances that plump up the skin or the tissue beneath it – are used to smooth out wrinkles that emerge as the skin's collagen and elastin fibres break down. Aging, excessive squinting, frowning, smiling, and, especially, smoking are all factors that contribute to this breakdown. Fillers can also be used to replace volume lost due to ageing or weight reduction.
Global Rare Disease Drug Market Size, Share & Trends Analysis Report By Drug Type (Biologics and Non-Biologics), and By Therapeutics Area (Cancer, Blood-related Disorders, Central Nervous System, Respiratory Disorders, Cardiovascular Disorders, and Others ) Forecast Period (2022-2028)
Published: Feb 2026
The global rare disease drug market is anticipated to grow at a significant CAGR of 11.4% during the forecast period. The rising prevalence of rare diseases and their implications for healthcare spending have boosted demand for specialized treatments, leading to growth in the rare disease drug market. In addition, as product development continues, new technologies for diagnosing uncommon genetic illnesses are becoming more available which is supporting the growth of the market. Furthermore, favorable government policies aimed at raising awareness about the treatment of rare diseases are leading to an increase in the use of effective medicines for uncommon disorders. However, limited understanding of pathology and progression is acting as a restraining factor to the growth of the market.
Global Probiotic Powder Market Size, Share & Trends Analysis, By Type (Bifidobacterium, Lactobacillus, and Others), By Application (Food and Beverage, Pharmaceuticals, Dietary Supplements, and Others), Forecast (2022-2028)
Published: Feb 2026
The global probiotic powder market is expected to grow at a significant CAGR 6.8% during the forecast period (2022-2028). When consumed in sufficient amounts, probiotics have beneficial effects on the body, including better gut health and reduced intestinal inflammation. Probiotics are important in preventive healthcare as they improve the immune system, which supports to prevent disease. The probiotics powder market is driven by consumer demand for health-related products, particularly among the younger population. Functional foods and beverages contain probiotics. Probiotic usage increased exponentially in 2020, according to a survey done by Natural Marketing Institute in May 2020.
Global Omega Products Market Size, Share & Trends Analysis Report By Type (Docosahexaenoic Acid, Eicosapentaenoic Acid, Alpha-Linolenic Acid), By Source (Marine, Plant Oils, and Nuts & Seeds), By Application (Dietary Supplements, Functional Food & Beverages, Pharmaceuticals, And Others) Forecast 2022-2028
Published: Feb 2026
Global Omega product market is anticipated to grow by 2028 at a CAGR of 7.9%. The factor which can be seen as a driving pull to the growing demand for omega products is growing awareness of consumers towards more healthy clean foods. Consumers are nowadays getting more attracted towards organic and pure consumables. Consumer awareness among people for building more immunity after the covid-19 pandemic is also seen as a major driver for this market. With changing times, gut problems are also arising in major populations, and omega products are seen to benefit in medical conditions related to the stomach such as Inflammatory bowel syndrome. Another driver for this market is the use of omega in animal and fish foods.
Global Human Immunoglobulin Market Size, Share & Trends Analysis Report By Type (Liquid and Powder), and By Disease Indication (Infectious hepatitis and Measles) Forecast 2022-2028
Published: Feb 2026
The global human immunoglobulin market is anticipated to grow at a significant CAGR of 6.4% during the forecast period. Hypogammaglobulinemia is considered a problem with the immune system that prevents it from making enough antibodies that are known as immunoglobulins. So, a large increase in the prevalence of hypogammaglobulinemia disorders around the globe is a considered major factor that is driving the growth of the market. Additionally, COVID-19 infection is common in cancer patients, especially those with hematologic malignancies.
Global Herbal Oil Market Size, Share & Trends Analysis Report, By Product Type (Orange, Citronella, Corn Mint, Eucalyptus, and Others), By Application (Food and Beverages, Pharmaceutical, Cosmetics and Personal Care Products, Spa and Salon Products, and Others), Forecast (2022-2028)
Published: Feb 2026
The global herbal oil market is expected to grow at a significant CAGR 6% during the forecast period (2022-2028). Manufacturers are shifting their attention from synthetic to natural products as consumer awareness of natural and herbal personal care products has grown, which in turn, is driving the growth of the market. Due to changing consumer lifestyles, a plethora of factors, such as growing awareness of the benefits of natural products, consumer focus on health and wellbeing, and millennial trends are some factors contributing to the market growth.
Global Gluten-Free Probiotics Market Size, Share & Trends Analysis, By Product (Bifidobacterium, Lactobacillus, Other), By Application (Food and Beverage, Pharmaceuticals, Dietary Supplements, and Others), Forecast (2022-2028)
Published: Feb 2026
The global gluten-free probiotics market is expected to grow at a significant CAGR 5.5% during the forecast period (2022-2028). Gluten is a protein that can be found in plants including wheat, rye, and barley. Gluten-intolerant people can switch to a gluten-free diet, which often includes beans, fresh meats, fresh eggs, fish, poultry, fruits and vegetables, as well as most dairy products. Furthermore, some grains and starches can be included in a gluten-free diet. A gluten-free probiotic aids in the proper functioning of digestive system. Most common digestive issues can be alleviated by taking a gluten-free probiotic supplement on a daily basis among people with gluten intolerance. One of the top benefits of gluten-free probiotics for women is improved vaginal health.
Global Resection Guides Market Size, Share and Trends Analysis Report, By Type (Knee Prosthesis, Hip Prosthesis, Ankle Prosthesis and Cranial Prosthesis), By Application (Hospitals and Surgical Clinics, Medical Colleges and Others), Forecast (2022-2028)
Published: Feb 2026
The global resection guides market is anticipated to grow at a significant CAGR 5.3% during the forecast period (2022-2028). Resection is the medical term used for surgically removing a part or all of a tissue, structure or organ and is performed for a wide variety of reasons. It may remove a tissue that is cancerous or diseased. The surgery may treat or cure a disease process. The major factor driving the demand for resection guides is the rising number of surgeries across the globe.
Oral Dissolvable Films Market Size, Share and Trends Analysis Report, By Product (Sublingual Film and Fast Dissolving Dental/Buccal Film), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Others), Forecast (2023-2030)
Published: Feb 2026
The global oral dissolvable films market is anticipated to grow at a significant CAGR 8.9% during the forecast period (2023-2030). Orally dissolving films (ODFs) are also known as oral thin films. It provides a quick release of an active pharmaceutical ingredient (API) when placed on the tongue without the intake of water and is used as an alternative to orally disintegrating tablets. It is a kind of drug delivery system. The major factor driving the demand for oral dissolvable films is the new product launches and approvals across the globe.
Global Meniscal Rasps Market Size, Share and Trends Analysis Report, By Type (Manual Meniscal Rasps and Electrical Meniscal Rasps), By Application (Hospital, Clinic and Others), Forecast (2022-2028)
Published: Feb 2026
The global meniscal rasps market is anticipated to grow at a significant CAGR 8.7% during the forecast period (2022-2028). Meniscal rasps provide the additional benefit of reduced healing time and plays important role in arthroscopic surgery of the knee involving meniscal tear. Arthroscopic surgeries that involve meniscal rasps are minimally invasive surgery. Hence, they are preferred as curative treatment of meniscal tears due to less healing time. The market is growing due to the increasing awareness about the benefits of meniscal rasps in arthroscopic surgeries as well as significant efforts by the key manufacturers in the global meniscal rasps market.
Global Coronary Guidewires Market Size, Share and Trends Analysis Report, By Material (Nitinol, Stainless Steel and Others), By Coating (Coated (Hydrophilic, Hydrophobic), and Non-Coated), Forecast (2022-2028)
Published: Feb 2026
The global coronary guidewires market is anticipated to grow at a significant CAGR 5.9% during the forecast period (2022-2028). Coronary guidewires are specialized pieces of equipment. They are used to deliver therapies to diseased areas of the coronary arterial system. These guidewires have the properties of steerability, traceability, flexibility and are used in minimally invasive surgeries. The major factor driving the demand for coronary guidewires is the rising number of minimally invasive surgeries along with the increasing prevalence of cardiovascular diseases (CVDs) across the globe.
Global Radiation Injury Drugs Market Size, Share & Trends Analysis Report, By Type (Aerosurf, BMX-001, C-2E2, C-2E5, Des-Asp Angiotensin 1, DG-3, and Others), By Application (Ambulatory Surgical Centers, Hospitals and Clinics, and Others), Forecast (2022-2028)
Published: Feb 2026
The global radiation injury drugs market is anticipated to grow at a significant CAGR 4.5% during the forecast period (2022-2028). Radiation injury is defined as the damage of tissues due to exposure of ionizing radiation. The ionizing radiation given in large dose may injure the healthy human cells and even result in acute illness leading to decrease in the production of blood cells and harm the gastrointestinal tract. It also results in the damage to cardiovascular health, blood vessels, brain and especially skin. The major factor attributable to the market growth include the high prevalence of cancer patients globally who further opt for the radiation therapy.
Global Flexible Spinal Implants Market Size, Share & Trend Analysis Report by Type (Cages, Rods, Screws, and Plates), by End-User (Hospitals and Clinics, and Ambulatory Surgical Centers) Forecast 2022-2028.
Published: Feb 2026
The global flexible spinal implants market is expected to grow at a significant CAGR of 4.8% during the forecast period. The spine problems caused due to aging in old-age people are expected to be the reason for the demand for spinal implants devices. According to United Nation reports, there were 703 million persons aged more than 65 years and the projected number of old-age people is expected to get double to 1.5 billion by 2050. The spinal implants make it easier for old age people to recover from damages and problems caused due to weakening of the spine with age.
Global Eye Health Ingredients Market Size, Share & Trends Analysis Report, By Product Type (Lutein, Zeaxanthin, Beta Carotene, and Others), By Source (Natural and Synthetic), By Disease Indication (Age related Macular Degeneration, Cataract, and Dry Eye Syndrome) Forecast (2022-2028)
Published: Feb 2026
The global eye health ingredients market is expected to grow at a significant CAGR 7% during the forecast period (2022-2028). The market has been growing in recent years, as the world's population has gotten older, and consumers have been more interested in nutrition-based age-related disease prevention. The carotenoids lutein and zeaxanthin, which are found in the inner region of the retina (the macula) and protect the eye from UV damage, are often utilized in eye health products. However, there are hundreds of other carotenoids found in nature that, while not found in the eye, have been shown to be beneficial to eye health in studies.
Global Eye Care Supplements Market Size, Share & Trends Analysis Report, By Type (Lutein and Zeaxanthin, Antioxidants, Omega-3 Fatty Acids, Coenzyme Q10, and Others), By Form (Tablets, Capsules, Powder, and Others), Forecast (2022-2028)
Published: Feb 2026
The global eye care supplements market is expected to grow at a significant CAGR 6.3% during the forecast period (2022-2028). The market is being driven by a growing senior population, increased exposure to blue light, and an increase in the prevalence of various vision problems such as macular degeneration, refractive errors, cataracts, inflammation, diabetic retinopathy, corneal opacity, trachoma, and dry eye syndrome. According to the World Health Organization, 2.2 billion individuals worldwide were affected by visual impairments or blindness in 2019, with 1 billion having moderate to severe distance vision impairment. Most of these vision impairments are due to uncorrected refractive errors (123.7 million) and cataract (65.2 million).
Global Erythropoietin Drugs Market Size, Share & Trends Analysis Report, By Drug Class (Epoetin Alfa, Epoetin Beta, and Others), By Application (Hematology, Kidney Disorder, Cancer, Others), Forecast (2022-2028)
Published: Feb 2026
The global erythropoietin drugs market is expected to grow at a significant CAGR 9.5% during the forecast period (2022-2028). Hematopoietin medications are also known as erythropoietin drugs. It's a glycoprotein hormone that controls erythropoiesis, or RBC creation. They are used to treat a variety of illnesses, including cancer, chronic kidney disease, AIDS, anaemia, and many more. When one or more of these factors are present, erythropoietin medications may fail to achieve an effective therapeutic response. Vitamin B12 or folate deficit, occult blood loss and/or iron deficiency Infection and inflammation are two terms used interchangeably.
Global Dental Wax Market Size, Share and Trends Analysis Report by Product Type (Pattern wax, Processing Wax, Impression Wax, Healing Wax), by Product Application (Hospitals, Dentist Clinics, and Academic and Research Centres) Forecast (2022-2028)
Published: Feb 2026
The global dental wax market is anticipated to grow at a CAGR of 4.73% during the forecast period 2022-2028. As dental wax is a mixture of different types synthetic used for casting, sizing, and mapping it is extensively used in the treatment of dental. The influence of media and the fashion industry on rising dental aesthetics demand and increasing awareness is increasing the growth of the dental market. There are several of wax used in dental treatment. Self-setting dental waxes are used for the purpose of mapping dental structures during the manufacturing of dental caps. Softer dental waxes are used to get relief from the discomfort caused by braces, wires, etc. Dental wax takes a long time to heal due to their tissue softening effect and this makes it difficult of the natural hardening tissue process which in turn may hamper the demand for the dental.
Global Dental Adhesive Market Size, Share and Trends Analysis Report by Application (Denture Adhesives, Pit and Fissure Sealants, Restorative Adhesives, and Others), By End-Use (Dental Hospitals and Clinics, Dental Academic and Research Institutes, and Laboratories), Forecast 2022-2028
Published: Feb 2026
The dental adhesive market is expected to grow at a significant CAGR of 6.0% during the forecast period. A dental adhesive is a water-soluble, non-toxic material used to apply to gums and dentures to hold them in place. Dental adhesives are available in different forms such as powder and cream and are typically used with traditional dentures. The reason behind the growth of the market is the increasing geriatric population having conditions such as dry mouth (xerostomia), periodontitis, root, and coronal caries, unhealthy food habits in the young population, and other factors.
Global Granulocyte Macrophage Colony Stimulating Factor Market Size, Share & Trends Analysis Report, By Route of Administration (Subcutaneous Bolus and Intravenous Infusion), By Application (Fungal Infections, Skin-Graft, Cut-Burn Wounds, Acute Myelogenous Leukemia, and Others), By End-User (Hospitals and Clinics, Surgical Centers, Diagnostic Centers, Research Centers, and Others), Forecast (2022-2028)
Published: Feb 2026
The global granulocyte macrophage colony stimulating factor market is anticipated to grow at a significant CAGR 10.8% during the forecast period (2022-2028). Granulocyte macrophage colony-stimulating factor, also called as CSF2 (colony stimulating factor 2), is a monomeric glycoprotein released by usual killer cells, T cells, mast cells, macrophages, fibroblasts, and endothelial cells that acts as a cytokine. The COVID-19 pandemic has significantly affected the global granulocyte macrophage colony stimulating factor market.
Global Inhalation and Nasal Spray Generic Drugs Market Size, Share & Trend Analysis Report by Indication (Allergic Rhinitis, Asthma, and COPD), by Class (Bronchodilators, Corticosteroids Antihistamine, Decongestant, and Others) Forecast (2022-2028)
Published: Feb 2026
The global inhalation and nasal spray generic drugs market is expected to grow at a significant CAGR of around 7.9% during the forecast years. Changing the environment can be expected to be the driver of growth in the market. As, these inhalation and nasal spray drugs are used for the treatment of runny, stuffy, itchy nose, sneezing, watery eyes, and many other allergy problems people face due to the continuous changing of environment. People nowadays are exposed to too much dirt which can cause these allergy problems increasing demand for these nasal and inhalation sprays to treat their allergies. For instance, there are several antihistamine and decongestant nasal sprays including Dymista Afrin, Vicks Sinex, Astelin, Astepro, and Many others.
Global Telomerase Reverse Transcriptase Market Size, Share & Trends Analysis Report, By Product (ASTVAC-1, ASTVAC-2, ETS-2300, and Others), By Application (Lung Cancer, Ovarian Cancer, Breast Cancer, and Others), Forecast (2022-2028)
Published: Feb 2026
The global telomerase reverse transcriptase market is anticipated to grow at a significant CAGR 3.1% during the forecast period (2022-2028). Telomerase is an enzyme that is vital for the aging of the cells. It has been a promising tool in biotechnology to treat cancer. Telomeres are made of repetitive sequences of non-coding DNA that protect the chromosome from damage. Each time a cell divides, the telomeres become shorter. Eventually, the telomeres become so short that the cell can no longer divide. Telomerase reverse transcriptase is a product of recombinant DNA technology which is formulated to treat major forms of cancers such as ovarian cancer, lung cancer, and breast cancer.
Global Polyclonal Antibody Market Size, Share & Trends Analysis Report, By Type (Primary Antibody and Secondary Antibody), By Application (Academic Research and Commercial), Forecast (2022-2028)
Published: Feb 2026
The global polyclonal antibody market is anticipated to grow at a significant CAGR 5.1% during the forecast period (2022-2028). These antibodies are defined as a composition of a mixture of antibodies that correspond to the natural immune response to an antigen and are highly used in general research applications. The major factor attributable to the market growth includes the increasing application of polyclonal antibody in various research applications. Adding to this, the rising incidence of cancer backed by the significant rise in awareness campaigns and research funding on cancer, is likely to boost further use of polyclonal antibodies in the disease treatment.
Global Plasma Thromboplastin Antecedent Market Size, Share & Trends Analysis Report, By Type (BAY-1213790, BMS-262084, EP-7041, IONIS-FXILRx, and Others), By Application (CVD, Infectious Disease, Thrombosis, and Others), Forecast (2022-2028)
Published: Feb 2026
The global plasma thromboplastin antecedent market is anticipated to grow at a significant CAGR 4.9% during the forecast period (2022-2028). Plasma thromboplastin antecedent is a clotting factor whose absence is associated with a form of hemophilia coagulation factor (whose deficiency results in a hemorrhagic tendency). The major factor attributable to the market growth includes the rising prevalence of CVD, thrombosis, infectious disease, and other diseases globally. Among these, the growing global population suffering from CVD illnesses is the primary factor for the increased market growth. Globally, almost 15 million people suffer from heart attacks or similar issues, according to the World Heart Federation. In the US, one person dies from cardiovascular disease every 36 seconds.
Global Lysosomal Alpha Glucosidase Market Size, Share & Trends Analysis Report, By Product (Myozyme and Lumizyme), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), Forecast (2022-2028)
Published: Feb 2026
The global lysosomal alpha glucosidase market is anticipated to grow at a significant CAGR 3.5% during the forecast period (2022-2028). Lysosomal alpha glucosidase is termed as a recombinant enzyme used to treat lysosomal storage disorder known as Pompe disease (which is also known by the name acid maltase deficiency or glycogen storage disease type II). Pompe disease is perceived as an inherited fatal muscular myopathy disorder caused due to the glycogen build-up in the body cells such as in cardiac, smooth, and skeletal muscle cells. The disease is further characterized by the absence and in some cases, deficiency of the lysosomal enzyme alpha-glucosidase.
Global Islet Amyloid Polypeptide Market Size, Share & Trends Analysis Report, By Type (AC-253, DACRA-042, DACRA-089, KBP-056, KBP-058, and Others), By Application (Metabolic Disorders, Gastrointestinal, Musculoskeletal Disorders, and Others), Forecast (2022-2028)
Published: Feb 2026
The global islet amyloid polypeptide market is anticipated to grow at a significant CAGR 2.4% during the forecast period (2022-2028). The islet amyloid polypeptide (or commonly known as amylin) is a type of hormone that plays a key role in glucose homeostasis though it aggregates to form islet amyloid in type-2 diabetes. Its formation contributes to ß-cell dysfunction and death due to the disease and to the failure of islet transplants. Clinical trials show a role for islet amyloid polypeptide aggregation in cardio related complications of type-2 diabetes and further highlights a possible role in type-1 diabetes.
Global Glycogen Synthase Kinase 3 Beta Market Size, Share & Trends Analysis Report, By Type (AZD1080, LY2090314, AP-001, AP-1, DM-204, Neu-120, and Others), By Indication (Musculoskeletal Disorder, Lung Cancer, Dyskinesia, Menkes Disease, Inflammatory Disease, and Others), Forecast (2022-2028)
Published: Feb 2026
The global glycogen synthase kinase 3 beta market is anticipated to grow at a significant CAGR 1.9% during the forecast period (2022-2028). Glycogen synthase kinase 3, or GSK-3 refers to a serine/threonine, proline-directed kinase that is associated with a diverse array of signaling pathways, which includes cellular adhesion and glycogen synthesis. The compounds derived from natural sources come mainly from plants or marine organisms, and include Indirubin, Hymenialdisine, Meridianins, Manzamines, Palinurin, and Tricantin. Another promising opportunity for the market growth includes the favorable outcome of the glycogen synthase kinase 3 beta in the treatment of bipolar disorder.
Global Glucosylceramidase Market Size, Share & Trends Analysis Report, By Type (AVRRD-02, LTI-291, NCGC-607, and Others), By Application (Genetic Disorders, Gaucher Disease, Parkinson’s Disease, and Others), Forecast (2022-2028)
Published: Feb 2026
The global glucosylceramidase market is anticipated to grow at a significant CAGR 2.9% during the forecast period (2022-2028). Glucosylceramidase belongs to the genus of hydrolases that catalyze the hydrolysis of glucocerebroside resulting in to glucose and ceramide, that is a normal decomposition pathway for membrane lipids. If Beta-glucocerebrosidase enzyme activity is compromised, this leads to the accumulation of lipid glucocerebroside in tissue macrophages (Gaucher cells).
Flunarizine Hydrochloride Market by Drug Formulation (Tablets and Capsules) by Application (Migraine, Vertigo, and Others) Forecast Period, (2026-2035)
Published: Mar 2026
Flunarizine hydrochloride market was valued at $97.2 million in 2025 and is projected to reach $177.3 million by 2035, growing at a CAGR of 6.2% during the forecast period (2026-2035). The Flunarizine Hydrochloride Market is growing due to the sustained clinical use of flunarizine in migraine prophylaxis and vestibular disorder management across established healthcare systems. Continued physician familiarity with the drug and its well-documented safety profile supports consistent prescription levels. Demand remains stable in cost-sensitive regions where affordable, off-patent therapies are preferred over newer alternatives. The availability of multiple generic formulations ensures a steady supply and competitive pricing, reinforcing long-term utilization. Additionally, gradual improvements in neurological diagnosis rates contribute to sustained market demand.
Global Beta Nerve Growth Factor Market Size, Share & Trends Analysis Report, By Type (KP-544, MEDI-7352, and Others), By Application (Mild Cognitive Impairment, Optic Nerve Injury, Sickle Cell Disease, and Others), Forecast (2022-2028)
Published: Feb 2026
The global beta nerve growth factor market is anticipated to grow at a significant CAGR 5.9% during the forecast period (2022-2028). NGF beta protein or the nerve growth factor is mainly involved with the maintenance, growth and proliferation of particular target growth neurons. The market growth is majorly attributed to the promising opportunities of clinical use of beta nerve growth factor in Alzheimer’s disease, and Parkinson’s disease patients as well as in peripheral neuropathies. The nerve growth factor is a neurotrophic growth factor called neutrophin which supports growth and elasticity of neurons of the peripheral and central nervous system.
Global Tyrosine Protein Kinase Fyn Market Size, Share and Trends Analysis Report, By Type (Dasatinib, Masitinib, VAL-201, and Others), By Application (Alzheimer’s Disease, Alcohol Addiction, Breast Cancer, Cancer Pain, and Others), Forecast (2022-2028)
Published: Feb 2026
The global tyrosine protein kinase Fyn market is anticipated to grow at a significant CAGR 2.7% during the forecast period (2022-2028). Tyrosine-protein kinase Fyn is a non-receptor tyrosine. It plays an important role in the learning and memory of both animal models and human beings and is also responsible for other psychological disorders or mental problems such as schizophrenia, bipolar disorder, and depression, among others. The major factor driving the growth of the market is the increasing prevalence of breast cncer across the globe.
Global T Lymphocyte Activation Antigen CD80 Market Size, Share and Trends Analysis Report, By Type (Abatacept, Abatacept Biosimilar, CUE-201, KAHR-102, and Others), By Application (Metabolic Disorders, Autoimmune Disorders, Acute Myelocytic Leukemia, and Others), Forecast (2022-2028)
Published: Feb 2026
The global T lymphocyte activation antigen CD80 market is anticipated to grow at a significant CAGR 3.3% during the forecast period (2022-2028). CD80 is a costimulatory molecule that is known for its role in T-cell activation. It also regulates the activity of normal and malignant B cells. The major factor driving the demand for T lymphocyte activation antigen CD80 is the increasing prevalence of acute myelocytic leukemia (AML) across the globe. According to the American Society of Clinical Oncology (ASCO), AML is uncommon and makes up about 1% of cancers. Additionally, in 2021, an estimated 20,240 people of all ages which include 11,230 men and boys and 9,010 women and girls was diagnosed with AML in the US.
Global T Cell Surface Glycoprotein CD Market Size, Share &Trends Analysis Report by Type (CD3, CD4, CD5 And Other), And by Application (HIV, AIDS, GVHD, SARS, Cancer and Other) Forecast (2022-2028)
Published: Feb 2026
The global T cell surface glycoprotein CD market is anticipated to grow at a significant CAGR during the forecast period (2022-2028).T cell surface glycoprotein CD is a type of protein that is found in the human body. It plays an important role in immune system responses which are made by the body. It is mainly present on the surface of T lymphocyte cells. When the T cell receptor is activated by antigen cells, CD3 chains mediate TCR-mediated signals that are transmitted across the cell membrane.
Post Polycythemia Vera Myelofibrosis (PPV MF) Market Size, Share, and Trends Analysis Report By Type (Durvalumab, Givinostat, Glasdegib, Idelalisib, IMG-7289, and Others), By Application (Hospital, Clinic, and Others) Forecast Period (2026-2035)
Published: Mar 2026
Global PPV-MF market was valued at $1.8 billion in 2025 and is projected to reach $3.8 billion by 2035, growing at a CAGR of 7.7% from 2026 to 2035. The global Post Polycythemia Vera Myelofibrosis (PPV-MF) market is witnessing consistent growth driven by increasing clinical recognition of the disease. Advancements in therapeutic research have led to the development of more targeted treatment options. Improved diagnostic capabilities are enabling earlier and more accurate identification of patients. Growing investment in rare disease drug development is strengthening the treatment pipeline. Healthcare providers are increasingly adopting specialized therapies to improve patient outcomes. These factors collectively support sustained market expansion over the forecast period.
Myoglobin Market Size, Share & Trends Analysis Report by Type (Human and Animal), and by End-User (Hospitals & Clinics, Research Institute, and Laboratories) Forecast Period, (2026-2035)
Published: Mar 2026
Myoglobin market was valued at $61.2 million in 2025 and is projected to reach $82.1 million by 2035, growing at a CAGR of 3.1% during the forecast period (2026-2035). The global myoglobin market is experiencing steady growth primarily due to the increasing demand for accurate and early detection of cardiovascular and muscular disorders. Myoglobin serves as a critical biomarker in clinical diagnostics, enabling rapid identification of myocardial infarction and other muscle-related conditions, which drives adoption across hospitals, clinics, and diagnostic laboratories. The expansion of research activities in proteomics and biomarker discovery further supports market development, as both human and animal myoglobin are essential for experimental studies and assay development. Additionally, the availability of recombinant myoglobin and standardized assay kits enhances testing efficiency and reliability, encouraging broader utilization in clinical and research settings.
Hepatitis A Virus Cellular Receptor 2 Market Size, Share and Trends Analysis Report, By Type (IMM-1802, LY-3321367, MCLA-134, CA-170, CA-327, ENUM-005, and Others), By Application (Colon Cancer, Myelodysplastic, and Non-Small Cell Lung Cancer) Forecast Period (2026-2035)
Published: Mar 2026
Global hepatitis A virus cellular receptor 2 market was valued at $XX million in 2025 and is projected to reach $XX million by 2035, growing at a CAGR of 4.5% from 2026 to 2035. The global market is expanding steadily, supported by sustained investment in immuno-oncology research and the growing emphasis on precision-driven therapeutic approaches. Increasing collaboration between pharmaceutical companies and research institutions is accelerating the translation of scientific findings into advanced therapeutic candidates. Improvements in biomarker identification and patient stratification are further strengthening development pipelines and clinical outcomes. In addition, rising healthcare expenditure across key regions is improving access to innovative treatments. Regulatory agencies are also adopting clearer evaluation pathways, helping streamline development timelines. Collectively, these factors are contributing to consistent market progression over the forecast period.
Bispecific Antibodies Market Size, Share & Trends Analysis Report, By Drug Type (Blinatumomab, Catumaxomab, Duligotumab, and Amivantamab), By Indication (Cancer, Infectious Disease, Inflammatory and Autoimmune Disorders, and CNS Disorders), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies) Forecast Period, (2026-2035)
Published: Mar 2026
Bispecific antibodies market was valued at $1,509.1 million in 2025 and is projected to reach $3,804.6 million by 2035, growing at a CAGR of 9.8% during the forecast period (2026-2035). The global bispecific antibodies market is experiencing steady growth driven by increasing demand for advanced biologic therapies capable of addressing complex disease mechanisms. Continued progress in antibody engineering has enabled the development of more precise and effective treatment options, particularly for conditions with limited response to conventional therapies. Rising investment in targeted drug development has supported the expansion of clinical pipelines across major pharmaceutical companies. Favorable regulatory pathways for innovative biologics have further encouraged product approvals and market entry. In parallel, improvements in manufacturing processes have enhanced the scalability and consistency of production.
B Cell Lymphoma-2 (BCL-2) Inhibitors Market Size, Share & Trends Analysis Report, By Product (Combination Therapy and Monotherapy), By Indication Type (Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Lymphoma (CLL), Mantle Cell Lymphoma, and Others) Forecast Period, (2026-2035)
Published: Mar 2026
B cell lymphoma-2 inhibitors market was valued at $2.7 billion in 2025 and is projected to reach $5.3 billion by 2035, growing at a CAGR of 7.2% during the forecast period (2026-2035). The global BCL?2 inhibitors market is experiencing steady growth as a result of increasing adoption of targeted therapies for hematologic malignancies. Rising prevalence of B-cell lymphomas, particularly chronic lymphocytic leukemia, has driven demand for effective treatment options. Advances in combination therapy and broader regulatory approvals are expanding the patient population eligible for BCL?2 inhibitors. Pharmaceutical companies are also strengthening distribution channels and enhancing access in emerging markets, contributing to higher commercial uptake. Additionally, ongoing clinical developments and positive treatment outcomes are encouraging physicians to incorporate these inhibitors into standard care protocols.
Adrenocorticotropic Hormone Receptor Market Size, Share & Trends Analysis Report By Type (AQB-565, BIM-23B065, and Corticotropin), By Application (Hormonal Disorder, Musculoskeletal Disorder, Crushing Disease, and Acromegaly) Forecast Period, (2026-2035)
Published: Mar 2026
Adrenocorticotropic hormone receptor market was valued at $1,042.0 million in 2025 and is projected to reach $1,738.3 million by 2035, growing at a CAGR of 5.3% during the forecast period (2026-2035). The global adrenocorticotropic hormone receptor market is progressing steadily as demand rises for targeted endocrine therapies and precision-driven approaches to hormonal disorder management. Growth is being supported by expanding clinical focus on adrenal and pituitary-related diseases, alongside increasing research activity aimed at selective receptor modulation. Advances in peptide engineering, receptor agonist development, and improved diagnostic characterization of hormone-related pathways are strengthening therapeutic outcomes. As healthcare systems emphasize mechanism-based treatments with improved safety profiles, ACTH receptor–targeted solutions are gaining importance in both clinical and research setting.
T-Cell Specific Surface Glycoprotein CD28 Market Size, Share and Trends Analysis Report, By Type (FPT-155, FR-104, Lulizumab Pegol, and Others), By Application (Plaque Psoriasis, Solid Tumor, Cancer, Acute Renal Failure (ARF), and Others), Forecast Period, (2026-2035)
Published: Mar 2026
T-cell specific surface glycoprotein CD28 market was valued at $XX million in 2025 and is projected to reach $XX million by 2035, growing at a CAGR of X.X% during the forecast period (2026-2035). The global T-cell-specific surface glycoprotein CD28 market is expanding as immunological research increasingly emphasizes precise T-cell costimulatory pathways. Growing demand for validated molecular targets in immune response modulation has strengthened the relevance of CD28-focused products. Regulatory emphasis on mechanism-driven therapeutic development has further encouraged consistent utilization of CD28-related tools. In addition, sustained funding for immune profiling studies has supported continuous procurement of specialized reagents. The market also benefits from long-term research programs requiring standardized immune markers. Collectively, these factors are contributing to steady and measurable market growth.
Melanocyte Protein PMEL Market Size, Share & Trends Analysis Report by Type (AE-M vaccine, SCIB-1, VPI-121, and Others) by Application (Glioblastoma Multiforme, Melanoma and Metastatic Melanoma) Forecast Period, (2026-2035)
Published: Mar 2026
Melanocyte protein PMEL market was valued at $250.2 million in 2025 and is projected to reach $437.1 million by 2035, growing at a CAGR of 5.8% during the forecast period (2026-2035). The global Melanocyte Protein PMEL market is experiencing steady growth as pharmaceutical companies, biotechnology firms, research institutions, and healthcare providers increasingly focus on advancing treatments for pigment-related disorders and melanoma. Growth is being driven by the rising adoption of PMEL-targeted therapies, diagnostic assays, and biomarker-based research, which enable precise disease characterization, early detection of pigmentary abnormalities, and development of personalized therapeutic interventions.
Indoleamine 2,3 Dioxygenase 1 Market Size, Share, and Trends Analysis Report by Type (BMS-986205, Dcellvax, Epacadostat, F-001287, Galanal, and Others), and by Application (Alopecia, Cervical Cancer, Gastric Cancer, Glioma, and Others) Forecast Period (2026-2035)
Published: Mar 2026
Global indoleamine 2,3 dioxygenase 1 market was valued at $420.1 million in 2025 and is projected to reach $832.2 million by 2035, growing at a CAGR of 7.1% from 2026 to 2035. The global market is witnessing steady development driven by sustained research activity and increasing strategic interest in novel therapeutic mechanisms. Growing awareness of complex disease biology has encouraged the exploration of targeted approaches that address underlying immune and metabolic pathways. Pharmaceutical developers are aligning resources toward differentiated product pipelines with long-term clinical relevance. This focus is supported by improvements in drug discovery platforms and translational science capabilities. Additionally, favorable research funding environments in key regions continue to support early- and mid-stage development. Collectively, these factors contribute to a measured yet consistent progression of the global market.
Global High Affinity Nerve Growth Factor Receptor Market Size, Share, and Trends Analysis Report By Drug Type (ASP-7962, AZD-7451, BNN-27, Cenegermin, CRB-0089, and Others) and By Application (Atopic Dermatitis, Cancer, and Others) Forecast 2022-2028
Published: Feb 2026
The global high-affinity nerve growth factor receptor market is anticipated to grow at a significant CAGR of 5.4% during the forecast period 2022-2028. Nerve growth factor (NGF) is a protein that resembles insulin. The rising prevalence of cancer around the globe is a primary factor driving market expansion. For instance, as per the information provided by the American Cancer Society, Inc., the estimated numbers of new cancer cases diagnosed were around 1.8 million and deaths in the US were nearly 606,520 in 2020.
Transmembrane Prolyl 4 Hydroxylase Market Size, Share & Trends Analysis Report By Type (Daprodustat, Dimethyloxalylglycine, FG-2216, FG-4497, and Others), By Application (Anemia, Inflammatory Bowel Disease, Brain Edema, Colitis and Others) Forecast Period, (2026-2035)
Published: Mar 2026
Transmembrane prolyl 4 hydroxylase market was valued at $2,152.0 million in 2025 and is projected to reach $3,589.5 million by 2035, growing at a CAGR of 5.3% during the forecast period (2026-2035). The global transmembrane prolyl 4 hydroxylase market is gaining momentum as pharmaceutical and biotechnology companies intensify efforts to address hypoxia-related and inflammatory disorders through targeted molecular therapies. Growth is being supported by increasing research activity around hypoxia-inducible factor (HIF) pathways and the expanding clinical pipeline of small-molecule inhibitors targeting prolyl hydroxylase enzymes. Rising prevalence of chronic conditions such as anemia associated with chronic kidney disease, inflammatory bowel disease, and ischemic disorders is further strengthening demand. As regulatory bodies encourage mechanism-driven and biomarker-supported drug development, transmembrane prolyl 4 hydroxylase inhibitors are emerging as critical components in next-generation therapeutic strategies aimed at improving efficacy and patient outcomes.
T Cell Antigen Market Size, Share and Trends Analysis Report, By Therapy (CAR T-Cell, Tumor-Infiltrating Lymphocytes, and Others), By Indication (Hematologic Malignancies, Solid Tumors, and Others), Forecast Period, (2026-2035)
Published: Mar 2026
T cell antigen market was valued at $5.0 billion in 2025 and is projected to reach $22.4 billion by 2035, growing at a CAGR of 16.2% during the forecast period (2026-2035). The global T cell antigen market is expanding as scientific understanding of immune-mediated disease mechanisms continues to advance. Improved methods for identifying and characterizing disease-specific antigens are supporting the development of more targeted therapeutic strategies. Increased clinical emphasis on immune-based treatments has strengthened demand for reliable antigen platforms in both research and development settings. Pharmaceutical and biotechnology companies are allocating greater resources to antigen-focused programs to improve treatment specificity and safety. Parallel progress in manufacturing and analytical technologies is improving consistency and scalability.
Global Somatostatin Receptor Type Market Size, Share & Trend Analysis Report by Type (SSTR 1, SSTR 2A, SSTR 2B, SSTR 3, SSTR 4, and SSTR 5), by Application (Alzheimer’s Disease, Cancer, and Hormonal Disorder), Forecast (2022-2028)
Published: Feb 2026
The global somatostatin receptor type market is expected to grow at a considerable CAGR during the forecast years. Somatostatin is the hormone that regulates various physiological functions in the human body. Somatostatin is produced by several tissues mostly of the digestive system and nervous system. Furthermore, it also inhibits the rapid production of normal or tumor cells. One of the key factors for the growth of the market is the increasing number of cancer patients due to which demand for the somatostatin receptor type is expected to increase, as the somatostatin receptor type actively inhibits cell proliferation.
Prostaglandin E Receptor EP Subtype Market Size, Share & Trends Analysis Report, By Type (EP1, EP2, EP3, and EP4), By Application (Clinic, Hospital, and Others), Forecast Period, (2026-2035)
Published: Mar 2026
Prostaglandin E receptor EP subtype market was valued at $525.0 million in 2025 and is projected to reach $1,635.4 million by 2035, growing at a CAGR of 12.1% during the forecast period (2026-2035). The global prostaglandin E receptor EP subtype market is expanding as therapeutic strategies increasingly prioritize pathway-specific modulation of inflammatory and immune responses. Continued progress in receptor selectivity has improved the safety and efficacy profile of EP-targeted compounds, supporting broader clinical adoption. Growing pharmaceutical interest in mechanism-driven drug design has strengthened development pipelines linked to EP subtypes. Regulatory clarity around targeted therapies is also encouraging sustained investment in this area. In parallel, rising demand for differentiated treatments is reinforcing commercial uptake.
Personal Care Products For Maternity Market Size, Share and Trends Analysis Report, By Product (Stretch Mark Minimizer, Breast Cream, Toning/Firming Lotion, Itching Prevention Cream, Nipple Protection Cream, Body Restructuring Gel, and Stressed Leg Product), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores, and Others), Forecast Period, (2026-2035)
Published: Mar 2026
Personal care products for maternity market was valued at $2,651.3 million in 2025 and is projected to reach $5,128.0 million by 2035, growing at a CAGR of 6.9% during the forecast period (2026-2035). The global personal care products for maternity market is experiencing steady growth, supported by rising awareness of maternal skin and body care during pregnancy and the postnatal period. Increasing emphasis on preventive self-care among expectant mothers is encouraging regular use of specialized formulations designed for physiological changes. Healthcare professionals are also playing a role by recommending dedicated maternity care products as part of routine prenatal guidance. In addition, product accessibility has improved through pharmacies, specialty stores, and digital retail platforms, enabling wider adoption. Ongoing product innovation focused on safety, tolerance, and targeted benefits is further strengthening consumer confidence.
Niemann Pick C1 Like Protein 1 Market Size, Share & Trends Analysis Report, By Type (KT-6971, HS-25, Bempedoic Acid, Ezetimibe, and Others), By Application (Hospital, Clinic, and Others), Forecast Period (2026-2035)
Published: Mar 2026
Global Niemann pick c1 like protein 1 market was valued at $1.7 billion in 2025 and is projected to reach $2.6 billion by 2035, growing at a CAGR of 4.2% from 2026 to 2035. The global market is experiencing steady expansion, supported by the rising prevalence of lipid metabolism disorders and the increasing burden of cardiovascular diseases worldwide. Growing awareness regarding early diagnosis and preventive treatment approaches has strengthened demand across healthcare settings. Advancements in pharmaceutical research and the introduction of targeted therapeutic options are further contributing to market momentum. In addition, improved access to healthcare infrastructure in emerging economies is facilitating broader patient reach. Strategic collaborations, product development initiatives, and regulatory approvals are also enhancing competitive dynamics. Collectively, these factors are creating a favorable environment for sustained market growth over the forecast period.
Metastatic Uveal Melanoma Therapeutics Market Size, Share & Trends Analysis Report, By Type (Sunitinib Malate, Vincristine Sulfate Liposomal, LY-2801653, Sotrastaurin Acetate, and Others), By Application (Hospital, Clinic, and Others), Forecast Period (2026-2035)
Published: Mar 2026
Global metastatic uveal melanoma therapeutics market was valued at $422.2 million in 2025 and is projected to reach $1,015.7 million by 2035, growing at a CAGR of 9.2% from 2026 to 2035. The global market is expanding steadily, supported by sustained advancements in therapeutic research and increasing clinical focus on complex oncological conditions. Greater investment in targeted treatment development and precision medicine approaches has strengthened the innovation pipeline. Improved diagnostic capabilities and earlier disease identification have also contributed to higher treatment uptake. In addition, regulatory support for breakthrough therapies has encouraged faster product development and commercialization. Strategic collaborations between biotechnology firms and larger pharmaceutical companies are further accelerating clinical progress. Collectively, these factors are reinforcing market momentum and shaping a favorable long-term growth outlook.
Intelligent Pills Market Size, Share & Trends Analysis Report, By Application (Sleeping Disorder, Capsule Endoscopy, Stress Management, Reflux Monitoring, and Others) By Type (Prescription-Based (Dexedrine, Ritalin, Adderall, and Others) and Non-Prescription-Based), Forecast Period (2026-2035)
Published: Mar 2026
Global intelligent pills market was valued at $1.8 billion in 2025 and is projected to reach $3.0 billion by 2035, growing at a CAGR of 5.2% from 2026 to 2035. The global market is experiencing steady expansion driven by continuous advancements in digital health technologies and minimally invasive diagnostic solutions. Growing demand for improved patient monitoring, enhanced treatment adherence, and real-time health data collection is supporting wider adoption across healthcare systems. Increasing awareness among patients and providers regarding early diagnosis and remote disease management is further contributing to market momentum. In addition, supportive regulatory pathways and ongoing product innovations are encouraging commercial development and broader clinical integration. Strategic collaborations between technology developers and healthcare institutions are also strengthening product accessibility and deployment. Collectively, these factors are reinforcing sustained growth across developed as well as emerging healthcare markets.
Human Rabies Vaccine Market Size, Share & Trends Analysis Report, By Product Type (Vero Cell, Baby Hamster Kidney (BHK), Chick Embryo Cell, Human Diploid Cells, and others), By Vaccination Type (Pre-Exposure Vaccination (PEV) and Post-Exposure Prophylaxis (PEP)), Forecast Period, (2026-2035)
Published: Mar 2026
Human rabies vaccine market was valued at $1,345.9 million in 2025 and is projected to reach $2,600.5 million by 2035, growing at a CAGR of 6.9% during the forecast period (2026-2035). The global human rabies vaccine market is expanding as immunization programs receive sustained public funding and stronger policy backing in endemic regions. Rising coordination between health ministries and international agencies has improved vaccine procurement and distribution efficiency. Broader integration of rabies prevention into primary healthcare systems has increased routine usage. Advances in manufacturing processes have also enhanced supply consistency and reduced production constraints. In parallel, improved disease surveillance has led to more timely medical intervention following exposure.
Fluorescent In Situ Hybridization (FISH) Testing Market Size, Share & Trends Analysis Report, By Product Type (Analytical Instruments, Kits and Reagents, and Software and Services), By Application (Cancer, Genetic Diseases, and Others), Forecast Period, (2026-2035)
Published: Mar 2026
Fluorescent in situ hybridization testing market was valued at $958.2 million in 2025 and is projected to reach $2,538.6 million by 2035, growing at a CAGR of 10.3% during the forecast period (2026-2035). The global FISH testing market is experiencing steady expansion supported by its continued relevance in advanced genetic analysis. Clinical laboratories increasingly rely on this technique for accurate identification of chromosomal alterations. Improvements in testing reliability have strengthened its role within diagnostic decision-making. Broader acceptance across hospital and reference laboratory settings has enhanced routine utilization. Expansion of diagnostic services in both developed and emerging markets has further supported demand.
Flu Shots Market Size, Share & Trends Analysis Report by Vaccine Type (Inactivated Influenza Vaccines (IIV), and Recombinant Influenza Vaccines), by Formulation (Trivalent Flu Shots, and Quadrivalent Flu Shots), and by Patient Group (Pediatric, Adult, and Geriatric), Forecast Period (2026-2035)
Published: Mar 2026
Flu shots market was valued at $9.20 billion in 2025 and is projected to reach $18.30 billion by 2035, growing at a CAGR of 7.2% during the forecast period (2026-2035). The global flu shots market is growing due to the sustained burden of seasonal influenza and the continued emphasis on preventive vaccination as a core public health measure. Recurrent influenza outbreaks across both developed and emerging economies have reinforced the need for annual immunization, supporting consistent demand across pediatric, adult, and geriatric populations. In parallel, government-led immunization programs and procurement initiatives play a central role in expanding vaccine coverage, particularly through national vaccination schedules and publicly funded campaigns. These programs improve access, reduce cost barriers, and provide demand stability for manufacturers across multiple regions.
Dysmenorrhea Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Hormonal Therapy, Antispasmodics), By Type (Primary Dysmenorrhea, Secondary Dysmenorrhea) Forecast Period, (2026-2035)
Published: Mar 2026
Dysmenorrhea treatment market was valued at $2,115.3 million in 2025 and is projected to reach $4,579.4 million by 2035, growing at a CAGR of 8.1% during the forecast period (2026-2035). The global dysmenorrhea treatment market is growing due to the high and consistent prevalence of menstrual pain among women of reproductive age, which sustains steady demand for pharmacological management. Increasing preference for over-the-counter pain relief medications has supported volume growth, particularly for NSAIDs and antispasmodics. Greater clinical recognition of secondary dysmenorrhea has led to higher utilization of hormonal therapies in managed care settings. Improved access to retail and online pharmacies has enhanced product availability across both developed and emerging economies. Ongoing patient awareness initiatives related to menstrual health continue to normalize treatment-seeking behavior, supporting stable market expansion.
Global Dental Crowns and Bridges Market Size, Share & Trends Analysis Report by Material (Ceramic materials, Metals, Porcelain-Fused-to-Metal (PFM)). By Product (Crowns, and Bridges) Forecast Period 2022-2028
Published: Feb 2026
The global dental crowns and bridges market is anticipated to grow at a CAGR of around 7.6% during the forecast period. Dental crowns and bridges are fixed prosthetics devices are used to restore the size, strength, and structure of teeth and are made up of ceramic or porcelain material. Dental crowns and bridges also improve the appearance of the teeth. Due to an increase in the number of edentulous populations, the application of dental crowns and bridges has surged in recent years.
Methicillin-Resistant Staphylococcus Aureus (MRSA) Drug Market Size, Share & Trends Analysis Report, By Drug Class (Lipopeptides, Oxazolidinones, Cephalosporin, Tetracycline, Folate Antagonist, and Others), By Route of Administration (Oral and Parenteral) Forecast Period (2026-2035)
Published: Mar 2026
Global MRSA market was valued at $3.4 billion in 2025 and is projected to reach $5.0 billion by 2035, growing at a CAGR of 4.1% from 2026 to 2035. The global market continues to expand, supported by the sustained clinical burden of resistant bacterial infections and the ongoing need for effective therapeutic options. Increased hospitalization rates associated with complex infections have reinforced demand for advanced antibacterial treatments across both acute and long-term care settings. Continued regulatory approvals and lifecycle management of established drug classes have helped maintain steady product availability in key markets. In parallel, improvements in hospital antimicrobial stewardship programs have driven more targeted and consistent utilization of specialized therapies. Growth is further supported by expanded access to parenteral treatments in emerging healthcare systems. Together, these factors contribute to a stable and measurable rise in global market activity over the forecast period.
Skin Adhesives Market Size, Share & Trends Analysis Report, By Material Type (Silicon-Based, Acrylic-Based, and Others), By Application (Wound Care, Burn and Skin Grafting, Surgical Cases, Wearable Sensors, Trauma, and Transdermal Patches), Forecast Period (2026-2035)
Published: Mar 2026
Global skin adhesives market was valued at $2.8 billion in 2025 and is projected to reach $5.6 billion by 2035, growing at a CAGR of 7.1% from 2026 to 2035. The global skin adhesives market is witnessing steady growth driven by increasing demand for advanced wound care and minimally invasive surgical solutions. Rising awareness among healthcare providers and patients about faster healing and reduced risk of infection is encouraging the adoption of skin adhesive products. Technological advancements in biocompatible and long?lasting adhesive materials, such as silicone- and acrylic-based formulations, are expanding their applications across surgical procedures and wearable medical devices. The growing prevalence of chronic wounds, burns, and dermatological conditions is further fueling market expansion. Additionally, the integration of adhesives in transdermal drug delivery systems and remote patient monitoring devices is creating new avenues for usage. Increasing investments by manufacturers in product innovation and regulatory approvals are also supporting the overall market growth.
Poly (ADP-Ribose) Polymerase (PARP) Inhibitors Market Size, Share & Trends Analysis Report, By Drugs (Talazoparib, Veliparib, Olaparib, and Others), By Indication (Ovarian Cancer, Fallopian Tube Cancer, Breast Cancer, and Others), Forecast Period (2026-2035)
Published: Mar 2026
Poly (ADP-Ribose) polymerase (PARP) inhibitors market was valued at $4.0 billion in 2025 and is projected to reach $9.37 billion by 2035, growing at a CAGR of 8.8 % during the forecast period 2026-2035. Rising utilization of PARP inhibitors in targeted cancer therapies, including ovarian, breast, and prostate cancers, is driving growth in the global market. Precision medicine and expanded genetic testing have made it possible to identify patients who are most likely to benefit from these treatments, increasing clinical adoption. Research into combination therapies and innovative treatment regimens is creating additional opportunities for market expansion. Regulatory approvals across multiple regions are facilitating wider access and supporting physician confidence. Awareness of personalized oncology approaches among healthcare providers and patients is encouraging broader uptake.
Global Metastatic Ovarian Cancer Drug Market Size, Share & Trends Analysis Report, By Product Type (E-7449, Crizotinib, CMB-305, G-305, LV-305, and Others) By Application (Hospital, Clinic, and Others), Forecast (2025-2035)
Published: Feb 2026
The global metastatic ovarian cancer drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor accelerating the demand for these drugs include the growing prevalence of metastatic ovarian cancer. Ovarian cancer is the second most common gynecologic cancer in the US. The American Cancer Society (ACS) estimates that there will be nearly 19,880 women receiving a new diagnosis of ovarian cancer in the US. The current research in ovarian cancer is focused on using novel treatments such as immunotherapy, targeted therapy, and most importantly combination regimens.
Global Interleukin (IL) Inhibitors Market Size, Share and Trends Analysis Report, By Type (IL-17, IL-23, IL-1, IL-5, IL-6, and Others), By Application (Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease, Cancer and Others), Forecast (2021-2027)
Published: Feb 2026
The global Interleukin (IL) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Interleukin (IL) is a group of naturally occurring proteins. They mediate communication between cells and regulate cell growth, differentiation, and motility. The major factor driving the demand for interleukin (IL) inhibitors is the increasing prevalence of cancer across the globe.
Global Inclusion Body Myositis Market Size, Share, and Trends, By Type (ACE-083, Aceneuramic Acid ER, ALZ-1903, UX-001P, UX-007, and Others), By End-User (Hospital, Clinic, and Others), Forecast (2022-2028)
Published: Feb 2026
The global inclusion body myositis (IBM) market is expected to grow at a significant CAGR during the forecast period (2022-2028). Muscle weakness and damage are caused by inclusion body myositis, which is a rare condition. Progressive weakness in the muscles of the hand, forearm, thigh, and lower leg are among the symptoms of IBM; however, the symptoms vary and are not unique to this condition. Furthermore, it is estimated to be 51-139 per 1,000,000 people over the age of 50 in the general population.
Hypoxia Inducible Factor Alpha Inhibitor Market Size, Share & Trends Analysis Report by Type (HIF-1 Alpha and HIF-2 Alpha), by Application (Cancer Therapy, Inflammatory & Autoimmune Disorders, Metabolic Disorders, Cardiovascular Diseases and Others), Forecast Period, (2026-2035)
Published: Mar 2026
Hypoxia Inducible Factor Alpha (HIF-?) market was valued at $720.2 million in 2025 and is projected to reach $1,426.6 million by 2035, growing at a CAGR of 7.1% during the forecast period (2026-2035). HIF-? inhibitor market is expanding due to the rising prevalence of hypoxia-driven malignancies, particularly renal cell carcinoma and other solid tumors. Increasing clinical validation of HIF-2?–targeted therapies has strengthened confidence in the pathway as a viable therapeutic target. Regulatory approvals across major markets have further accelerated commercial adoption and geographic penetration. In addition, ongoing late-stage clinical trials and combination therapy strategies are broadening the potential treatment landscape. Continued investment by pharmaceutical and biotechnology companies is supporting innovation in next-generation molecules with improved selectivity and safety profiles. Collectively, these factors are contributing to sustained growth and heightened competitive activity within the global HIF-? inhibitor market.
Global High Mobility Group Protein B1 Market Size, Share, and Trends, by Type (Dociparstat Sodium, RBM-005, EV-007156, and Others), by Application (Autoimmune Disorders, Chemotherapy Effects, and Others), and Forecast (2022-2028)
Published: Feb 2026
The global high mobility group protein B1 market is expected to grow at a significant CAGR during the forecast period. High mobility group box 1 (HMGB1) is a chromatin-associated protein that is not histone. It is crucial in the pathogenesis of hematopoietic malignancies. Furthermore, in leukaemia and multiple myeloma, this protein autophagy promotes chemotherapy resistance. The increasing prevalence of leukaemia globally is the one of the prominent factors, the demand for high mobility group protein B1 is increasing at rapid rate. It is estimated that, there are around 9,900 new leukaemia cases in the UK every year.
Drugs for Vancomycin Resistant Enterococcus Faecium Market Size, Share & Trends Analysis Report, By Type (Daptomycin, Linezolid, Quinupristin/Dalfopristin, Ampicillin, Chloramphenicol, and Others), By Route of Administration (Intravenous (IV) and Oral) and By Application (Hospital, Clinic, and Others), (2026-2035)
Published: Mar 2026
Drugs for vancomycin resistant enterococcus faecium market was valued at $350.2 million in 2025 and is projected to reach $525.2. million by 2035, growing at a CAGR of 4.2% during the forecast period (2026-2035). The global drugs for vancomycin resistant enterococcus faecium market is witnessing sustained growth driven by the increasing prevalence of antimicrobial-resistant infections acrosshealthcare settings. Rising hospital-acquired infections and prolonged hospital stays have intensified the demand for effective targeted antibiotic therapies. Continuous surveillance programs and improved diagnostic capabilities are enabling early identification of resistant strains, thereby supporting timely treatment interventions. Additionally, the introduction of advanced antimicrobial agents and expanded clinical guidelines for resistant infections are strengthening therapeutic adoption. Growing investments in antibiotic research and stewardship initiatives are further contributing to market expansion during the forecast period of 2026–2035.
Community Acquired Methicillin Resistant Staphylococcus Aureus Drug Market Size, Share & Trends Analysis Report, By Product (VAL-301, GLPG-1492, Solithromycin, and Acorafloxacin Hydrochloride), By Application (Hospital, Clinic, and Others) Forecast Period (2026-2035)
Published: Mar 2026
Global community acquired methicillin resistant staphylococcus aureus drug market was valued at $590.1 million in 2025 and is projected to reach $799.3 million by 2035, growing at a CAGR of 3.1% from 2026 to 2035. The global market is experiencing steady growth, supported by the increasing clinical focus on managing resistant bacterial infections and the rising incidence of community-based cases. Advancements in therapeutic research have encouraged the development of targeted treatment options, contributing to gradual market expansion. Greater awareness among healthcare professionals has led to earlier diagnosis and more consistent treatment practices. Improvements in healthcare access across both developed and emerging regions have also supported wider adoption of approved therapies. In addition, regulatory initiatives aimed at addressing antimicrobial resistance have created a more structured environment for product commercialization. Together, these factors are contributing to sustained market development over the forecast period.
Charcot Marie Tooth Disease Type 1 A Drug Market Size, Share & Trends Analysis Report, By Product Type (ADX-71441, AFC-5128, and Others), By Application (Hospital, Clinic, and Others), Forecast Period (2026-2035)
Published: Mar 2026
The global market for Charcot-Marie-Tooth Disease Type 1A drugs is experiencing steady growth, driven primarily by increasing awareness of rare genetic neuropathies and the rising demand for targeted therapies. Advances in drug development, particularly in gene therapy and novel small-molecule treatments, are expanding treatment options for patients. The growing prevalence of hereditary peripheral neuropathies has also prompted healthcare providers to adopt specialized interventions. Additionally, supportive regulatory frameworks and orphan drug incentives are encouraging pharmaceutical companies to invest in innovative solutions. Enhanced diagnostic capabilities and early detection methods are facilitating timely treatment initiation. Collectively, these factors are contributing to sustained growth in the CMT1A drug market.
BCL-2-Like Protein Market Size, Share & Trends Analysis Report by Product Type (BCL-2 Protein Inhibitors, BCL-xL Protein Inhibitors, BCL-w Protein Inhibitors, MCL-1 Protein Inhibitors, and Others), and by Application (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospitals and Diagnostic Laboratories, and Others), Forecast Period (2026-2035)
Published: Mar 2026
BCL-2-Like Protein market was valued at $3.04 billion in 2025 and is projected to reach $5.42 billion by 2035, growing at a CAGR of 6.1% during the forecast period (2026-2035). The market is growing due to the rising clinical focus on apoptosis-targeted therapies in oncology, particularly for hematological malignancies, where BCL-2 family proteins play a central role in disease progression and treatment resistance. Increasing adoption of BCL-2 and related protein inhibitors in pharmaceutical and biotechnology research pipelines is supporting steady demand across key product types, including BCL-2, BCL-xL, and MCL-1 inhibitors. In parallel, sustained investment in cancer drug discovery and translational research is driving consistent uptake of BCL-2-like protein tools among academic and research institutes. The market is further supported by expanding collaboration between industry and research organizations, which accelerates target validation and compound development.
Basal Cell Nevus Syndrome Drug Market Size, Share & Trends Analysis Report by Type (Itraconazole, Patidegib Hydrochloride, REM-001, TG-1042, Trifarotene, and Others), and by Application (Hospital, Clinics / Outpatient Centers, and Others), Forecast Period (2026-2035)
Published: Mar 2026
Basal cell nevus syndrome drug market was valued at $9.50 million in 2025 and is projected to reach $19.05 million by 2035, growing at a CAGR of 7.3% during the forecast period (2026-2035). The market is growing due to the increasing clinical recognition of the disorder and the rising need for long-term pharmacological management to reduce recurrent basal cell carcinoma burden. Greater awareness among dermatologists and oncologists has supported earlier diagnosis, leading to higher treatment uptake across hospital and outpatient settings. In parallel, progress in targeted therapies, particularly hedgehog pathway inhibitors such as patidegib hydrochloride and itraconazole-based treatments, has expanded therapeutic options beyond surgical intervention. These drugs address the underlying disease mechanism, supporting sustained use in chronic management. Additionally, ongoing clinical development of novel agents and improved formulation approaches continues to strengthen the treatment landscape, reinforcing steady market expansion.
Alpha N Acetylglucosaminidase Market Size, Share & Trends Analysis Report, By Type (Lesinidase Alfa, ABO-101, BMN-250, EGT-201, and Others), By Application (In-Patient and Out-Patient), Forecast Period (2026-2035)
Published: Mar 2026
Global alpha n acetylglucosaminidase market was valued at $XX.X million in 2025 and is projected to reach $XX.X million by 2035, growing at a CAGR of XX.X% from 2026 to 2035. The global market is witnessing steady expansion, supported by continuous advancements in therapeutic research and increasing clinical focus on rare metabolic disorders. Growing awareness among healthcare professionals and improved diagnostic capabilities are contributing to earlier identification and intervention. Strategic collaborations between biotechnology firms and research institutions are further strengthening product development pipelines. In addition, regulatory incentives and orphan drug designations are encouraging investment in specialized treatments. Expanding healthcare infrastructure across emerging economies is also facilitating broader patient access. Collectively, these factors are creating a favorable environment for sustained market growth over the forecast period.
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size, Share and Trend Analysis Report, By Type (PQR-514, KA-2237, GSK-2636771, BAY-1082439, and Others), By Application (Cancer, Myelofibrosis, Renal Cell Carcinoma, and Others), Forecast Period (2026-2035)
Published: Mar 2026
The global Phosphatidylinositol 4,5?Bisphosphate 3?Kinase Catalytic Subunit Beta Isoform market is experiencing steady growth driven by increasing research and development in targeted therapies. The rising prevalence of cancers and rare hematological disorders has intensified demand for precision treatment options. Advances in molecular biology and improved understanding of signaling pathways are enabling the development of more selective inhibitors. Expansion of clinical trials and regulatory approvals for novel compounds is supporting market momentum. Strategic collaborations between pharmaceutical companies and biotechnology firms are accelerating product pipelines. Additionally, growing awareness among healthcare providers about targeted therapeutic approaches is contributing to the broader adoption of these treatments.
Tyrosine Protein Kinase SYK Market Size, Share & Trends Analysis Report By Type (HMPL-523, C-13, CVXL-0074, ASN-002, FF-10102, and Others), By Application (Anaphylactic Shock, Arthritis, Fallopian Tube Cancer, Lupus Nephritis, and Others) Forecast Period, (2026-2035)
Published: Mar 2026
Tyrosine protein kinase SYK market valued at $355.2 million in 2025 and is projected to reach $820.2 million by 2035, growing at a CAGR of 8.8% during the forecast period (2026-2035). The global tyrosine protein kinase SYK market is advancing steadily as pharmaceutical companies intensify efforts to develop targeted therapies for autoimmune disorders, hematologic malignancies, and inflammatory diseases. Spleen tyrosine kinase (SYK) plays a central role in B-cell receptor signaling and immune-cell activation, making it a critical therapeutic target across multiple immune-mediated conditions. Growing emphasis on precision-targeted kinase inhibition and oral small-molecule therapies is reinforcing investment in SYK-focused drug development. As clinical pipelines expand and strategic licensing agreements accelerate innovation, SYK inhibitors are emerging as an important segment within the broader kinase inhibitor market.
Transforming Growth Factor Beta Market Size, Share & Trends Analysis Report by Type (Beta 1, Beta 2, Beta 3 and Beta 4), and by Application (Wound Healing, Angiogenesis, Cancer and Others), Forecast Period 2026-2035
Published: Mar 2026
Transforming growth factor beta market was valued at $1,100.4 million in 2025 and is projected to reach $1,618.0 million by 2035, growing at a CAGR of 4% during the forecast period (2026-2035). The transforming growth factor beta market is experiencing steady expansion driven by the rising prevalence of cancer and chronic fibrotic disorders globally. Increasing research focus on the tumor microenvironment and immune modulation has accelerated the development of targeted biologics and antibody-based therapies. Growing investments in biotechnology innovation and precision medicine are further supporting pipeline advancement across TGF-? isoforms. In addition, expanding clinical trials evaluating combination immunotherapies are strengthening future commercialization prospects. Improved diagnostic capabilities and biomarker identification are enabling more selective patient targeting. Collectively, these factors are contributing to sustained market growth throughout the forecast period 2026–2035.
Proteasome Inhibitors Market Size, Share and Trends Analysis Report, By Drugs (Bortezomib, Carfilzomib, and Ixazomib), By Application (Lymphoma, Mantle Cell Lymphoma, and Multiple Myeloma), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy), Forecast Period (2026-2035)
Published: Mar 2026
Proteasome inhibitors market was valued at $2.0 billion in 2025 and is projected to reach $4.18 billion by 2035, growing at a CAGR of 7.7% during the forecast period 2026-2035. Rising incidences of cancer and protein-related disorders are fuelling demand for proteasome inhibitors globally. Significant investments in research have led to the development of novel therapies with enhanced effectiveness and safety. The integration of these inhibitors into combination and personalized treatment plans is expanding their clinical applications. Growing awareness among medical professionals and patients is supporting wider adoption across healthcare settings. Meanwhile, improvements in healthcare infrastructure in emerging regions are increasing accessibility to these therapies.
Orexin Receptor Market Size, Share & Trends Analysis Report by Type (Orexin 1 Receptor and Orexin 2 Receptor) and by Application (Insomnia, Anxiety, Sleep Disorders, Major Depressive Disorder and Other), (2026-2035)
Published: Mar 2026
Orexin receptor market was valued at $800.2 million in 2025 and is projected to reach $1,436.1 million by 2035, growing at a CAGR of 6.1% during the forecast period (2026-2035). The global orexin receptor market is projected to experience sustained growth over the forecast period from 2026 to 2035, driven by increasing recognition of sleep and neuropsychiatric disorders worldwide. Rising prevalence of insomnia, anxiety, major depressive disorder, and related conditions has significantly expanded the demand for targeted therapeutics acting on orexin 1 and orexin 2 receptors. Continuous advancements in neuroscience research and drug development have strengthened the clinical pipeline, encouraging innovation in receptor-specific therapies. Favorable regulatory support and improved diagnostic awareness are further contributing to market expansion across developed and emerging economies. Strategic collaborations among pharmaceutical companies and research institutions are accelerating product development and commercialization efforts. Growing healthcare expenditure and enhanced access to specialized treatment options are also supporting revenue growth in this segment. Collectively, these factors are expected to sustain steady market expansion throughout the forecast horizon.
N-Formyl Peptide Receptor Market Size, Share and Trends Analysis Report, By Type (FPR1, FPR2 and FPR3), By Application (Inflammation, Diabetes, Allergies, Brain Ischemia, Metastatic Cancer and Others), Forecast Period (2026-2035)
Published: Mar 2026
Global n-formyl peptide receptor market was valued at $29.1 million in 2025 and is projected to reach $54.4 million by 2035, growing at a CAGR of 6.5% from 2026 to 2035. The global market is expanding steadily, supported by sustained investments in targeted research and advanced therapeutic development across multiple clinical areas. Increasing emphasis on precision medicine and receptor-specific drug discovery has encouraged deeper scientific exploration and product innovation. Growing collaboration between academic institutions, biotechnology firms, and pharmaceutical manufacturers is further accelerating translational research efforts. Improvements in molecular screening technologies and biologics development platforms are also strengthening the commercial pipeline. In addition, rising healthcare expenditure and improved diagnostic capabilities are contributing to broader adoption across developed and emerging economies. Collectively, these factors are fostering a stable and progressive growth trajectory over the forecast period.
Weight Loss Supplement Market Size, Share and Trends Analysis Report, By Ingredients (Natural Extract/ Botanicals, Amino Acids, and Vitamins and Minerals), By End-User (18-40 Years and Under 18 Years), By Distribution Channel (Online and Offline), By Type (Powder and Pills), Forecast Period (2026-2035)
Published: Mar 2026
Global weight loss supplement market was valued at $27.3 billion in 2025 and is projected to reach $51.2 billion by 2035, growing at a CAGR of 6.5% from 2026 to 2035. The global weight loss supplement market is experiencing steady expansion, supported by increasing consumer focus on preventive healthcare and personal fitness. Rising awareness regarding obesity management and metabolic health has encouraged the adoption of dietary supplements formulated with botanicals, amino acids, vitamins, and minerals. Growing urbanization and sedentary lifestyles have further contributed to the demand for convenient nutrition solutions available in powder and pill formats. In addition, expanding e-commerce platforms and improved retail penetration have enhanced product accessibility across both developed and emerging economies. Continuous product innovation, clean-label positioning, and targeted formulations for specific age groups are also strengthening market penetration. Collectively, these structural and consumer-driven factors are sustaining long-term growth across global markets.
Vitamin Ingredients Market Size, Share and Trends Analysis Report, By Type (Vitamin A, Vitamin B, Vitamin C, Vitamin D, Vitamin E, and Vitamin K), By Form (Solid, Liquid, and Powder), By Application (Cosmetics, Animal Feed, Pharmaceuticals, Processed and Packaged Food and Beverages, and Others), Forecast Period (2026-2035)
Published: Mar 2026
Global vitamin ingredients market was valued at $14.1 billion in 2025 and is projected to reach $24.4 billion by 2035, growing at a CAGR of 5.2% from 2026 to 2035. The global market continues to witness steady expansion, supported by rising health awareness and increased emphasis on preventive nutrition across diverse population groups. Growing consumer preference for fortified and functional products has encouraged manufacturers to enhance formulation capabilities and broaden their product portfolios. Advancements in production technologies and quality standards have further strengthened supply consistency and regulatory compliance across regions. In addition, expanding applications across multiple end-use industries have contributed to sustained demand. Emerging economies are also demonstrating notable growth, driven by urbanization, changing dietary habits, and improved access to healthcare products. Collectively, these factors are reinforcing long-term market development and investment activity worldwide.
Shark Liver Oils Market Size, Share & Trends Analysis Report by Source (Deep Sea Shark Liver Oil, Dogfish Liver Oil, Basking Shark Liver Oil, and Others), by Application (Pharmaceuticals, Dietary Supplements, Functional Food Ingredients, Cosmetics and Personal Care, Industrial Applications, and Biofuel and Energy), and by Distribution Channel (Online Distribution, and Offline Distribution), Forecast Period (2026-2035)
Published: Mar 2026
Shark liver oils market was valued at $156.2 million in 2025 and is projected to reach $263.6 million by 2035, growing at a CAGR of 5.5% during the forecast period (2026-2035). The market is growing due to sustained demand from the pharmaceuticals and dietary supplements segments, where shark liver oil is valued for its alkylglycerols and squalene content. Increasing consumer preference for marine-derived bioactive ingredients in immune health and preventive wellness formulations continues to support product uptake across offline and online distribution channels. At the same time, expansion in cosmetics and personal care applications, particularly for squalene-based emollients used in skin hydration and anti-aging formulations, is strengthening commercial demand. Manufacturers are responding through improved extraction, purification, and standardization processes that enhance product quality and regulatory compliance.
Proteinase Activated Receptor Market Size, Share & Trends Analysis Report By Type (PAR1, PAR2, PAR3, and PAR4), By Application (Hemostasis, Thrombosis, Embryonic Development, Wound Healing, Inflammation and Cancer) Forecast Period, (2026-2035)
Published: Mar 2026
Proteinase activated receptor market valued at $XX.X million in 2025 and is projected to reach $X.XX million by 2035, growing at a CAGR of X.XX% during the forecast period (2026-2035). The global proteinase activated receptor market is advancing as research institutions and pharmaceutical companies intensify their focus on targeted therapies addressing inflammation, thrombosis, oncology, and cardiovascular disorders. Growth is being supported by increasing exploration of receptor-mediated signaling pathways and their role in disease progression. Expanding understanding of PAR biology, particularly PAR-1 and PAR-2, is driving drug discovery programs aimed at modulating coagulation, immune response, and tumor microenvironment interactions. As precision medicine approaches gain momentum, receptor-targeted therapies are becoming increasingly important in developing safer and more effective treatment options. Regulatory emphasis on novel mechanisms of action and differentiated therapeutics further reinforces market expansion.
Nitric Oxide Synthase Brain Market Size, Share & Trends Analysis Report by Type (Neuronal NOS (NNOS), Endothelial NOS (ENOS), Inducible NOS (INOS)), and by End-User (Research Institute, Biotechnology, Pharmaceutical Company, and Others) Forecast Period, (2026-2035)
Published: Mar 2026
Nitric oxide synthase brain market was valued at $1,120.3 million in 2025 and is projected to reach $1,778.4 million by 2035, growing at a CAGR of 4.8% during the forecast period (2026-2035). The global nitric oxide synthase brain market is advancing as pharmaceutical and biotechnology companies intensify efforts to develop targeted therapies for neurological and neurodegenerative disorders. Growth is being driven by the rising adoption of selective NOS inhibitors, advanced biomarker-driven research, and high-precision screening platforms that accelerate early-stage drug discovery and validation. Demand is further supported by the increasing prevalence of brain-related disorders and the growing understanding of nitric oxide’s role in neuroinflammation, synaptic signaling, and neuronal survival. As regulatory agencies emphasize mechanistic evidence and safety-driven development processes, NOS-focused therapeutics and associated research tools are becoming indispensable in optimizing treatment efficacy and reducing time-to-market for novel brain-targeted interventions.
Integrin Alpha V Market Size, Share & Trends Analysis Report By Type (MK-0429, C-16Y, 264-RAD, AC-301, and Others), By Application (Metabolic Disorders, Ophthalmology, Respiratory, Infectious Disease, and Others) Forecast Period, (2026-2035)
Published: Mar 2026
Integrin alpha V market valued at $2,015.6 million in 2025 and is projected to reach $3,351.6 million by 2035, growing at a CAGR of 5.8% during the forecast period (2026-2035). The global integrin alpha V market is advancing steadily as research and therapeutic development increasingly focus on targeted molecular pathways involved in oncology, fibrosis, and inflammatory disorders. Growth is being reinforced by expanding clinical investigation into integrin alpha V inhibitors and monoclonal antibodies designed to regulate cell adhesion, migration, and angiogenesis. Rising interest in precision medicine and biomarker-driven treatment approaches is further strengthening demand for integrin-focused therapeutics. As regulatory agencies emphasize targeted biologics and pathway-specific interventions, integrin alpha V–based therapies are becoming increasingly relevant in next-generation drug development strategies.
EPA/DHA (Omega 3) Market Size, Share & Trends Analysis Report By Source (Anchovy/Sardine Oil, High Concentrates, Medium Concentrates, Low Concentrates, Algae Oil, Tuna Oil, Cod Liver Oil, Salmon Oil, Krill Oil, and Menhaden Oil), By Application (Dietary supplements, Pharmaceuticals, Functional Foods, Pet & Animal Feed, and Infant Formulas) Forecast Period, (2026-2035)
Published: Mar 2026
EPA/DHA (omega 3) market valued at $10,400.1 million in 2025 and is projected to reach $17,294.0 million by 2035, growing at a CAGR of 5.8% during the forecast period (2026-2035). The global EPA/DHA (omega-3) market is expanding steadily as consumers and healthcare providers increasingly recognize the role of essential fatty acids in cardiovascular, cognitive, and metabolic health. Growth is being reinforced by rising demand for preventive nutrition, functional foods, and dietary supplements enriched with eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Expanding clinical research supporting omega-3 benefits in heart health, maternal nutrition, and inflammatory conditions is further strengthening market adoption. As regulatory authorities and health organizations promote nutritional awareness and evidence-based supplementation, EPA/DHA products are becoming integral to global wellness and therapeutic nutrition strategies.
End-Stage Kidney Disease Treatment Market Size, Share & Trends by Diagnosis (Dialysis and Medication and Kidney Transplantation) and by Application (Clinics and Hospitals) Forecast (2022-2028)
Published: Feb 2026
The global end-stage kidney disease treatment market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). Chronic kidney disease is also referred to as kidney failure, which involves a gradual loss of kidney function. The rise in the prevalence of chronic kidney diseases is anticipated to drive the global end-stage kidney disease treatment market. For instance, in 2021, according to National Center for Biotechnology Information (NCBI), Chronic kidney disease has been recognized as the leading public health problem globally. Further, NCBI estimated that the prevalence of chronic kidney disease (CKD) is 13.4 % globally. Moreoevr, patients with end-stage kidney disease (ESKD) in the need of kidney replacement therapy is estimated between 4.9 million to 7 million in 2021.
Cyclin Dependent Kinase Market Size, Share & Trends Analysis By Type (Specific Inhibitors, Non-Specific or Broad Range Inhibitors and Multiple Target Inhibitors), By Route of Administration (Nasal, Oral, Intravenous, and Intramuscular), By Application (Breast Cancer, Lymphoma, Multiple Myeloma, Ovarian Cancer, and Others) Forecast Period, (2026-2035)
Published: Mar 2026
Cyclin dependent kinase market valued at $8,012.3 million in 2025 and is projected to reach $13,323.4 million by 2035, growing at a CAGR of 5.8% during the forecast period (2026-2035). The global cyclin dependent kinase market is expanding steadily as oncology research increasingly prioritizes targeted cell-cycle regulation therapies. Growth is being reinforced by the rising prevalence of cancer, expanding clinical applications of CDK inhibitors, and growing adoption of precision medicine approaches. Pharmaceutical companies are intensifying their investment in selective CDK inhibitors designed to improve therapeutic efficacy while minimizing off-target toxicity. As regulatory agencies emphasize biomarker-driven treatment strategies and accelerated pathways for oncology drugs, CDK-targeted therapies are becoming integral components of modern cancer treatment protocols.
Tissue Engineered Bone Market Size, Share and Trend Analysis Report, By Type (Inorganic Material, Organic Material, and Composite Material), By Application (Bone Repair, Bone Regeneration, and Others), Forecast Period (2026-2035)
Published: Jun 2026
Tissue engineered bone market was valued at $4.80 billion in 2025 and is projected to reach $10.41 billion by 2035, growing at a CAGR of 8.1% during the forecast period 2026-2035. Steady expansion in the global tissue-engineered bone market is being supported by measurable shifts in clinical practice and manufacturing capability. Advances in scaffold design and biomaterial engineering have improved structural integrity and biological performance, increasing adoption in complex orthopedic procedures. Rising volumes of trauma, reconstructive, and revision surgeries continue to create sustained demand for engineered bone solutions. At the same time, regulatory frameworks in several regions are becoming more clearly defined, enabling smoother commercialization and wider clinical use. Greater investment in translational research has accelerated the movement of laboratory innovations into approved medical products.
Global Orthopaedic navigation systems Market Size, Share & Trends Analysis Report by Technology (Electromagnetic Localizers, Optical Tracking, Fluoroscopy, and Others), By Application (Knee surgery, Spine surgery, Hip surgery, and Others), By End-use Industry (Hospitals, and Ambulatory surgical centers) Forecast Period 2022-2028
Published: Feb 2026
The global market for Orthopaedic navigation systems is projected to have a considerable CAGR of around 14.3% during the forecast period. Various orthopedic diseases, such as osteoporosis, osteoarthritis, rheumatoid arthritis, cubital tunnel syndrome, and ligament injuries of the knee, are becoming more prevalent. These disorders affect the musculoskeletal system of the body, which includes muscles, bones, ligaments, edema, cartilages, and tendons.
Global Wellness Tourism Market Size, Share & Trends Analysis Report By Travel Type (Domestic, and International) By Service Type (Transport, Lodging, Food & Beverages, Others) Forecast 2022-2028
Published: Feb 2026
The global wellness tourism market is anticipated to grow at a considerable CAGR of 6.4% during the forecast period. The wellness tourism is much broader term, which not only includes spas, wellness retreats, thermal springs, and boot camps, but also includes healthy eating, exercise, fitness, and yoga, mind body practices through which the people feel relax physically and mentally.
Cannabis Testing Market Size, Share & Trends Analysis Report By Products (Instruments, Consumables, and Software), By Test Type (Potency Testing, Terpene Profiling, Heavy Metal Testing, Pesticide Screening, Microscopy Testing, Residual Solvent Screening, and Others) by End-User (Laboratories, Cannabis Cultivators/Growers, Cannabis Drug Manufacturers, and Others) Forecast Period, (2026-2035)
Published: Mar 2026
Cannabis testing market was valued at $1,760.1 million in 2025 and is projected to reach $6,238.7 million by 2035, growing at a CAGR of 13.6% during the forecast period (2026-2035). The global cannabis testing market is evolving rapidly as regulators, producers, and consumers place growing emphasis on product safety, quality assurance, and regulatory compliance. Market growth is being driven by the expansion of legalized cannabis markets, which has led to stricter testing mandates for potency, contaminants, pesticides, heavy metals, and microbial content across both medical and adult-use segments. Demand is further reinforced by advancements in analytical technologies such as chromatography, mass spectrometry, and rapid microbial testing, which enable laboratories to deliver more accurate, high-throughput results within shorter turnaround times. As product portfolios diversify into edibles, concentrates, and infused beverages, testing protocols are becoming more complex, increasing reliance on specialized laboratory services and automation-enabled workflows.
Analytical Standards Market Size, Share & Trends Analysis by Type (Organic Analytical Standards, and Inorganic Analytical Standards), By Technique (Chromatography, Spectroscopy, Titrimetry, and Physical Property Testing), By Testing Type (Bioanalytical Testing, Stability Testing, Raw Material Testing, Dissolution Testing, Microbiological Testing, and Others), By Application (Pharmaceutical & Life Sciences Analysis, Environmental Analysis, Food & Beverage Analysis, Petrochemical Analysis, Forensic Analysis, Veterinary Drug Analysis, and Others), Forecast Period (2026-2035)
Published: May 2026
Analytical standards market was valued at $1.7 billion in 2025 and is projected to reach $3.1 billion by 2035, growing at a CAGR of 6.5% during the forecast Period (2026-2035). The market is witnessing steady growth, driven by rising consumer demand for convenient, portable, and easy-to-prepare beverages. Powdered soft drinks, available in flavors like cola, orange, and fruit blends, are popular across households, workplaces, and educational institutions. Key growth factors include long shelf life, affordability, and increasing interest in functional and fortified formulations. Major distribution channels include supermarkets, online retail, and convenience stores. The market is expected to expand further as manufacturers innovate to meet evolving consumer preferences.
Prenatal Diagnostic Market Size, Share & Trends Analysis Report by Method (Blood, Urine, Ultrasound, Amniocentesis, and Others), and By Test Type (Invasive, and Non-Invasive), and By End-User (Hospitals, Specialty Clinics, and Diagnostic Centers) Forecast Period, (2026-2035)
Published: May 2026
Prenatal diagnostic market valued at $11,500.3 million in 2025 and is projected to reach $24,857.4 million by 2035, growing at a CAGR of 8.0% during the forecast period (2026-2035). The global prenatal diagnostic market is advancing as healthcare providers and expectant parents increasingly prioritize early detection of fetal abnormalities and genetic disorders. Growth is being driven by the rising adoption of non-invasive prenatal testing (NIPT), advanced imaging technologies, and molecular diagnostics that enable accurate risk assessment and early intervention. The increasing prevalence of genetic disorders, rising maternal age, and growing awareness of prenatal care benefits are further supporting market expansion. As regulatory authorities emphasize the importance of evidence-based screening and patient safety, prenatal diagnostic solutions are becoming an indispensable part of modern obstetric care.
Global Demerol Meperidine Market Size, Share and Trends Analysis Report, By Product Type (Powder and Liquid), By Application (Anaesthesia, Cough Treatment, and Diarrhoea Treatment), Forecast (2021-2027)
Published: Feb 2026
The global demerol meperidine market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to fuel the growth of the market during the forecast period include the growth in the incidence of infectious diseases & chronic pain and a rise in disposable income and a surge in the geriatric population.
Global Topical Hemostatic Agents Market Size, Share and Trend Analysis Report, By Type (Gelatin Sponge, Oxidized Regenerated Cellulose Based Hemostats, and Others), By End-User (Ambulatory Surgical Centres, Hospitals, and Others), Forecast (2021-2027)
Published: Feb 2026
The global topical hemostatic agents market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Topical hemostats are used to set surgery or trauma as adjuncts to maintain hemostasis. Gelatin sponges, collagens, fibrin sealants, and active thrombin preparations are different types of topical hemostat products that are applied locally to stop blood flow.
Tissue Expanders Market Size, Share & Trends Analysis Report By Shape (Round Tissue Expanders, Rectangular Tissue Expanders, Crescent Tissue Expanders, Anatomical Tissue Expanders and Others), By Application (Breast Reconstruction, Forehead Skin & Scalp Reconstruction, Face & Neck Reconstruction, Others), By End-Use (Hospitals, Cosmetology Clinics, and Ambulatory Surgical Centers), Forecast (2026-2035)
Published: Mar 2026
Tissue expander market was valued at $824.0 million in 2025 and is projected to reach $1,398.3 million by 2035, growing at a CAGR of 5.5% during the forecast period (2026-2035). The global tissue expander market is experiencing steady growth, driven by the rising demand for reconstructive and cosmetic surgical procedures. Increasing awareness of breast reconstruction following mastectomy has contributed significantly to market expansion. Advancements in medical technology and the introduction of innovative tissue expander designs have enhanced surgical outcomes, supporting higher adoption rates. The prevalence of chronic skin injuries and trauma cases also fuels the need for tissue expansion solutions. Growing investments by healthcare providers in advanced surgical devices further accelerate market development. Additionally, the expansion of healthcare infrastructure in emerging regions is creating new opportunities for tissue expander manufacturers worldwide.
Global Ostomy Deodorants Market Size, Share and Trend Analysis Report, By Product (Liquid, Tablets, and Others), By Application (Hospital, Clinics, and Others), Forecast (2021-2027)
Published: Feb 2026
The global ostomy deodorants market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Ostomy deodorants are designed to eliminate ostomy odors from inside the pouch by killing odor-producing bacteria and providing a scent to lubricating products to help to prevent pancaking when stool gets stuck on the top portion of the bag.
Global Gastrointestinal (GI) Stents Market Size, Share and Trend Analysis Report, By Product (Biliary Stents, Duodenal Stents, Colonic Stents, Pancreatic Stents and Esophageal Stents), By Application (Colorectal Cancer, Biliary Disease, Inflammatory Bowel Disease, Stomach Cancer, and Others), Forecast (2021-2027)
Published: Feb 2026
The global gastrointestinal (GI) stents market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The gastrointestinal (GI) stent is a medical device used for effective endoscopic procedures. It is tube-shaped and acts as a substitute for many other medical processes.
Global Ear Drops Market Size, Share and Trend Analysis Report, By Product Type (Ciprodex Ear Drop, Gentisone HC Ear Drop and Ciproxin HC Ear Drop), By Application (Adults, Children, and Elderly), Forecast (2021-2027)
Published: Feb 2026
The global ear drops market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Ear drops are a liquid medicine that is used to treat or prevent ear infections of the outer ear and ear canal (otitis externa). It also supports remove ear wax as well as for short-term treatment and are easily available over-the-counter or with a prescription.
Global Disposable Surgical Kits Market Size, Share, and Trends Analysis Report by Type (General Purpose Kit, Dressing Change Kit, Incision and Drainage Kit, Dialysis Kit, and Others) and by Application (Hospitals & Clinics, Emergency Centres, and Others) Forecast 2022-2028
Published: Feb 2026
The global disposable surgical kits market is anticipated to grow at a significant CAGR of 7.% during the forecast period 2022-2028. Disposable surgical kits are not only cost-effective, but they also reduce the requirement for instrument cleaning and recycling, as well as the risk of infection during surgery. The key driver of market n is the growing need for cost-effective surgical products, coupled with rising hygiene awareness in emerging countries. In addition, the market is growing as the number of procedures conducted around the world rises. According to the World Health Organization (WHO), surgical therapy and interventions account for 13% of total disability-adjusted life years in the world.
Global Crohn’s Disease Drugs Market Size, Share and Trends Analysis Report, By Drug Type (Anti-Inflammatory, Immune System Suppressors, Antibiotics, and Others), By Route of Administration (Oral and Injectable), Forecast (2021-2027)
Published: Feb 2026
The global Crohn’s disease drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to accelerate the growth of the market include the increasing incidence of inflammatory bowel syndrome, such as Crohn’s disease and ulcerative colitis.
Bio-Implants Market Size, Share & Trends Analysis Report, By Product Type (Orthopaedic, Cardiovascular, Dental, Neurological, Ophthalmic, and Cosmetic & Reconstructive), By Material Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials), By Application (Orthopedic, Cardiovascular Treatment, Dental Restoration, Neurological Disorders, Ophthalmic Correction, and Cosmetic & Reconstructive Procedures), and By Fixation Type (Cemented Implants, Cementless Implants, and Hybrid Fixation), Forecast Period (2026–2035)
Published: May 2026
Global bio-implants Market is projected to reach $136.6 billion by 2035, growing from $263.8 billion in 2025 at a steady CAGR of 6.8% during the forecast period. The Bio-Implants Market is witnessing strong expansion driven by rising chronic diseases, ageing populations, and rapid advancements in biomaterials and surgical technologies. Bio-Implants are widely used across orthopaedic surgery, cardiovascular treatment, dental restoration, neurological disorders, ophthalmology, and cosmetic reconstruction, making them critical in modern healthcare systems. According to the World Health Organisation (WHO), musculoskeletal and cardiovascular diseases remain among the leading causes of long-term disability globally, significantly increasing implant demand. Additionally,
Global Rare Neurodegenerative Disease Treatment Market Size, Share & Trends Analysis Report by Indications (Parkinson’s Disease, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Multiple Sclerosis, Spinal Muscular Atrophy, Huntington Disease, and Other Indications), by Drug Class (Immunomodulator Drugs, Cholinesterase Inhibitors, Dopamine Agonists, N-methyl-D-Aspartate Receptor Antagonists, and Others) Forecast 2022-2028
Published: Feb 2026
The global rare neurodegenerative disease treatment market is anticipated to grow at a significant CAGR of 6.8% during the forecast period. Neurodegenerative disease generally occurs when the nerve cells in the brain lose their functions and day by day die. Some of the physical and mental symptoms of this disease can be helped through treatment, but there are several ways to slow the disease progression. The risk of this disease generally increases with age. Research says that this disease develops by the combination of a person’s genes and the environment contributes to increasing the chances of this disease.
Global Pegfilgrastim Biosimilar Market Size, Share & Trends Analysis Report, By Application (Chemotherapy Treatment, Transplantation, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others) Forecast (2021-2027)
Published: Feb 2026
The global pegfilgrastim biosimilar market is expected to grow at a significant CAGR during the forecast period (2021-2027). The global pegfilgrastim biosimilar market is expanding as the number of people diagnosed with various diseases, such as cancer and HIV/AIDS, rises.
Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size, Share & Trends Analysis Report, By Drug Class (Lipopeptide, Oxazolidinone, Tetracycline, Cephalosporin, Lipoglycopeptide, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Forecast (2021-2027)
Published: Feb 2026
The global methicillin-resistant staphylococcus aureus (MRSA) drugs market is expected to grow at a significant CAGR during the forecast period (2021-2027). Staphylococcus aureus is a bacterium that can be found on healthy people's nose or skin.
Global Botanical and Plant-Derived Drugs Market Size, Share & Trends Analysis Report, By Source (Plant, Algae, Macroscopic fungi, and Others), By Dosage Form (Pills, Tablets, Capsules, and Others), By Therapeutic Application (CVD, Infectious Diseases, Dermatology, Central Nervous System, Respiratory Diseases, and Others), Forecast (2021-2027)
Published: Feb 2026
The global botanical and plant-derived drugs market is expected to grow at a significant CAGR during the forecast period (2021-2027). Botanical drugs are made from plants that have therapeutic properties. Algae and vegetable components, as well as microscopic fungus, are found in botanical drugs.
Global Adaptogens Market Size, Share & Trends Analysis Report, By Nature (Natural and Synthetic), By Source (Ashwagandha, Ginseng, Astragalus, Turmeric, and Others), By Application (Food & Beverages, Pharmaceuticals, Nutraceuticals, Cosmetics & Personal Care, and Animal Feed), Forecast (2021-2027)
Published: Feb 2026
The global adaptogens market is expected to grow at a significant CAGR during the forecast period (2021-2027). Adaptogens are herbal products that aid the body in dealing with physical and mental stress. Some adaptogens, such as Holy Basil, can be eaten whole, while others can be taken as supplements or brewed into teas.
Global Varicella Live Vaccine Market Size, Share & Trends Analysis Report, By Type (Monovalent Vaccine and Combination Vaccine), By Application (Chickenpox Immunization, Herpes Zoster Immunization, and MMRV Immunization), Forecast (2021-2027)
Published: Feb 2026
The global varicella live vaccine market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The zoster virus is also known as human alphaherpesvirus 3 which is responsible for causing chickenpox and herpes zoster in the human body.
Global Vaccines for Children Market Size, Share & Trends Analysis Report, By Disease Indication (Infectious Disease, Cancer, CVD, Allergy and Respiratory, CNS, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Forecast (2021-2027)
Published: Feb 2026
The global vaccines for children market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). As people's awareness rises, the trend towards vaccination has increased. Healthcare workers prescribe a series of vaccines at birth.
Global Prostate Health Market Size, Share & Trends Analysis Report by Disease Indication (Prostate Cancer, Benign Prostatic Hyperplasia, and Prostatitis), and by Treatment (Chemotherapy, Biological Therapy, Hormone Therapy, and Others), Forecast (2021-2027)
Published: Feb 2026
The global prostate health market is anticipated to grow at a significant CAGR of around 8.8% during the forecast period. The increasing prevalence of benign prostatic hyperplasia is considered as the primary factor attributable to the growth in the prostate health market.
Global Fitness App Market Size, Share & Trends Analysis Report by Operating System (IOS and Android), and by Application (Exercise & Weight Loss, Diet & Nutrition, Activities Tracking, and Others), Forecast (2021-2027)
Published: Feb 2026
The global fitness app market is anticipated to grow at a significant CAGR of 20.8 % during the forecast period. Rising awareness among the population across the globe towards the health coupled with inclination towards the adoption of healthy lifestyle has propelled the growth of the market.
Global Wireless Health Market Size, Share & Trends Analysis Report by Technology (WLAN/Wi-Fi, WPAN, WIMAX, and WWAN), by Component (Hardware and Software & Services), and by End-Users (Providers, Payers, and Patients/Individuals), Forecast (2021-2027)
Published: Feb 2026
The global wireless health market is anticipated to grow at a significant CAGR of approx. 22.3% during the forecast period. Wireless health is an advanced technique that is mainly used for the treatment and monitoring of patients.
Global Hospital Supplies Market, Size, Share and Trend Analysis Report By Product Type (Operating Room Equipments, Sterilization and Disinfectant, Syringes and Needles, Examination Devices, Transportation Equipment, Others), Forecast Period (2020-2027)
Published: Feb 2026
The global hospital supplies market is anticipated to grow at a significant CAGR during the forecast period. The increasing prevalence of chronic diseases like cancer, diabetes, cardiovascular diseases, asthma, and many others will fuel the growth of the market.
Global Bluetooth Low Energy (BLE) Beacon Market Size, Share & Trends Analysis Report By Technology (iBeacon, Eddystone, and Others), By End-User (Retail, Travel and Tourism, Healthcare, Financial Institutions, and Others), Forecast (2021-2027)
Published: Feb 2026
The global Bluetooth Low Energy (BLE) beacon market is expected to grow at a significant CAGR of 26.6% during the forecast period (2021-2027). The major factors contributing to the growth of the global BLE beacon market include rising disposable income and increased demand for proximity marketing.
Global Hand Geometry Biometrics Market Size, Share & Trends Analysis Report By Technology (Access Control, Time and Attendance Systems), By Application (Government and Defense, BFSI, Travel and Tourism, Healthcare, Consumer Electronics), Forecast (2021 – 2027).
Published: Feb 2026
The global hand geometry biometrics market is anticipated to grow at a significant CAGR during the forecast period. The major factor for growth of the market is the increasing awareness regarding the security in commercial as well as personal spaces.
Global Deep Packet Inspection Market Size, Share & Trends Analysis Report, By Application (Intrusion Detection System (IDS), Intrusion Prevention System (IPS), Others), By Service (Training, Consulting, Integration, Others), By Organization Size (Small and Medium-sized Enterprises (SMEs), Large Enterprises), By Verticals (Banking, Financial Services, and Insurance (BFSI), Government and Defense, Healthcare, IT and Telecom, Manufacturing, Retail, Others (Includes transportation; energy and utilities; and media and entertainment)) (Forecast (2021-2027)
Published: Feb 2026
The Global Deep Packet Inspection Market is estimated to grow at a moderate CAGR during the forecast period. Deep packet inspection is a sort of network packet filtering that is also known as DPI, information extraction, or complete packet inspection.
Global Fluidics for Preclinical Market Size, Share & Trends Analysis Report By Product Type (Software and Accessories, and Precision Syringe Pumps) by Application (Life Science Research and Clinical Application) and Forecast (2021-2027)
Published: Feb 2026
The Global Fluidics for Preclinical Market is expected to grow at a significant CAGR during the forecast period. The demand for advanced treatments has increased as the incidence of various illnesses and chronic disorders have increased.
Medical Billing Outsourcing Market Size, Share & Trends Analysis by Service (Front-End, Middle-End, Back-End), by Type of Deployment (On-Premise, Cloud-based), and by End User (Hospitals, Physicians’ Offices, and Ambulatory/Other Providers), Forecast Period (2026-2035)
Published: Feb 2026
Medical billing outsourcing market was valued at $15.4 billion in 2025 and is projected to reach $51.8 billion by 2035, growing at a CAGR of 11.8% during the forecast period (2026-2035). The market is experiencing strong growth, driven by the increasing complexity of healthcare reimbursement processes, rising administrative costs, and the growing demand for streamlined revenue cycle management solutions. Outsourcing medical billing allows healthcare providers to focus on patient care while reducing errors and improving cash flow through specialized third-party expertise. The market is also benefiting from the rapid adoption of digital health technologies, electronic health records (EHRs), and automation tools that enhance claim accuracy and efficiency. Furthermore, the shift toward cloud-based billing systems, coupled with the global shortage of skilled medical coders, continues to accelerate the market’s expansion across hospitals, physician offices, and ambulatory care centers.
Topical Pain Relief Market Size, Share & Trends Analysis by Formulation (Cream, Gel, Spray, and Others), and by Distribution Channel (Online and Offline) Forecast Period (2026-2035)
Published: Feb 2026
Topical pain relief market was valued at $11.3 billion in 2024 and is projected to reach $20.7 billion by 2035, growing at a CAGR of 5.7% during the forecast period (2026-2035). The market is driven by the rising prevalence of chronic pain conditions, a growing preference for non-invasive, lower-side-effect treatments, and an aging global population. The other key factors include technological innovations in drug delivery, the expansion of the over-the-counter (OTC) market, increased online retail, and demand from athletes. However, factors like skin irritation and strong odors can hinder market growth.
Cell and Gene Therapy Manufacturing Services Market Size, Share & Trends Analysis by Therapy (Cell Therapy, and Gene Therapy), by Scale (Pre-commercial/ R&D Scale Manufacturing, and Commercial Scale Manufacturing) by Indication (Oncology, Cardiovascular Diseases, Orthopedic Diseases, Infectious Diseases, Ophthalmology Diseases, and Others) and by End User (Pharmaceutical and Biotechnology Companies, and Academic and Research Institutes) Forecast Period (2025-2035)
Published: Feb 2026
Cell and gene therapy manufacturing services market was valued at $7.74 billion in 2024 and is projected to reach $76.20 billion by 2035, growing at a CAGR of 23.1% during the forecast period (2025-2035). The market is growing due to factors like the rising prevalence of chronic diseases, advances in gene editing, and increasing investment. Key drivers also include the growing demand for personalized medicine, the supportive regulatory environment for new therapies, and the expansion of contract manufacturing organizations (CMOs) to handle complex production.
Invisible Orthodontics Market Size, Share & Trends Analysis Report by Product (Clear aligners, Ceramic Braces, Lingual Orthodontics, and Clear Retainers) by Group (Children, Adolescents, and Adults) by End-User (Hospital Facilities and Dental & Orthodontic Clinics), Forecast Period (2025-2035)
Published: Feb 2026
Invisible orthodontics market was valued at $5.7 billion in 2024 and is projected to reach $12.5 billion by 2035, growing at a CAGR of 7.5% during the forecast period (2025–2035). The market growth is driven by increasing consumer demand for aesthetics, discreet treatments, and rising awareness of malocclusion and available options. Its key factors fueling growth include technological advancements like AI and 3D printing, an increase in disposable income enabling more people to afford treatment, and the growing number of adults seeking orthodontic correction.
Healthcare Automatic Identification and Data Capture (AIDC) Market Size, Share & Trends Analysis Report by Technology (Barcode, RFID, and Biometric), by Component (Software and Services, and Hardware), and by Application (Clinical and Non-Clinical), Forecast Period (2026-2035)
Published: Mar 2026
Healthcare automatic identification and data capture (AIDC) market is expected to reach approximately $17.1 billion by 2035, growing at a CAGR of 6.9% from 2026 to 2035, up from $8.9 billion in 2025. The global healthcare automatic identification and data capture (AIDC) market is experiencing steady expansion, driven by the increasing need for accurate data handling and operational efficiency across healthcare facilities. Healthcare providers are progressively adopting automated identification solutions to enhance patient safety, reduce manual errors, and improve workflow transparency. The growing emphasis on traceability in clinical and administrative processes has further supported the uptake of AIDC technologies. In addition, advancements in digital healthcare infrastructure and the integration of identification systems with hospital information platforms are strengthening market adoption. Rising demand for efficient asset and inventory management within hospitals is also contributing to market growth.
Patient-Derived Xenograft/PDX Model Market Size, Share & Trends Analysis Report By Type (Mice Model, and Rat Model) By Tumor Models (Gynecological, Gastrointestinal, Respiratory Tumor Model and Others) By Application (Preclinical drug development, Biomarker analysis, and Basic Cancer Research) By End-User (Pharmaceutical & Biotechnology Companies, CROs, and Academic & Research Institutions), Forecast Period (2026-2035)
Published: Mar 2026
Patient-derived xenograft/PDX model market is expected to reach approximately $1,330.5 million by 2035, growing at a CAGR of 11.6% from 2026 to 2035, up from $445.6 million in 2025. The growth of the global patient-derived xenograft (PDX) model market is primarily driven by the increasing demand for more predictive preclinical models in oncology research. Rising investment in targeted cancer therapies and immuno-oncology has amplified the need for accurate models that closely mimic human tumor biology. Additionally, the expansion of contract research organizations and academic collaborations has facilitated broader adoption of PDX models for drug efficacy and biomarker studies. Advances in genetic engineering and humanized mouse models have further enhanced the reliability and applicability of these models. Moreover, the growing emphasis on personalized medicine and translational research has reinforced the role of PDX models in bridging laboratory findings with clinical outcomes.
North America Long-Term Care Market Size, Share & Trends Analysis Report by Service Type (Medical Services (In-house Therapy, Skilled Nursing, and Others) and Assisted Living Services) and by Point of Care (Homecare and Hospitals (Rehabilitation Center), Forecast Period (2026-2035)
Published: Feb 2026
North America long-term care market was valued at $157.9 billion in 2025 and is projected to reach $237.3 billion by 2035, growing at a CAGR of 4.2% during the forecast period (2026–2035). The long-term care sector in North America continues to expand as more individuals require consistent medical support and daily assistance. The region’s rising elderly population is creating a sustained need for supervised care environments and professional health services. Providers are strengthening their clinical teams and enhancing rehabilitation programs to keep pace with changing patient needs. Many facilities are also updating their infrastructure to offer safer and more comfortable living arrangements. Regulatory attention on quality standards has further prompted organizations to refine their service delivery models.
European Long-Term Care Market Size, Share & Trends Analysis Report by Service Type (Medical Services (In-house Therapy, Skilled Nursing, and Others) and Assisted Living Services) and by Point of Care (Homecare and Hospitals (Rehabilitation Center), Forecast Period (2026-2035)
Published: Feb 2026
European long-term care market was valued at $112.3 billion in 2025 and is projected to reach $156.4 billion by 2035, growing at a CAGR of 3.4% during the forecast period (2026–2035). The long-term care market in Europe is expanding as more individuals require structured support to manage daily living and age-related health needs. Changing family dynamics and greater workforce participation are reducing the availability of informal care, leading to a stronger dependence on organized providers. Many countries are also investing in improved eldercare infrastructure, which is strengthening service availability and standards. Public policies that prioritize accessible and sustainable care solutions are further supporting growth. At the same time, families are increasingly seeking reliable long-term care options that balance comfort and quality.
Asia-Pacific Long-Term Care Market Size, Share & Trends Analysis Report by Service Type (Medical Services (In-house Therapy, Skilled Nursing, and Others) and Assisted Living Services) and by Point of Care (Homecare and Hospitals (Rehabilitation Center), Forecast Period (2026-2035)
Published: Feb 2026
Asia-Pacific long-term care market was valued at $52.7 billion in 2025 and is projected to reach $93.5 billion by 2035, growing at a CAGR of 6.0% during the forecast period (2026–2035). The long-term care market across Asia-Pacific continues to expand as more households look for structured support for ageing family members. Rising life expectancy and a steady increase in chronic health needs are prompting greater reliance on organized care services rather than informal arrangements. Many countries in the region are also upgrading their healthcare and social support systems, which is helping providers widen their service capabilities. Alongside this, families are showing a stronger preference for dependable home-based and community-oriented care options.
Long-Term Care Market Size, Share & Trends Analysis Report by Service Type (Medical Services (In-house Therapy, Skilled Nursing, and Others) and Assisted Living Services) and by Point of Care (Homecare and Hospitals (Rehabilitation Center), Forecast Period (2026-2035)
Published: Feb 2026
Long-term care market was valued at $350.8 billion in 2025 and is projected to reach $524.7 billion by 2035, growing at a CAGR of 4.2% during the forecast period (2026-2035). The global long-term care market is witnessing significant growth driven by increasing demand for personalized and comprehensive healthcare solutions for the aging population. The rising prevalence of chronic diseases and post-operative care requirements is fueling the adoption of skilled nursing and in-home therapy services. Additionally, a growing preference for assisted living arrangements and home-based care is reshaping patient care dynamics. Technological advancements in rehabilitation and telehealth services are enhancing the efficiency and accessibility of long-term care. Expanding healthcare infrastructure and supportive government policies in developed and emerging economies are further propelling market expansion.
Global Biosimulation Market Size, Share & Trends Analysis Report, By Application (Drug Discovery and Drug Development), By Product (Software and Services), By End-User (Biotechnology and Pharmaceutical Companies, Contract Research Organizations (CROs), Regulatory Authorities, and Others) and Forecast, 2021-2027
Published: Feb 2026
The global biosimulation market is growing at a CAGR of nearly 16.0% during the forecast period. The major factors that are augmenting the growth of the market is urgency to develop and promote modern drugs. Furthermore, rising trend of surrogacy, growing infrastructure and increasing healthcare spending by government are also estimated to be the major factors that are contributing significantly towards the growth of the market.
US eHealth Market Size, Share & Trends Analysis Report by Type (Electronic Health Records (EHR), Telemedicine, Health Information System (HIS/HIE), mHealth, Clinical Decision Support System (CDSS), and Others) and by End-User (Healthcare Provider, Healthcare Consumers, and Others) Forecast Period (2026-2035)
Published: Feb 2026
US eHealth market was valued at $19.6 billion in 2025 and is projected to reach $61.1 billion by 2035, growing at a CAGR of 12.1% during the forecast period (2026–2035). The US eHealth market is experiencing significant expansion driven by the adoption of advanced digital healthcare technologies and an increasing focus on patient-centered care. Rising demand for real-time health data accessibility and the integration of AI-driven tools into clinical workflows are further propelling market growth. Government initiatives promoting interoperability and digital health records have strengthened infrastructure investment across hospitals and clinics. Telehealth and mobile health applications are being increasingly embraced by consumers seeking convenience and improved access to healthcare services. Strategic collaborations between technology providers and healthcare organizations are enhancing service delivery. As a result, the market is poised for sustained growth over the forecast period, supported by continuous innovation and regulatory support.
UK eHealth Market Size, Share & Trends Analysis Report by Type (Electronic Health Records (EHR), Telemedicine, Health Information System (HIS/HIE), mHealth, Clinical Decision Support System (CDSS), and Others) and by End-User (Healthcare Provider, Healthcare Consumers, and Others) Forecast Period (2026-2035)
Published: Feb 2026
UK eHealth market was valued at $2.4 billion in 2025 and is projected to reach $7.1 billion by 2035, growing at a CAGR of 11.7% during the forecast period (2026–2035). The UK eHealth market is expanding steadily as healthcare organizations adopt digital solutions to enhance patient care and operational efficiency. Growing emphasis on data-driven decision-making and secure patient information management is encouraging investment in advanced health technologies. Government programs supporting electronic health record integration and interoperability are further accelerating digital adoption. Increasing consumer preference for remote healthcare services and teleconsultations is driving demand across both urban and rural regions. Collaborations among technology vendors and NHS trusts are facilitating the implementation of innovative solutions. As a result, the market is expected to experience sustained growth over the forecast period, supported by regulatory support and technological advancements.
North American eHealth Market Size, Share & Trends Analysis Report by Type (Electronic Health Records (EHR), Telemedicine, Health Information System (HIS/HIE), mHealth, Clinical Decision Support System (CDSS), and Others) and by End-User (Healthcare Provider, Healthcare Consumers, and Others) Forecast Period 2026-2035
Published: Feb 2026
North American eHealth Market was valued at $21.4 billion in 2025 and is projected to reach $65.7 billion by 2035, growing at a CAGR of 12.0% during the forecast period (2026–2035). The digital?health market in North America is expanding rapidly as hospitals, clinics, payers, and patients increasingly rely on electronic systems for medical records, remote consultations, and patient monitoring. A combination of strong healthcare IT infrastructure, favorable reimbursement policies, and rising acceptance of virtual care has accelerated the adoption of eHealth solutions. This shift is supported by increased incidence of chronic diseases, rising demand for patient?centric care, and growing pressure to reduce costs and improve access. As a result, more healthcare providers and consumers in the U.S. and Canada are embracing telemedicine, mHealth, and integrated health?information systems. The region’s advanced regulatory and technological environment is creating a sustainable foundation for long?term growth and innovation in digital healthcare.
India eHealth Market Size, Share & Trends Analysis Report by Type (Electronic Health Records (EHR), Telemedicine, Health Information System (HIS/HIE), mHealth, Clinical Decision Support System (CDSS), and Others) and by End-User (Healthcare Provider, Healthcare Consumers, and Others) Forecast Period (2026-2035)
Published: Feb 2026
India eHealth market was valued at $1.4 billion in 2025 and is projected to reach $5.4 billion by 2035, growing at a CAGR of 14.0% during the forecast period (2026–2035). India’s eHealth market is advancing steadily as healthcare institutions accelerate the adoption of digital tools to streamline clinical and administrative processes. Increased investment in connected care platforms, combined with a broader shift toward data-driven decision-making, is strengthening the overall ecosystem. Providers are placing greater emphasis on platforms that improve patient access, enable secure data exchange, and support timely clinical interventions. The market is also benefiting from improved digital infrastructure, which is encouraging both public and private players to scale technology-enabled health services. Growing familiarity with remote health solutions is further expanding usage across urban and semi-urban regions. Together, these factors are reinforcing India’s transition toward a more efficient and technology-supported healthcare system.
European eHealth Market Size, Share & Trends Analysis Report by Type (Electronic Health Records (EHR), Telemedicine, Health Information System (HIS/HIE), mHealth, Clinical Decision Support System (CDSS), and Others) and by End-User (Healthcare Provider, Healthcare Consumers, and Others) Forecast Period 2026-2035
Published: Feb 2026
European eHealth market was valued at $14.8 billion in 2025 and is projected to reach $43.2 billion by 2035, growing at a CAGR of 11.4% during the forecast period (2026–2035). The global eHealth industry continues to strengthen as healthcare providers adopt digital solutions that improve clinical efficiency and patient coordination. Investments are shifting toward platforms that support interoperability, secure data handling, and integrated care delivery. Market expansion is also influenced by the growing emphasis on remote consultations and real-time monitoring. Companies are modernizing their digital infrastructure, enabling better decision support and data-driven interventions. Government programs encouraging digital health adoption are further accelerating progress. Overall, the sector is heading toward a more connected and outcome-focused healthcare system.
Asia-Pacific eHealth Market Size, Share & Trends Analysis Report by Type (Electronic Health Records (EHR), Telemedicine, Health Information System (HIS/HIE), mHealth, Clinical Decision Support System (CDSS), and Others) and by End-User (Healthcare Provider, Healthcare Consumers, and Others) Forecast Period 2026-2035
Published: Feb 2026
Asia-Pacific eHealth market was valued at $12.1 billion in 2025 and is projected to reach $42.4 billion by 2035, growing at a CAGR of 13.5% during the forecast period (2026–2035). The Asia-Pacific eHealth landscape is advancing as healthcare systems across the region deepen their reliance on digital tools to manage rising clinical demand. Growth is supported by increased investment in hospital information systems, broader access to mobile-based health platforms, and an expanding base of digitally aware consumers. Providers are placing greater emphasis on solutions that streamline clinical coordination and support timely medical decisions. Governments across the region continue to strengthen digital health frameworks, accelerating adoption among both public and private institutions. As integration becomes more critical, technology vendors are refining platforms to meet local operational requirements. This shift highlights the region’s transition toward more connected, efficient, and patient-oriented care delivery.
US Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others), Forecast Period (2026-2035)
Published: Feb 2026
US drug discovery informatics market was valued at $1,466.8 million in 2025 and is projected to reach $3,252.3 million by 2035, growing at a CAGR of 8.3% during the forecast period (2026–2035). The US Drug Discovery Informatics Market is expanding due to the rising adoption of AI-driven platforms and advanced computational tools in pharmaceutical research. Companies like Schrödinger, Inc. are providing comprehensive software solutions for molecular modeling, docking, and predictive analytics to accelerate early-stage drug discovery. Strong government and private funding for biomedical research are creating favorable conditions for rapid technological integration. Platforms such as Certara’s Simcyp are combining modeling and simulation with real-world data to optimize candidate selection and clinical trial design. These initiatives enhance research efficiency and reduce development timelines across therapeutic areas. Increasing partnerships between technology providers and pharmaceutical companies continue to strengthen market growth.
UK Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others), Forecast Period (2026-2035)
Published: Feb 2026
UK drug discovery informatics market was valued at $242.2 million in 2025 and is projected to reach $502.1 million by 2035, growing at a CAGR of 7.6% during the forecast period (2026–2035). The UK Drug Discovery Informatics Market is expanding due to increasing demand for data-driven research solutions and advanced computational platforms. Companies such as AstraZeneca and GlaxoSmithKline are investing in integrated informatics systems to accelerate target identification and streamline drug design workflows. Government initiatives supporting digital innovation in life sciences are creating a favorable environment for the wider adoption of AI and machine-learning tools. Technology providers are collaborating with research institutions to develop cloud-based platforms that enhance data management and predictive modeling capabilities. These efforts improve R&D efficiency and enable more precise therapeutic development. Growing partnerships between pharmaceutical companies and software innovators continue to strengthen the market’s growth trajectory.
North American Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others) Forecast Period, (2026-2035)
Published: Feb 2026
North American Drug Discovery Informatics Market was valued at $1,588.3 million in 2025 and is projected to reach $3,491.5 million by 2035, growing at a CAGR of 8.3% during the forecast period (2026–2035). The North American Drug Discovery Informatics Market is expanding as pharmaceutical companies, biotechnology firms, and academic institutions increasingly prioritize digital R&D acceleration and data-driven decision-making. Rising complexity in drug discovery, combined with the demand for faster, more cost-efficient development cycles, is driving the adoption of informatics tools such as molecular modeling, docking, sequencing analysis, and predictive analytics. Regulatory expectations from the FDA regarding data integrity, transparency, and reproducibility are further encouraging organizations to invest in advanced informatics platforms. Manufacturers and solution providers are developing next-generation AI- and cloud-enabled software that enhances analysis accuracy, boosts workflow efficiency, and supports large-scale biological and chemical datasets.
Indian Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others), Forecast Period (2026-2035)
Published: Feb 2026
Indian drug discovery informatics market was valued at $69.7 million in 2025 and is projected to reach $207.7 million by 2035, growing at a CAGR of 11.6% during the forecast period (2026–2035). The Indian drug discovery informatics market is expanding as research organizations and pharmaceutical companies increase their reliance on digital tools to strengthen early-stage development. Major domestic players are integrating advanced computational platforms to improve target identification, streamline screening processes, and enhance data accuracy. Growing investment in AI-driven modeling and cloud-based analytics is supporting faster decision-making within drug discovery programs. Government initiatives promoting biotech innovation and digital healthcare infrastructure are further accelerating adoption. Companies are also collaborating with technology providers to modernize research workflows and improve interoperability across systems. Together, these developments are reinforcing sustained growth in Indian’s drug discovery informatics ecosystem
European Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others) Forecast Period, (2026-2035)
Published: Feb 2026
European drug discovery informatics market was valued at $1,029.9 million in 2025 and is projected to reach $1,967.4 million by 2035, growing at a CAGR of 6.7% during the forecast period (2026–2035). The European Drug Discovery Informatics market is growing steadily as pharmaceutical companies, biotech firms, and research institutions increasingly prioritize data-driven R&D. Rising complexity in drug development and the need for faster, more accurate decision-making are driving adoption of advanced informatics platforms across the region. Investments in digital transformation, coupled with strong government and EU-level support for research innovation, are accelerating the use of tools such as molecular modeling, docking, sequencing analytics, and AI-enabled discovery engines. Collaborative research ecosystems linking academia, industry, and technology providers are further boosting demand for integrated, cloud-based solutions that enhance workflow efficiency.
Asia-Pacific Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others) Forecast Period, (2026-2035)
Published: Feb 2026
Asia-Pacific drug discovery informatics market was valued at $729.5 million in 2025 and is projected to reach $1,950.5 million by 2035, growing at a CAGR of 10.4% during the forecast period (2026–2035). The Asia-Pacific drug discovery informatics market is gaining momentum as research organizations and life-science companies deepen their reliance on computational tools to support modern R&D practices. Growing investment in biotechnology infrastructure, paired with stronger government backing for innovation-driven healthcare initiatives, is encouraging broader adoption of advanced analytics and modeling platforms. Regional institutions are increasingly integrating informatics solutions to handle expanding genomic and molecular datasets generated through precision-medicine and translational research programs. At the same time, technology providers are tailoring platforms to meet local workflow needs and regulatory expectations, improving accessibility and performance across diverse research environments. Supported by expanding pharmaceutical activity and a rapidly evolving scientific ecosystem, the region continues to experience steady growth in informatics utilization.
Myasthenia Gravis Treatment Market Size, Share & Trends Analysis Report, By Treatment Modality (Pharmacological Therapies, Rapid Immunotherapies, Surgical Treatment), By Route of Administration (Oral, Intravenous (IV), Subcutaneous (SC)), By End User (Hospitals, Specialty Neurology Clinics, Ambulatory Surgical Centers, Homecare Settings, Others), Forecast Period (2026–2035)
Published: May 2026
Myasthenia gravis treatment market was valued at $2.2 billion in 2025 and is projected to reach $5.9 billion by 2035, expanding at a CAGR of 10.6% during 2026–2035. The market is primarily driven by the increasing adoption of targeted biologics such as FcRn inhibitors and complement inhibitors, alongside growing awareness and diagnosis rates of autoimmune neuromuscular disorders. According to the World Health Organization (WHO), rare neurological disorders, including myasthenia gravis, are increasingly recognized due to improved diagnostic infrastructure globally. Additionally, data from the U.S. Food and Drug Administration (FDA) highlights a growing number of orphan drug approvals in autoimmune diseases, supporting innovation in MG therapies.
North America Oncology Information System Market Size, Share & Trends Analysis Report by Application (Medical Oncology, Radiation Oncology, Surgical Oncology), by End-User (Hospitals, Cancer Treatment Centers, Research & Academic Institutes), and Forecast Period (2026–2035)
Published: May 2026
North America oncology information system market was valued at $1.5 billion in 2025 and is expected to reach $3.3 billion by 2035, registering a CAGR of 8.8% during the forecast period (2026–2035). Oncology information systems are essential healthcare IT solutions that enable the efficient management of patient data, streamline clinical workflows, and support comprehensive treatment planning across medical, radiation, and surgical oncology. These systems play a crucial role in enhancing clinical decision-making, improving patient outcomes, and ensuring seamless coordination among multidisciplinary cancer care teams. By integrating various oncology functions into a unified platform, they help healthcare providers deliver more precise and timely care.
UK Oncology Information System Market Size, Share & Trends Analysis Report by Application (Medical Oncology, Radiation Oncology, Surgical Oncology), by Product Type (Software, Services), by End-User (Hospitals, Cancer Treatment Centers, Research & Academic Institutes), and Forecast Period (2026–2035)
Published: May 2026
UK oncology information system market was valued at $222.2 million in 2025 and is projected to reach $503.2 million by 2035, registering a CAGR of 8.6% during the forecast period. Oncology information systems are sophisticated healthcare IT solutions designed to manage cancer patient data, streamline clinical workflows, and support comprehensive treatment planning across oncology departments. These systems integrate electronic health records, imaging data, radiotherapy planning tools, and clinical decision support systems, enabling healthcare providers to deliver more coordinated, efficient, and personalized cancer care. The market growth is primarily driven by the rising prevalence of cancer, increasing demand for digital transformation in healthcare, and the growing adoption of precision medicine approaches across the UK.
US Oncology Information System Market Size, Share & Trends Analysis Report by Product Type (Software, Services), by Application (Medical Oncology, Radiation Oncology, Surgical Oncology), by End-Use Industry (Hospitals, Cancer Treatment Centers, Research & Academic Institutes), and Forecast Period (2026–2035)
Published: May 2026
US oncology information system (OIS) market was valued at $1.3 billion in 2025 and is projected to reach $3.1 billion by 2035, registering a CAGR of 8.9% from 2026 to 2035. Oncology information systems are advanced healthcare IT platforms designed to manage patient data, optimize oncology workflows, and support clinical decision-making across medical, radiation, and surgical oncology. These systems integrate critical functions such as imaging, diagnostics, treatment planning, and patient monitoring, enabling healthcare providers to deliver accurate and personalized cancer care. Market growth is primarily driven by the rising incidence of cancer, increasing adoption of digital health technologies, and the growing need for efficient data management in oncology practices.
Canada Oncology Information System Market Size, Share & Trends Analysis Report by Product Type (Software, Services), by Application (Medical Oncology, Radiation Oncology, Surgical Oncology), by End-User (Hospitals, Cancer Treatment Centers, Research & Academic Institutes), and Forecast Period (2026–2035)
Published: May 2026
Canada oncology information system market was valued at $1.3 billion in 2025 and is projected to reach $3.1 billion by 2035, growing at a CAGR of 8.9% from 2026 to 2035. Oncology information systems are advanced healthcare IT solutions designed to manage patient data, streamline oncology workflows, and support clinical decision-making across the entire cancer care continuum. These systems integrate information from multiple departments, including diagnostics, imaging, and treatment planning, enabling a more coordinated and comprehensive approach to cancer management. The market is primarily driven by the rising incidence of cancer, increasing demand for precision medicine, and the rapid digital transformation of healthcare infrastructure. Healthcare providers across Canada are increasingly adopting these systems to improve operational efficiency, enhance patient safety, and ensure more accurate and timely treatment delivery.
European Oncology Information System Market Size, Share & Trends Analysis Report Product Type (Software, Services), by Application (Medical Oncology, Radiation Oncology, Surgical Oncology), by End-Use Industry (Hospitals, Cancer Treatment Centers, Research & Academic Institutes), and Forecast Period (2026–2035)
Published: May 2026
European oncology information system market was valued at $1.0 billion in 2025 and is projected to reach $2.2 billion by 2035, expanding at a CAGR of 8.1% during the forecast period (2026–2035). Oncology Information Systems (OIS) are advanced healthcare IT platforms that enable the efficient management of cancer patient data, streamline clinical workflows, and support precise treatment planning across oncology departments. These systems integrate radiology, pathology, and electronic health records, allowing healthcare providers to deliver coordinated and data-driven cancer care. The increasing incidence of cancer across Europe, coupled with the rising adoption of digital health technologies and the growing emphasis on precision medicine, is significantly driving market growth. Moreover, healthcare providers are continuously investing in advanced OIS platforms to enhance clinical outcomes, improve operational efficiency, and ensure seamless data integration across multidisciplinary care teams.
Germany Oncology Information System Market Size, Share & Trends Analysis Report by Product Type (Software, Services), by Application (Medical Oncology, Radiation Oncology, Surgical Oncology), by End-User (Hospitals, Cancer Treatment Centers, Research & Academic Institutes), and Forecast Period (2026–2035)
Published: May 2026
Germany oncology information system market was valued at $199.6 million in 2025 and is projected to reach $424.6 million by 2035, expanding at a CAGR of 7.9% from 2026 to 2035. The market comprises advanced digital platforms and software solutions that streamline oncology workflows, manage patient information, support treatment planning, and track clinical outcomes. These systems are increasingly vital in modern cancer care, as they enhance coordination among healthcare providers, improve diagnostic precision, and enable personalized treatment approaches. The rising prevalence of cancer, along with Germany’s well-established healthcare infrastructure, is significantly driving the adoption of oncology information systems across hospitals and specialized cancer treatment centers.
eHealth Market Size, Share & Trends Analysis Report by Type (Electronic Health Records (EHR), Telemedicine, Health Information System (HIS/HIE), mHealth, Clinical Decision Support System (CDSS), and Others) and by End-User (Healthcare Provider, Healthcare Consumers, and Others) Forecast Period (2026-2035)
Published: Feb 2026
Global eHealth market was valued at $54.8 billion in 2025 and is projected to reach $173.0 billion by 2035, growing at a CAGR of 12.3% from 2026 to 2035. The global eHealth industry continues to advance as healthcare organizations pursue more connected, data-led ways of delivering care. Market expansion is supported by rising digital literacy among patients, broader adoption of virtual clinical workflows, and the need for reliable, interoperable systems across care settings. Providers are increasingly prioritizing tools that simplify documentation, strengthen decision-making, and improve oversight of clinical operations. Investment momentum is also shifting toward platforms capable of integrating diverse data streams into unified environments. As healthcare systems emphasize efficiency without compromising patient outcomes, digital solutions are becoming indispensable. This sustained transition underscores the sector’s long-term relevance across both mature and emerging markets.
Global Digital Assistant in Healthcare Market Size, Share & Trends Analysis Report by Product (Smart Speakers and Chatbots) and by Application (Diagnosis, Virtual Nursing Assistance, Patient Tracking, Drug Dosage, and Others) and Forecast 2020-2026
Published: Feb 2026
The global digital assistant in healthcare market is growing at a significant CAGR of around 35.0% during the forecast period (2020-2026). The digital technology is rapidly expanding in healthcare sector, encouraging the replacement of human physicians with AI technology-based doctors in future.
Hospital Supplies Market Size, Share & Trends Analysis Report by Technology (Disposable / Consumable Supplies, Sterilization & Infection, Control Supplies, Diagnostic & Testing Supplies, Surgical & Operating Room Supplies, Patient Care & General Supplies), and by End-User (Hospitals & Clinics, Ambulatory Surgical Centres, Diagnostic Centres, Nursing Facilities and Others) Forecast Period (2026-2035)
Published: Jun 2026
Hospital supplies market was valued at $152.5 billion in 2025 and is projected to reach $233.8 billion by 2035, growing at a CAGR of 4.4% during the forecast period (2026-2035). The hospital supplies market is expanding steadily, driven by the increasing volume of surgical procedures and hospital admissions worldwide. A growing emphasis on infection prevention and control has led to sustained demand for sterilization and disposable medical products. Additionally, the rising prevalence of chronic diseases continues to necessitate consistent use of diagnostic and patient care supplies. Healthcare infrastructure development, particularly in emerging economies, is further supporting procurement of essential hospital consumables. Moreover, regulatory standards and quality requirements are encouraging healthcare providers to adopt standardized, high-quality supplies, contributing to market growth.
Passenger Information System (PIS) Market Size, Share & Trends Analysis Report, By Component (Hardware, Software, Services), By Transportation Mode (Railways, Roadways, Airways, Waterways), By System Type (Stationary PIS, On-board PIS, Mobile/Cloud-based PIS), By Technology (GPS-based Systems, IoT-enabled PIS, Cloud-based Systems, AI & Predictive Analytics-enabled Systems), Forecast Period (2026–2035)
Published: Jun 2026
Passenger information system (PIS) market was valued at $37.60 billion in 2025 and is projected to reach $92.30 billion by 2035, expanding at a CAGR of 13.5% during 2026–2035, driven by rapid digitalization in transportation infrastructure. The market. A major growth driver is the rising global demand for smart mobility solutions. According to the International Telecommunication Union (ITU), over 5.4 billion people globally were connected to the internet in 2023, enabling real-time data integration across transport networks. Furthermore, the International Energy Agency (IEA) estimates that urban passenger transport demand will grow by more than 60% by 2050, necessitating advanced passenger communication systems. Passenger Information Systems are increasingly adopted across railways, airports, and public bus networks to enhance passenger experience, operational efficiency, and safety. Governments worldwide are investing in smart city initiatives, integrating PIS with IoT and AI technologies to provide real-time updates, predictive alerts, and improved transit management.
Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others) Forecast Period, (2026-2035)
Published: Feb 2026
Drug discovery informatics market was valued at $3,525.7 million in 2025 and is projected to reach $7,682.1 million by 2035, growing at a CAGR of 8.2% during the forecast period (2026-2035). The Global Drug Discovery Informatics Market is advancing as pharmaceutical and biotechnology companies intensify their focus on precision-driven R&D and data-centric decision frameworks. Growth is being reinforced by the rising adoption of AI-enabled molecular modeling, high-throughput screening analytics, and cloud-based platforms that streamline early-stage discovery workflows. Demand is further supported by the increasing volume of complex biological datasets requiring specialized computational tools for target identification and validation. As regulatory agencies emphasize evidence-backed development processes, informatics solutions are becoming indispensable in reducing cycle times and improving prediction accuracy.
Healthcare Inventory Management Systems Market Size, Share & Trends Analysis Report, By Product Type (Software, Hardware, Services), By Technology (RFID-based Systems, Barcode-based Systems, IoT-enabled Smart Inventory Systems, AI/ML-enabled Predictive Inventory Systems), By End User (Hospitals, Clinics & Physician Practices, Pharmacies, Diagnostic Laboratories, Long-term Care Facilities), Forecast Period (2026-2035)
Published: May 2026
Healthcare inventory management systems market size was valued at $8.4 billion in 2025 and is projected to reach $20.2 billion by 2035, growing at a CAGR of 9.2% during 2026 to 2035. The market growth is primarily driven by increasing demand for efficient supply chain management in healthcare facilities, rising adoption of automation technologies, and the need to minimize operational inefficiencies. Healthcare institutions are under pressure to manage rising patient volumes and complex supply chains. According to the World Health Organization (WHO), global healthcare expenditure has exceeded 10% of global GDP, emphasizing the importance of cost optimization in hospital operations. Inventory management systems help reduce wastage, prevent stockouts, and enhance operational efficiency. Additionally, the adoption of RFID, IoT, and AI-based predictive analytics is transforming inventory tracking and forecasting. Hospitals, pharmacies, and diagnostic laboratories are the primary end users, leveraging these systems to improve patient safety, regulatory compliance, and financial performance. The increasing digital transformation across healthcare infrastructure globally is expected to sustain long-term market growth.
Impact of COVID-19 on Netherlands Economy, Deviation & Trends Analysis Report, By Verticals (Electronics, Energy, Healthcare, Retail & E-commerce, Aviation, Manufacturing, Travel & Tourism, Others) and Forecast 2019-2025
Published: Feb 2026
The first case related to COVID-19 in the Netherlands was witnessed on 27th February 2020. By 11th April 2020, the cases related to COVID-19 increased to more than 23,000 and has registered more than 2,500 fatalities. As per the International Monetary Fund, the GDP of the Netherlands was $902 billion in 2019.
Global Health Intelligent Virtual Assistant Market Size, Share & Trends Analysis Report by Technology (Speech Recognition, Voice Recognition, Text-To-Speech), by Product (Smart Speakers and Chatbots), and Forecast 2019-2025
Published: Feb 2026
The global health intelligent virtual assistant market is significantly growing at a CAGR during the forecast period. The factors such as growing lifestyle-related disorders and growing health consciousness, significant number of smartphone users, increasing the use of healthcare applications are boosting the growth of the health intelligent virtual assistant market during the forecast period.
Global Healthcare Interoperability Solutions Market Size, Share & Trends Analysis Report by Level (Foundational, Structural, and Semantic), by Deployment Type (Cloud-Based and On-Premises), by End-Users (Hospitals and Diagnostic Centers, Ambulatory Surgical Centers, and Others), Forecast Period 2019-2025
Published: Feb 2026
The healthcare interoperability solutions market is anticipated to grow at a CAGR 8.2% during the forecast period. The factor such as increasing focus on patient care and government initiatives for improving the patient care experience is propelling the growth of the healthcare interoperability solutions market. Interoperability of systems, data access, and information exchange play an important role in enhancing health outcomes.
Healthcare Assistive Robot Market Size, Share & Trends Analysis Report by Application (Orthopedics, Cognitive & Motor Skills, Strokes, and Sports), by Portability (Fixed Base, Mobile), Forecast Period 2023-2030
Published: Feb 2026
Healthcare assistive robot market is anticipated to grow at a significant CAGR of 16.4% during the forecast period. Healthcare assistive robots are widely used to provide support to the patient with stroke or injuries to the orthopedic system, which includes muscles, bones, joints, tendons, and ligaments. Further, increasing insurance coverage for medical exoskeletons and rising in the number of people suffering from strokes and spinal cord injuries also lead to the healthcare assistive robots market growth.
US Healthcare Cloud Computing Market Size, Share & Trends Analysis Report by Application (Clinical Information Systems and Nonclinical Information Systems) By Deployment Type (Private Cloud, Public Cloud and Hybrid Cloud) Forecast period (2019-2025)
Published: Feb 2026
US healthcare cloud computing market is anticipated to grow at a CAGR around 20.6% during the forecast period. Technological innovations such as IoT in information and technology are transforming healthcare. The evolution of cloud technology has resulted in improved workflow. The US is the one of the highest spenders in healthcare across the globe.
UK Healthcare Cloud Computing Market Size, Share & Trends Analysis Report by Application (Clinical Information Systems and Nonclinical Information Systems) By Deployment Type (Private Cloud, Public Cloud and Hybrid Cloud) Forecast period (2019-2025)
Published: Feb 2026
UK healthcare cloud computing market is anticipated to grow at a CAGR around 21.3% during the forecast period. The digitalization of banking, Insurance, healthcare and business services in the country are the key driver for the growth of the market. According to the export.gov, the country has been a notable destination for cloud services due to advanced economy and mature IT market.
North American Healthcare Cloud Computing Market Size, Share & Trends Analysis Report by Application (Clinical Information Systems and Nonclinical Information Systems) By Deployment Type (Private Cloud, Public Cloud and Hybrid Cloud) Forecast period (2019-2025)
Published: Feb 2026
North American healthcare cloud computing market is anticipated to grow at a CAGR around 20.8% during the forecast period. The factor such as well-developed infrastructure and presence of key market players such as Amazon Web Services, Google Inc., Microsoft are estimated to be the major factors that are backing the growth of the market. Further, activities of players such as merger, acquisition, product launch are the also estimated to contribute towards the growth of the market.
Japan Healthcare Cloud Computing Market Size, Share & Trends Analysis Report by Application (Clinical Information Systems and Nonclinical Information Systems) By Deployment Type (Private Cloud, Public Cloud and Hybrid Cloud) Forecast period (2019-2025)
Published: Feb 2026
Japan healthcare cloud computing market is anticipated to grow at a CAGR around 22.9% during the forecast period. The Japan has well-developed healthcare infrastructure & technologically developed market. The Japan Government initiated various awareness programs in medical field for the people & with the increase in awareness of the market is expected to show a vital growth.
Italy Healthcare Cloud Computing Market Size, Share & Trends Analysis Report by Application (Clinical Information Systems and Nonclinical Information Systems) By Deployment Type (Private Cloud, Public Cloud and Hybrid Cloud) Forecast period (2019-2025)
Published: Feb 2026
Italy healthcare cloud computing market is anticipated to grow at a CAGR around 20.4% during the forecast period. Rising adoption of electronic health records and government initiatives to support such kind of health information is increasing the growth of the Italy healthcare cloud computing market.
Indian Healthcare Cloud Computing Market Size, Share & Trends Analysis Report by Application (Clinical Information Systems and Nonclinical Information Systems) By Deployment Type (Private Cloud, Public Cloud and Hybrid Cloud) Forecast period (2019-2025)
Published: Feb 2026
Indian healthcare cloud computing market is anticipated to grow at a CAGR around 25.4% during the forecast period. The major reason for the growth of the Indian healthcare cloud computing market is the developing healthcare infrastructure in the country along with that, increasing geriatric population, increasing disposable income and increasing healthcare spending of the people is anticipated to grow the market during forecasted period.
Germany Healthcare Cloud Computing Market Size, Share & Trends Analysis Report by Application (Clinical Information Systems and Nonclinical Information Systems) By Deployment Type (Private Cloud, Public Cloud and Hybrid Cloud) Forecast period (2019-2025)
Published: Feb 2026
Germany healthcare cloud computing market is anticipated to grow at a CAGR around 21.2% during the forecast period. Germany’s sophisticated economy is one of the major drivers of advancing digitalization in all areas of personal life and business. Germany’s well-established infrastructure and consumer base are driving demand for cloud services in the country. As per an estimation, 26% of the German companies do not use or plan to use cloud services currently in their operations.
European Healthcare Cloud Computing Market Size, Share & Trends Analysis Report by Application (Clinical Information Systems and Nonclinical Information Systems) By Deployment Type (Private Cloud, Public Cloud and Hybrid Cloud) Forecast period (2019-2025)
Published: Feb 2026
European healthcare cloud computing market is anticipated to grow at a CAGR around 20.9% during the forecast period. Increasing adoption of the cloud-based services among SMEs in Europe is estimated to be one of the major factors that is driving the growth of the market. Various benefits offered by cloud services such as flexibility, scalability, cost efficiency is estimated to be the major factors that is driving the growth of the market.
China Healthcare Cloud Computing Market Size, Share & Trends Analysis Report by Application (Clinical Information Systems and Nonclinical Information Systems) By Deployment Type (Private Cloud, Public Cloud and Hybrid Cloud) Forecast period (2019-2025)
Published: Feb 2026
China healthcare cloud computing market is anticipated to grow at a CAGR around 24.5% during the forecast period. The factor such as improved infrastructure, government support, and large customer base are some reason for the growth of the china healthcare cloud computing market. Government Policies in China, about each healthcare provider has its own electronic health record (EHR) system.
Asia-Pacific Healthcare Cloud Computing Market Size, Share & Trends Analysis Report by Application (Clinical Information Systems and Nonclinical Information Systems) By Deployment Type (Private Cloud, Public Cloud and Hybrid Cloud) Forecast period (2019-2025)
Published: Feb 2026
Asia-Pacific healthcare cloud computing market is anticipated to grow at a CAGR around 24.3% during the forecast period. Asia Pacific is estimated to be the fastest growing during the forecast period. The major economies which are contributing in the market are China, India and Japan. These economies are expected to be a large contributor in the market. Along with that, South Korea, Australia and Thailand are economies with advance healthcare facilities and will show a significant growth rate during the forecasted period.
US EHR Market Size, Share & Trends Analysis Report by Deployment (On-Premise, Cloud-Based), by Type (Inpatient EHR and Ambulatory EHR), and Forecast 2019-2025
Published: Feb 2026
The US EHR market is estimated to exhibit a significant CAGR during the forecast period. The factors that are contributing significantly to the market growth include R&D and high healthcare expenditure. Moreover, the US consists of a well-developed information communication technology (ICT) and employs the adoption of a larger number of connected devices.
North American EHR Market Size, Share & Trends Analysis Report by Deployment (On-Premise, Cloud-Based), by Type (Inpatient EHR and Ambulatory EHR), and Forecast 2019-2025
Published: Feb 2026
The North American EHR market is estimated to exhibit a significant CAGR during the forecast period. The factors that are contributing significantly to the market growth include R&D and high healthcare expenditure. Moreover, the region consists of a well-developed information communication technology (ICT) and employs the adoption of a larger number of connected devices.
US Healthcare Information System Market Size, Share & Trends Analysis Report by Deployment (On-Premises and Cloud-Based) By Application (Hospital Information system, Laboratory Information system, Pharmacy Information System, and Radiology Information System), By End-User (Hospitals and Diagnostic Centers), and Forecast 2019-2025
Published: Feb 2026
The US healthcare information system market is expected to exhibit a remarkable CAGR during the forecast period. The healthcare Information system collects health-related data from healthcare providers or from other relevant sources and analyzes and store the data, such that it can be accessed in the future for making medical decisions and for other purposes.
UK Healthcare Information System Market Size, Share & Trends Analysis Report by Deployment (On-Premises and Cloud-Based) By Application (Hospital Information system, Laboratory Information system, Pharmacy Information System, and Radiology Information System), By End-User (Hospitals and Diagnostic Centers), and Forecast 2019-2025
Published: Feb 2026
The UK healthcare information system market is expected to grow at a significant rate during the forecast period. Major factors contributing to the UK healthcare information system market include the integration of technology in the healthcare sector, growing public and private investment to improvise healthcare service management, and innovation in the healthcare sector such as AI, IoT, big data and others.
North American Healthcare Information System Market Size, Share & Trends Analysis Report by Deployment (On-Premises and Cloud-Based) By Application (Hospital Information system, Laboratory Information system, Pharmacy Information System, and Radiology Information System), By End-User (Hospitals and Diagnostic Centers), and Forecast 2019-2025
Published: Feb 2026
The North American healthcare information system market is expected to grow at a significant rate during the forecast period. The healthcare Information system collects health-related data from healthcare providers or from other relevant sources and analyzes and store the data, such that it can be accessed in the future for making medical decisions and for other purposes.
European Healthcare Information System Market Size, Share & Trends Analysis Report by Deployment (On-Premises and Cloud-Based), By Application (Hospital Information system, Laboratory Information system, Pharmacy Information System, and Radiology Information System), By End-User (Hospitals and Diagnostic Centers), and Forecast 2019-2025
Published: Feb 2026
The European healthcare information system market is expected to grow at a significant rate during the forecast period. Europe is considered to be one of the dominating regions in the healthcare information system market as it has high healthcare expenditure and infrastructure. Major factors contributing to the healthcare information system market include the integration of technology in the healthcare sector, growing public and private investment to improvise healthcare service management, and innovation in the healthcare sector such as AI, IoT, big data and others.
Asia-Pacific Healthcare Information System Market Size, Share & Trends Analysis Report By Deployment (On-Premises and Cloud-Based) By Application (Hospital Information system, Laboratory Information system, Pharmacy Information System, and Radiology Information System), By End-User (Hospitals and Diagnostic Centers), and Forecast 2019-2025
Published: Feb 2026
The Asia-Pacific healthcare information system market is expected to grow at a significant rate during the forecast period. The major countries that would contribute to the growth of the market include China, India, and Japan. Asia-Pacific region has a potential market due to the increasing R&D expenditure by the government of key economies for increasing the penetration of information technology in the medical field so as to streamline the flow of data.
US Clinical Decision Support System (CDSS) Market Size, Share & Trends Analysis Report by Deployment (On-Premise, Cloud-Based), by Product Type (Hardware and Software & Services), By End-User (Hospitals & Clinics, Diagnostic Centers, Retail Pharmacy, and Others), and Forecast 2019-2025
Published: Feb 2026
The US CDSS market is expected to grow at CAGR of 9.8% during the forecast period. The factors that are contributing to the market growth include R&D and high healthcare expenditure. Moreover, the US consists of a well-developed information communication technology (ICT) and employs the adoption of a larger number of connected devices. The US is home to the largest companies, in terms of revenue, which include Abbott Laboratories, Inc., Cerner Corp., IBM Corp., and General Electric Co.
UK Clinical Decision Support System (CDSS) Market Size, Share & Trends Analysis Report by Deployment (On-Premise, Cloud-Based), by Product Type (Hardware and Software & Services), By End-User (Hospitals & Clinics, Diagnostic Centers, Retail Pharmacy, and Others), and Forecast 2019-2025
Published: Feb 2026
The UK CDSS market is estimated to grow at CAGR of 12.2% during the forecast period. Major factors contributing to the UK CDSS market include the integration of technology in the healthcare sector, growing public and private investment to improvise healthcare service management, and innovation in the healthcare sector such as AI, IoT, big data and others.
North American Clinical Decision Support System (CDSS) Market Size, Share & Trends Analysis Report by Deployment (On-Premise, Cloud-Based), by Product Type (Hardware and Software & Services), By End-User (Hospitals & Clinics, Diagnostic Centers, Retail Pharmacy, and Others), and Forecast 2019-2025
Published: Feb 2026
The North American CDSS market is expected to grow at CAGR of 10.2% during the forecast period. The factors that are contributing significantly to the market growth include R&D and high healthcare expenditure. Moreover, the region consists of a well-developed information communication technology (ICT) and employs the adoption of a larger number of connected devices.
European Clinical Decision Support System (CDSS) Market Size, Share & Trends Analysis Report by Deployment (On-Premise, Cloud-Based), by Product Type (Hardware and Software & Services), By End-User (Hospitals & Clinics, Diagnostic Centers, Retail Pharmacy, and Others), and Forecast 2019-2025
Published: Feb 2026
The European CDSS market is estimated to grow at CAGR of 10.9% during the forecast period. Europe is considered to be one of the significant regions in the CDSS market as it has high healthcare expenditure and infrastructure. Major factors contributing to the healthcare information system market include the integration of technology in the healthcare sector, growing public and private investment to improvise healthcare service management, and innovation in the healthcare sector such as AI, IoT, big data and others.
Asia-Pacific Clinical Decision Support System (CDSS) Market Size, Share & Trends Analysis Report by Deployment (On-Premise, Cloud-Based), by Product Type (Hardware and Software & Services), By End-User (Hospitals & Clinics, Diagnostic Centers, Retail Pharmacy, and Others), and Forecast 2019-2025
Published: Feb 2026
The Asia-Pacific CDSS market is estimated to grow at CAGR of 13.0% during the forecast period. The major countries that would contribute to the growth of the market include China, India, and Japan. Asia-Pacific region has a potential market due to the increasing R&D expenditure by the government of key economies for increasing the penetration of information technology in the medical field so as to streamline the flow of data.
China Medical Simulation Market Size, Share & Trends Analysis Report by Offerings (Simulation Products, Simulation Software, and Simulation Training Services), by Simulation Products (Manikin-Based Simulation Products, Model-Based Simulation Products, VR Hardware & Interfaces, and Accessories & Consumables), by Simulation Software (Web-Based Simulation Software, VR / AR / MR Simulation Software, Manikin Control & Physiology Software, Simulation & Performance Recording Software, and Virtual Tutors & AI Coaching Software), by End User(Academic Institutes & Research Centers, Hospitals, and Military Organizations), Forecast Period (2026-2035)
Published: Mar 2026
China medical simulation market was valued at $161.8 million in 2025 and is projected to reach $762.4 million by 2035, growing at a CAGR of 16.8% during the forecast period (2026–2035). The market is growing due to increasing demand for advanced clinical training solutions that enhance healthcare workforce competency while minimizing patient risk. Adoption of simulation-based education is being accelerated by academic institutes and hospitals seeking to standardize training for complex procedures, supported by rising government initiatives to improve patient safety and clinical outcomes. Investments in sophisticated simulation technologies, including VR/AR interfaces and manikin-based systems, are further enabling realistic, hands-on learning experiences that replicate diverse clinical scenarios. Additionally, the expansion of specialized simulation software and performance monitoring tools allows institutions to assess trainee proficiency and optimize curricula efficiently.
Asia-Pacific Medical Simulation Market Size, Share & Trends Analysis Report by Offerings (Simulation Products, Simulation Software, and Simulation Training Services), by Simulation Products (Manikin-Based Simulation Products, Model-Based Simulation Products, VR Hardware & Interfaces, and Accessories & Consumables), by Simulation Software (Web-Based Simulation Software, VR / AR / MR Simulation Software, Manikin Control & Physiology Software, Simulation & Performance Recording Software, and Virtual Tutors & AI Coaching Software), by End User(Academic Institutes & Research Centers, Hospitals, and Military Organizations), Forecast Period (2026-2035)
Published: Mar 2026
Asia-Pacific medical simulation market was valued at 373.3 million in 2025 and is projected to reach 1,743.5 million by 2035, growing at a CAGR of 16.7% during the forecast period (2026–2035). The market is growing due to the rapid expansion of healthcare education infrastructure and increasing government investment in clinical training modernization across the Asia-Pacific. Countries such as China, India, Japan, and Australia are establishing new medical colleges and upgrading teaching hospitals, which is driving the procurement of manikin-based simulation products and structured simulation training services. At the same time, rising patient volumes and greater scrutiny on clinical quality are encouraging hospitals to adopt VR / AR / MR simulation software and performance recording systems to strengthen competency assessment before real-world exposure. Public funding programs and national healthcare capacity-building initiatives are further supporting the development of dedicated simulation centers within academic institutes and tertiary care facilities.
Asia-Pacific Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)
Published: Jun 2026
Asia-Pacific sleep-wake disorder market was valued at $5.1 billion in 2025 and is projected to reach $9.5 billion by 2035, growing at a CAGR of 6.3% from 2026 to 2035. The Asia-Pacific sleep-wake disorder market is witnessing steady expansion owing to the increasing adoption of advanced diagnostic technologies across healthcare facilities and sleep clinics. Rising work-related stress, irregular lifestyles, and prolonged screen exposure have contributed to a higher demand for clinical evaluation and long-term sleep management solutions. In addition, healthcare providers across countries such as Japan, China, India, and Australia are strengthening access to specialized treatment services and home-based monitoring systems. Growing awareness regarding the impact of untreated sleep conditions on cardiovascular, neurological, and mental health outcomes is further supporting market development. Technological progress in wearable sleep tracking devices and non-invasive therapeutic equipment is also improving patient engagement and treatment adherence across the region.
China Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)
Published: Jun 2026
China sleep-wake disorder market was valued at $1.8 billion in 2025 and is projected to reach $3.4 billion by 2035, growing at a CAGR of 6.4% from 2026 to 2035. The market in China is experiencing steady expansion driven by increasing demand across multiple end-use sectors. Continuous improvements in industrial capabilities and infrastructure development are further supporting this upward trajectory. Rising investments in technology adoption and modernization initiatives are strengthening market performance. In addition, favorable government policies and supportive regulatory frameworks are contributing to sustained growth momentum. Expanding consumer awareness and evolving preferences are also playing a significant role in shaping demand patterns. Overall, the market is expected to maintain a positive growth outlook in the coming years.
European Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)
Published: Jun 2026
European sleep-wake disorder market was valued at $6.0 billion in 2025 and is projected to reach $10.7 billion by 2035, growing at a CAGR of 6.0% from 2026 to 2035. The European market continues to expand steadily, supported by rising healthcare expenditure, improved access to specialized treatment facilities, and growing public awareness regarding sleep-related health conditions. Increased adoption of advanced diagnostic technologies and therapeutic solutions has further strengthened market development across several countries in the region. In addition, favorable reimbursement structures and ongoing clinical research activities are encouraging the introduction of innovative treatment approaches. The presence of established healthcare infrastructure and a strong focus on patient-centered care are also contributing to sustained demand. Furthermore, changing lifestyle patterns and increasing stress-related disorders have led to greater attention toward long-term sleep health management across Europe.
Germany Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)
Published: Jun 2026
Germany sleep-wake disorder market was valued at $1.6 billion in 2025 and is projected to reach $3.0 billion by 2035, growing at a CAGR of 6.4% from 2026 to 2035. The Germany market is witnessing steady expansion driven by multiple structural and economic factors. Rising demand across key end-use sectors is contributing significantly to this upward trajectory. Advancements in technology and increasing adoption of innovative solutions are further strengthening market performance. In addition, supportive regulatory frameworks and government initiatives are encouraging business growth and investment. Expanding consumer awareness and evolving preferences are also playing an important role in shaping demand patterns. Overall, these combined factors are fostering sustained development and long-term market opportunities in Germany.
North American Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)
Published: Jun 2026
North American sleep-wake disorder market was valued at $8.3 billion in 2025 and is projected to reach $15.1 billion by 2035, growing at a CAGR of 6.1% from 2026 to 2035. The North American market continues to witness steady expansion, supported by increasing clinical attention toward long-term neurological and sleep-related health conditions. Greater availability of advanced diagnostic facilities and wider adoption of home-based monitoring technologies have strengthened patient access to treatment solutions across the region. In addition, favorable reimbursement frameworks and higher healthcare spending have encouraged the integration of innovative therapeutic approaches into routine care practices. Market growth is further supported by ongoing research activities, rising awareness regarding the impact of untreated sleep conditions, and the presence of established healthcare infrastructure across the United States and Canada.
UK Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)
Published: Jun 2026
UK sleep-wake disorder market was valued at $1.3 billion in 2025 and is projected to reach $2.3 billion by 2035, growing at a CAGR of 6.3% from 2026 to 2035. The growth of the UK sleep-wake disorder market is being supported by a combination of rising clinical awareness and improved recognition of sleep-related conditions across healthcare settings. The increasing prevalence of lifestyle-related sleep disturbances, driven by stress, irregular routines, and aging demographics, is contributing to higher diagnosis rates. Advances in diagnostic technologies and the wider availability of home-based sleep monitoring solutions are further strengthening patient identification. In parallel, expanding access to specialized treatments and therapeutic interventions is improving overall care pathways.
US Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)
Published: Jun 2026
US sleep-wake disorder market was valued at $7.6 billion in 2025 and is projected to reach $13.8 billion by 2035, growing at a CAGR of 6.2% from 2026 to 2035. The US market continues to witness steady expansion supported by increasing clinical attention toward neurological and sleep-related health conditions. Greater availability of advanced diagnostic technologies across hospitals and specialty care centers has strengthened treatment accessibility. In addition, rising healthcare expenditure and broader insurance coverage for sleep-related therapies are encouraging patient adoption of long-term care solutions. Pharmaceutical innovation and the introduction of technologically enhanced therapeutic devices are further contributing to industry development.
US Medical Simulation Market Size, Share & Trends Analysis Report by Offerings (Simulation Products, Simulation Software, and Simulation Training Services), by Simulation Products (Manikin-Based Simulation Products, Model-Based Simulation Products, VR Hardware & Interfaces, and Accessories & Consumables), by Simulation Software (Web-Based Simulation Software, VR / AR / MR Simulation Software, Manikin Control & Physiology Software, Simulation & Performance Recording Software, and Virtual Tutors & AI Coaching Software), by End User(Academic Institutes & Research Centers, Hospitals, and Military Organizations), Forecast Period (2026-2035)
Published: Mar 2026
US medical simulation market was valued at $714.1 million in 2025 and is projected to reach $3,314.4 million by 2035, growing at a CAGR of 16.7% during the forecast period (2026–2035). The market is growing due to increasing emphasis on patient safety and the need to improve clinical competency through structured training environments. Healthcare institutions and academic institutes are adopting simulation platforms to allow medical students and professionals to practice complex procedures without risk to patients, which strengthens clinical decision-making and procedural accuracy. Continuous technological progress in simulation products and software, including high-fidelity manikins, VR-based training environments, and performance assessment systems, is further improving the realism and effectiveness of simulation-based education. In addition, hospitals and training centers are integrating simulation programs into routine medical curricula and continuing professional development to standardize skill development.
UK Medical Simulation Market Size, Share & Trends Analysis Report by Offerings (Simulation Products, Simulation Software, and Simulation Training Services), by Simulation Products (Manikin-Based Simulation Products, Model-Based Simulation Products, VR Hardware & Interfaces, and Accessories & Consumables), by Simulation Software (Web-Based Simulation Software, VR / AR / MR Simulation Software, Manikin Control & Physiology Software, Simulation & Performance Recording Software, and Virtual Tutors & AI Coaching Software), by End User(Academic Institutes & Research Centers, Hospitals, and Military Organizations), Forecast Period (2026-2035)
Published: Mar 2026
UK medical simulation market was valued at $108.0 million in 2025 and is projected to reach $498.3 million by 2035, growing at a CAGR of 16.6% during the forecast period (2026–2035). The UK Medical Simulation Market is growing due to the increasing emphasis on patient safety and the expansion of simulation-based medical education across healthcare institutions. Hospitals and academic institutes are integrating simulation technologies to allow healthcare professionals and students to practice complex procedures in controlled environments before performing them on patients. This approach supports the development of clinical competencies while reducing the risk of medical errors during real-world treatment. In addition, the healthcare system is experiencing rising demand for continuous professional training as new medical technologies and treatment protocols become more advanced.
North America Medical Simulation Market Size, Share & Trends Analysis Report by Offerings (Simulation Products, Simulation Software, and Simulation Training Services), by Simulation Products (Manikin-Based Simulation Products, Model-Based Simulation Products, VR Hardware & Interfaces, and Accessories & Consumables), by Simulation Software (Web-Based Simulation Software, VR / AR / MR Simulation Software, Manikin Control & Physiology Software, Simulation & Performance Recording Software, and Virtual Tutors & AI Coaching Software), by End User(Academic Institutes & Research Centers, Hospitals, and Military Organizations), Forecast Period (2026-2035)
Published: Mar 2026
North America medical simulation market was valued at $793.4 million in 2025 and is projected to reach $3,544.8 million by 2035, growing at a CAGR of 16.2% during the forecast period (2026–2035). The market is growing due to the increasing institutional emphasis on patient safety and competency-based clinical education across North America. Academic institutes and hospitals are expanding the use of simulation products, particularly manikin-based systems and VR-enabled platforms, to ensure structured skills assessment before direct patient exposure. At the same time, persistent healthcare workforce shortages in the US and Canada are accelerating investments in scalable simulation software and training services to standardize learning outcomes and reduce training variability. Regulatory and accreditation bodies continue to reinforce simulation-supported evaluation frameworks, further embedding these technologies into core curricula and hospital credentialing processes.
Germany Medical Simulation Market Size, Share & Trends Analysis Report by Offerings (Simulation Products, Simulation Software, and Simulation Training Services), by Simulation Products (Manikin-Based Simulation Products, Model-Based Simulation Products, VR Hardware & Interfaces, and Accessories & Consumables), by Simulation Software (Web-Based Simulation Software, VR / AR / MR Simulation Software, Manikin Control & Physiology Software, Simulation & Performance Recording Software, and Virtual Tutors & AI Coaching Software), by End User(Academic Institutes & Research Centers, Hospitals, and Military Organizations), Forecast Period (2026-2035)
Published: Mar 2026
Germany medical simulation market was valued at $132.3 million in 2025 and is projected to reach $599.1 million by 2035, growing at a CAGR of 16.4% during the forecast period (2026–2035). The market is growing due to the increasing emphasis on patient safety and the need for structured clinical training across healthcare institutions. Medical simulation enables students and healthcare professionals to practice complex procedures in controlled environments, reducing the likelihood of medical errors during real patient care. In addition, healthcare providers and academic institutes are expanding simulation-based education to address the rising complexity of medical technologies and treatment protocols. The adoption of advanced simulation platforms, including manikin-based systems and immersive VR training environments, supports competency-based learning and standardized skill assessment.
European Medical Simulation Market Size, Share & Trends Analysis Report by Offerings (Simulation Products, Simulation Software, and Simulation Training Services), by Simulation Products (Manikin-Based Simulation Products, Model-Based Simulation Products, VR Hardware & Interfaces, and Accessories & Consumables), by Simulation Software (Web-Based Simulation Software, VR / AR / MR Simulation Software, Manikin Control & Physiology Software, Simulation & Performance Recording Software, and Virtual Tutors & AI Coaching Software), by End User(Academic Institutes & Research Centers, Hospitals, and Military Organizations), Forecast Period (2026-2035)
Published: Mar 2026
European medical simulation market was valued at $563.6 million in 2025 and is projected to reach $ 2,447.5 million by 2035, growing at a CAGR of 15.9% during the forecast period (2026–2035). The market is growing due to the increasing emphasis on structured, competency-based clinical training across European academic institutes, hospitals, and military medical units. Regulatory expectations around patient safety and clinical risk reduction are prompting institutions to adopt manikin-based simulation products, task trainers, and simulation and performance recording software to standardize training outcomes. At the same time, the integration of digital health technologies is accelerating demand for VR and AR-based simulation software, virtual tutors, and AI-driven coaching tools that enable repeatable, data-tracked learning without exposing patients to procedural risk. Hospitals are also investing in in situ simulation and manikin control and physiology software to improve multidisciplinary coordination and emergency preparedness.
US Cardiology Market Size, Share & Trends Analysis Report by Device Type (Angioplasty, Cardiovascular stents, Cardiovascular catheters, Cardiac rhythm management, and Cardiovascular assistive devices), By Drug Type (Antithrombotic drugs, Antidyslipidemic drugs, Antihypertensive drugs, and Anti-stroke drugs), By Mechanism ( Beta blockers, Beta agonists, Alpha blockers, Alpha agonists, Sodium channel blockers, Calcium channel blockers, Vasodilators, Renin inhibitors, Angiotensin receptor blockers, Diuretics, Thrombolytics), By Surgeries type(Coronary artery bypass grafting, Transmyocardial laser revascularization, Heart valve repair, Arrhythmia treatment, Aneurysm repair, Heart transplant) and Forecast 2019-2025
Published: Feb 2026
The US cardiology market is estimated to grow significantly at a CAGR of around 6.0% during the forecast period. The market is mainly due to the significant prevalence of CVD in the country. The US has a high incidence & prevalence rate of heart diseases due to a sedentary lifestyle, excessive consumption of alcohol, consumption of junk food, high intake of cholesterol and a huge number of diabetic & obese patients.
UK Cardiology Market Size, Share & Trends Analysis Report by Device Type (Angioplasty, Cardiovascular stents, Cardiovascular catheters, Cardiac rhythm management, and Cardiovascular assistive devices), By Drug Type (Antithrombotic drugs, Antidyslipidemic drugs, Antihypertensive drugs, and Anti-stroke drugs), By Mechanism ( Beta blockers, Beta agonists, Alpha blockers, Alpha agonists, Sodium channel blockers, Calcium channel blockers, Vasodilators, Renin inhibitors, Angiotensin receptor blockers, Diuretics, Thrombolytics), By Surgeries type(Coronary artery bypass grafting, Transmyocardial laser revascularization, Heart valve repair, Arrhythmia treatment, Aneurysm repair, Heart transplant) and Forecast 2019-2025
Published: Feb 2026
UK cardiology market is estimated to grow significantly at a CAGR of around 6.4% during the forecast period. UK has the highest number of CVD, Congenital heart disease (CHD), stroke, heart failure, atrial fibrillation and other heart related disease that further contributing to the growth of the market.
North American Cardiology Market Size, Share & Trends Analysis Report by Device Type (Angioplasty, Cardiovascular stents, Cardiovascular catheters, Cardiac rhythm management, and Cardiovascular assistive devices), By Drug Type (Antithrombotic drugs, Antidyslipidemic drugs, Antihypertensive drugs, and Anti-stroke drugs), By Mechanism ( Beta blockers, Beta agonists, Alpha blockers, Alpha agonists, Sodium channel blockers, Calcium channel blockers, Vasodilators, Renin inhibitors, Angiotensin receptor blockers, Diuretics, Thrombolytics), By Surgeries type(Coronary artery bypass grafting, Transmyocardial laser revascularization, Heart valve repair, Arrhythmia treatment, Aneurysm repair, Heart transplant) and Forecast 2019-2025
Published: Feb 2026
The North American cardiology market is estimated to grow significantly at a CAGR of 6.2% during the forecast period. North America's cardiology market is projected to grow due to the highest consumption of cardiology devices and surgeries.
Japan Cardiology Market Size, Share & Trends Analysis Report by Device Type (Angioplasty, Cardiovascular stents, Cardiovascular catheters, Cardiac rhythm management, and Cardiovascular assistive devices), By Drug Type (Antithrombotic drugs, Antidyslipidemic drugs, Antihypertensive drugs, and Anti-stroke drugs), By Mechanism ( Beta blockers, Beta agonists, Alpha blockers, Alpha agonists, Sodium channel blockers, Calcium channel blockers, Vasodilators, Renin inhibitors, Angiotensin receptor blockers, Diuretics, Thrombolytics), By Surgeries type(Coronary artery bypass grafting, Transmyocardial laser revascularization, Heart valve repair, Arrhythmia treatment, Aneurysm repair, Heart transplant) and Forecast 2019-2025
Published: Feb 2026
Japan cardiology market is projected to grow significantly at a CAGR of around 6.5% during the forecast period. There are various factors that provide substatial growth ot the Japan cardiology market including availability of developed healthcare infrastructure and technological advancement in cardiology device technologies in the country.
Germany Cardiology Market Size, Share & Trends Analysis Report by Device Type (Angioplasty, Cardiovascular stents, Cardiovascular catheters, Cardiac rhythm management, and Cardiovascular assistive devices), By Drug Type (Antithrombotic drugs, Antidyslipidemic drugs, Antihypertensive drugs, and Anti-stroke drugs), By Mechanism ( Beta blockers, Beta agonists, Alpha blockers, Alpha agonists, Sodium channel blockers, Calcium channel blockers, Vasodilators, Renin inhibitors, Angiotensin receptor blockers, Diuretics, Thrombolytics), By Surgeries type(Coronary artery bypass grafting, Transmyocardial laser revascularization, Heart valve repair, Arrhythmia treatment, Aneurysm repair, Heart transplant) and Forecast 2019-2025
Published: Feb 2026
Germany cardiology market is estimated to grow significantly at a CAGR of around 6.0% during the forecast period owing to the massive population of CVD, CHD &stroke and rise in adoption of cardiology surgeries for Angioplasty and CABG surgeries.
France Cardiology Market Size, Share & Trends Analysis Report by Device Type (Angioplasty, Cardiovascular stents, Cardiovascular catheters, Cardiac rhythm management, and Cardiovascular assistive devices), By Drug Type (Antithrombotic drugs, Antidyslipidemic drugs, Antihypertensive drugs, and Anti-stroke drugs), By Mechanism ( Beta blockers, Beta agonists, Alpha blockers, Alpha agonists, Sodium channel blockers, Calcium channel blockers, Vasodilators, Renin inhibitors, Angiotensin receptor blockers, Diuretics, Thrombolytics), By Surgeries type(Coronary artery bypass grafting, Transmyocardial laser revascularization, Heart valve repair, Arrhythmia treatment, Aneurysm repair, Heart transplant) and Forecast 2019-2025
Published: Feb 2026
France cardiology market is estimated to grow significantly at
a CAGR of around 6.3% during the forecast period due to the adoption of
innovative cardiology devices such as innovative cardiac stents, catheters and
guiding wires. France has a quality healthcare system and favourable government
policies which are boosting the cardiology market.
European Cardiology Market Size, Share & Trends Analysis Report By Device Type (Angioplasty, Cardiovascular stents, Cardiovascular catheters, Cardiac rhythm management, and Cardiovascular Assistive Devices), By Drug Type (Antithrombotic drugs, Antidyslipidemic drugs, Antihypertensive drugs, and Anti-stroke drugs), By Mechanism ( Beta-Blockers, Beta-Agonists, Alpha-Blockers, Alpha agonists, Sodium channel blockers, Calcium channel blockers, Vasodilators, Renin inhibitors, Angiotensin receptor blockers, Diuretics, Thrombolytics), By Surgeries type(Coronary artery bypass grafting, Transmyocardial laser revascularization, Heart valve repair, Arrhythmia Treatment, Aneurysm Repair, Heart transplant) and Forecast 2019-2025
Published: Feb 2026
The European cardiology market is estimated to grow significantly at a CAGR of around 6.2% during the forecast period. The market is mainly driven owing to the well-developed healthcare sector and considerably high healthcare expenditure and infrastructure in its economies such as Germany, UK, France and others.
China Cardiology Market Size, Share & Trends Analysis Report By Device Type (Angioplasty, Cardiovascular stents, Cardiovascular catheters, Cardiac rhythm management, and Cardiovascular assistive devices), By Drug Type (Antithrombotic drugs, Antidyslipidemic drugs, Antihypertensive drugs, and Anti-stroke drugs), By Mechanism ( Beta blockers, Beta agonists, Alpha blockers, Alpha agonists, Sodium channel blockers, Calcium channel blockers, Vasodilators, Renin inhibitors, Angiotensin receptor blockers, Diuretics, Thrombolytics), By Surgeries type(Coronary artery bypass grafting, Transmyocardial laser revascularization, Heart Valve Repair, Arrhythmia treatment, Aneurysm repair, Heart transplant) and Forecast 2019-2025
Published: Feb 2026
China cardiology market is projected to grow significantly at
a CAGR of around 6.4% during the forecast period. Coronary bypass procedures,
ONCAB, OPCAB, and heart valve replacement devices are widely adopted in China
that further provided significant growth in the cardiology market.
Asia-Pacific Cardiology Market Size, Share & Trends Analysis Report by Device Type (Angioplasty, Cardiovascular stents, Cardiovascular catheters, Cardiac rhythm management, and Cardiovascular assistive devices), By Drug Type (Antithrombotic drugs, Antidyslipidemic drugs, Antihypertensive drugs, and Anti-stroke drugs), By Mechanism ( Beta blockers, Beta agonists, Alpha blockers, Alpha agonists, Sodium channel blockers, Calcium channel blockers, Vasodilators, Renin inhibitors, Angiotensin receptor blockers, Diuretics, Thrombolytics), By Surgeries type(Coronary artery bypass grafting, Transmyocardial laser revascularization, Heart valve repair, Arrhythmia treatment, Aneurysm repair, Heart transplant) and Forecast 2019-2025
Published: Feb 2026
Asia-Pacific cardiology market is projected to grow significantly
at a CAGR of around 7.0% during the forecast period. The market is mainly
driven owing to the large population with CVD, CHD, Stroke and other heart
diseases. The other factors contributing to the market include rising
healthcare spending, improving infrastructure and rising standards of living.
European Artificial Tears Market Size, Share & Trends Analysis Report by Type (Cellulose Derived Tears, Glycerin Derived Tears, and Oil-Based Emulsion Tears), by Delivery Method (Artificial Eye Drops and Ointments), and by Application (Dry Eyes Treatment, Contact Lenses Moisture, and Others) and Forecast 2019-2025
Published: Feb 2026
The European artificial tears market is estimated to grow modestly, at a CAGR of around 4.2%, during the forecast period. Europe has a huge potential for the growth in the artificial tears market owing to the prevalence of cataracts and other eye diseases.
Healthcare Information System Market Size, Share & Trends Analysis Report by Deployment Type (On-Premises, and Cloud-Based), by Application (Hospital Information Systems, Laboratory Information Systems, Pharmacy Information Systems, Radiology Information Systems, Electronic Health Records and Electronic Medical Records, and Other Healthcare IT Systems), and by End-User (Hospitals, Clinics, Diagnostic Centers, and Other Healthcare Facilities), Forecast Period (2026-2035)
Published: Jun 2026
Healthcare information system market was valued at $36.0 billion in 2025 and is projected to reach $ 78.5 billion by 2035, growing at a CAGR of 8.1% during the forecast period (2026-2035). The market is growing due to the increasing adoption of digital healthcare infrastructure and the rising need for efficient clinical and administrative data management across healthcare facilities. Healthcare providers are steadily transitioning from paper-based records to integrated electronic systems, driven by the need to improve patient outcomes, reduce medical errors, and streamline workflows. In parallel, the expansion of cloud-based deployment models is supporting this shift by enabling scalable, cost-efficient, and remotely accessible solutions, particularly for small and mid-sized healthcare facilities. Additionally, the growing volume of patient data, coupled with regulatory requirements for data accuracy and interoperability, is reinforcing the demand for advanced healthcare information systems.
Global Protein Engineering Market Size, Share & Trends Analysis Report by Technology (Rational Protein Design and Irrational Protein Design), by Protein Type (Monoclonal Antibodies, Insulin, Erythropoietin, Interferon, Colony Stimulating Factor, Coagulation Factor, Vaccines, and Others), By Product (Instruments, Services and Software, and Reagents), and by End-User (Academic Research Institutes, Pharmaceutical, and Biotechnology Companies, and Contract Research Organizations), and Forecast 2022-2028
Published: Feb 2026
The global protein engineering market is anticipated to grow at a significant CAGR of around 12.5% during the forecast period (2022-2028). Protein engineering holds an immense opportunity in the agrochemical industry as engineering in proteins may lead to the generation of enzymes with an improved function that may increase the crop yield or facilitate biofuel production. It is also likely to play an important role as a tool to attain increased crop yield needed to meet future needs. Some methods are used for protein engineering such as site-directed mutagenesis, random mutagenesis, random mutagenesis, homology modeling, cell surface display technology, and DNA shuffling technology.
Global Medical Device Vigilance Market Size, Share & Trends Analysis Report by Delivery Mode (On-Premise and On-Demand), By End-User (Contract Research Organizations (CROs), Business Process Outsourcing (BPO), and Original Equipment Manufacturers (OEM)) and Forecast 2019-2025
Published: Feb 2026
The global medical device
vigilance market is estimated to grow significantly, at a CAGR of 8.7%, during
the forecast period. Medical device vigilance assists in improving the
protection of healthcare professionals, safety and health of patients, and
other end-users of medical devices by reducing the chances of reoccurrence of
incidents associated with the use of medical devices.
Global Gynecology Software Market Size, Share & Trends Analysis Report by Deployment (On-Premise Gynecology Software and Cloud-based Gynecology Software) and by End-User (Gynecology Clinics, Fertility Centers, and Hospitals) and Forecast 2019-2025
Published: Feb 2026
The global gynecology software market is estimated to grow significantly, at a CAGR of over 9%, during the forecast period. The major factors contributing to the market growth include the rise in prevalence of chronic diseases such as cervical cancer, polycystic ovarian syndrome (PCOS), and endometriosis, among others.
Global BioCloud Market Size, Share & Trends Analysis Report, By Biology Type (Plant Biology, Animal Biology, Human Biology, and Microbiology), By Deployment Type (Public Cloud, Private Cloud, and Hybrid Cloud), By Application (Discovery and Pre-Clinical Research, Clinical Trials, Pharma Manufacturing, Commercialization, and Plant and Microbial Gene Analysis), and End-User (Pharmaceutical and Biotechnology Companies, Research Institutes, CROs, Clinical Laboratories, and Hospitals and Diagnostic Centers) and Forecast 2019-2025
Published: Feb 2026
The global biocloud market is estimated to grow significantly, at a CAGR of over 15%, during the forecast period. The rising need to integrate supply chains to gain visibility is increasing the adoption of cloud technology in biology. This further is connected with the implementation of healthcare reforms and healthcare insurance policies in developed economies.
Global Bio Decontamination Market Size, Share & Trends Analysis Report by Product Type (Equipment, Consumables and Services), by Agent Type (Nitrogen Dioxide, Hydrogen Peroxide, Peracetic Acid, and Chlorine Dioxide), and by End-User (Hospitals, Pharmaceutical & Medical Device Companies, and Research Institutes) and Forecast 2019-2025
Published: Feb 2026
The global bio-decontamination market is estimated to grow at a CAGR of 5%, during the forecast period. The major factors contributing to the market growth include growing infections in hospitals and laboratories, coupled with the increasing surgical procedures in hospitals.
Cardiovascular Information System (CVIS) Market Size, Share & Trends Analysis Report by Component (Software (Imaging & Visualization, Workflow & Clinical Reporting, Data Management & Analytics, and Other), Hardware (Servers & Storage, Workstations & Displays, and Networking & Infrastructure), Services (Implementation & Integration, Support & Maintenance, and Training & Consulting)), by Deployment Mode (On-premise and Cloud-based), and by Application (ECG, Catheterization, Cardiothoracic, Echocardiography Lab and Other), Forecast Period, (2026-2035)
Published: May 2026
Cardiovascular information system market was valued at $1.6 billion in 2025 and is projected to reach $3.0 billion by 2035, growing at a CAGR of 6.7% during the forecast period (2026-2035). The global Cardiovascular Information System (CVIS) market is witnessing steady expansion, driven by the increasing demand for advanced cardiovascular data management solutions across healthcare facilities. Growing adoption of digital healthcare infrastructure and integrated clinical systems is supporting improved workflow efficiency and patient care outcomes. Rising prevalence of cardiovascular diseases is further encouraging healthcare providers to invest in specialized diagnostic and information systems. Technological advancements in medical imaging, data storage, and cloud-based platforms are enhancing system capabilities and accessibility. Additionally, the shift toward value-based healthcare delivery is accelerating the implementation of CVIS solutions in hospitals and diagnostic centers. Overall, the market is expected to maintain consistent growth momentum over the forecast period due to continuous innovation and increasing clinical demand.
Healthcare BPO Market Size, Share & Trends Analysis Report Payer Services (Analytics and Fraud Management Services, Billing and Accounts Management Services, Claims Management Services, HR Services, Integrated Front-End Services and Back Office Operations, Member Management Services, Provider Management Services, Care Management Service, and Product Development & Acquisition Services), by Life Sciences Services (Manufacturing Services, Non-Clinical Services, Research and Development), and by Provider Services (Revenue Cycle Management, Patient Enrollment, and Patient Care) Forecast Period (2024-2031)
Published: Feb 2026
Healthcare BPO market is anticipated to grow at a significant CAGR of 9.3% during the forecast period (2024-2031). Healthcare BPO includes outsourced business activity or process that provides support (admin or otherwise) to medical institutions, staff, and organizations. Implementation of the Patient Protection and Affordable Care Act (PPACA) and patent expiration of the blockbuster drugs are the major factors that augment the demand of the market. A patent cliff is a reduction in revenues of the medical organization due to the patent expiry of one or more leading products. Patent cliffs have created losses for traditional pharmaceuticals and provide a portal for smaller companies to emerge with generics. This presents a growing opportunity for generic drug manufacturers.
Infusion Pump Software Market Size, Share & Trends Analysis Report by Type (Dose Error Reduction Software (DERS), Clinical Workflow Software, and Interoperability Software), by End-user (Hospitals & Clinics, Ambulatory Care Settings, and Others), and Forecast, 2019–2025
Published: Feb 2026
The global infusion pump software market is expected to grow at a CAGR of 6% during the forecast period. Infusion pumps are medical devices that supply nutrients and medicines such as antibiotics, chemotherapy drugs, insulin or other hormones, and pain relievers into the patient's body with controlled dosages.
Clinical Workflow Solutions Market Size, Share & Trends Analysis Report, by Product (Data Integration, Nurse Call System, Unified Communication, And Patient Flow Management), by End-Use (Hospitals, Long-Term Care Facilities, And Ambulatory Care Centers) and Forecast, 2019-2025.
Published: Feb 2026
With the advancement
in the healthcare IT sector, the demand for more advanced clinical workflow
solutions is on the rise which is fueling the growth of the global clinical
workflow solutions market. The growing demand among consumers towards
curtailing healthcare costs and rising prevalence of chronic diseases has
resulted in the increased volume of patients.
Back-End Revenue Cycle Management Market Size, Share, Growth & Industry Analysis Report by Delivery Mode (Cloud-Based and On-Premises) and by Product & Services (Software and Services) and Forecast, 2019-2025
Published: Feb 2026
Back-end revenue
cycle management allows healthcare providers to manage the process of
healthcare billing and reimbursement rates, eligibility checks and claims
submission and payments. Various government initiatives to modernize healthcare
infrastructures coupled with the integration of IT technologies in healthcare
tend to drive the growth of the global back-end revenue cycle management market.
Healthcare Interoperability Solutions Market by Type (EHR Interoperability Solutions, Healthcare Information Exchange Interoperability Solutions, Enterprise Interoperability Solutions, Imaging System Interoperability Solutions, and Others), by Interoperability Solutions (Foundational, Structural, and Semantic), and by End-User – Industry Size, Share, Global Trends, Competitive Analysis and Forecast, 2019 to 2025
Published: Feb 2026
The growing healthcare market is experiencing an enormous revolution, as
technology is widely being used to engage patients, caregivers,
consumers and provide real-time information and support with better use
of data and analytics. Besides, the healthcare industry is focusing on
the improvement of the quality of healthcare facilities and operational
effectiveness, which includes diminishing medical errors occurring while
conducting medical procedures and reducing the cost of medical
procedures. To maintain a good clinical workflow, the hospitals and
clinics should have the right information about the patient,
Legionella Testing Market Size, Share, Trends, Growth, Industry Analysis Report and Forecast, 2019 – 2025
Published: Feb 2026
Legionella testing market is expected to grow at a
considerable rate during the forecast period 2019-2025. Legionella
testing is used for diagnostic and detection of legionella bacteria
which is a key cause of numerous diseases including pneumonia and other
types of flu symptoms. Legionella infection affects respiratory track
and Pontiac fever.
Hair Removal Devices Market Size, Share, Trends & Forecast to 2025
Published: Feb 2026
The market of global hair removal devices is divided on the basis of
type and end-user. On the basis of type, the market is sub-segmented
into laser-based devices, IPL, and energy-based devices. Moreover, on
the basis of end-user, the market is further sub-segmented into
dermatology clinics, beauty clinics, and others.
Healthcare Contract Research Organizations (CRO) Market Size, Share, Industry Analysis and Forecast, 2026-2035
Published: Feb 2026
Healthcare contract research organizations (CRO) market
has been growing significantly owing to the rising R&D programs in
healthcare and growing demand for CRO in pharmaceutical, medical and
other healthcare industries.
Medical Tourism Market Size, Share & Trends Analysis Report by Treatment Type (Cosmetic Procedures, Fertility Treatment, Orthopedic Treatments, Cardiovascular Treatments, Oncology Treatments, Wellness & Alternative Medicine, and Others), by Tourism Type (International and Domestic), and by Facility Type (Multi-specialty Hospitals, Specialty Hospitals, Wellness & Rehabilitation Centers, and Alternative Medicine Centers), Forecast Period, (2026-2035)
Published: May 2026
Medical Tourism market was valued at $38.9 billion in 2025 and is projected to reach $85.6 billion by 2035, growing at a CAGR of 8.3% during the forecast period (2026-2035). The global medical tourism market is witnessing sustained expansion, supported by rising disparities in healthcare costs across regions and increasing patient willingness to access specialized treatment beyond domestic systems. Improvements in clinical infrastructure, coupled with the growing availability of advanced medical technologies in emerging healthcare destinations, are further strengthening cross-border healthcare flows. Expanding networks of internationally accredited hospitals are enhancing confidence in overseas treatment options. In addition, greater integration of digital health services is improving coordination and continuity of care for international patients. The increasing prevalence of chronic conditions and elective procedure demand is also contributing to higher outbound patient mobility. Collectively, these factors are reinforcing long-term growth momentum across the global medical tourism landscape.
Cranial Implants Market Size, Share & Trends Analysis by Product Type (Customized and Non-Customized), by Material Type (Polymer, Metal, and Ceramic), By Clinical Indication (Trauma, Tumor, and Congenital Defects), By End-User (Hospitals, Neurosurgery centers, and Ambulatory Surgical Centers/Specialty Clinics), by Anatomical Location (Frontal, Parietal, Temporal, Occipital, and Sphenoid), Forecast Period (2026-2035)
Published: May 2026
Cranial implants market was valued at $2.4 billion in 2025 and is projected to reach $4.7 billion by 2035, growing at a CAGR of 6.8% from 2026 to 2035. The global market is growing due to the steady rise in neurosurgical procedures associated with traumatic injuries, tumor resections, and congenital conditions requiring cranial reconstruction. Increasing reliance on precise surgical outcomes has encouraged the adoption of advanced implant solutions that support functional and structural restoration. Improvements in surgical planning and manufacturing techniques have enhanced the reliability and acceptance of these implants in clinical practice. Healthcare systems are also placing greater emphasis on reducing complications and improving recovery timelines,
Healthcare Biometrics Market Size, Share & Trends Analysis Report by Biometric Modality (Fingerprint Recognition, Iris Recognition, Facial Recognition, Palm Vein Recognition, Voice Recognition, and Multimodal Biometrics), by Component (Hardware, Software, and Services), by End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmacies, Health Insurance Companies, Research & Clinical Trial Organizations, and Government & Public Health Agencies), Forecast Period (2026–2035)
Published: May 2026
Healthcare biometrics market was valued at $3.9 billion in 2025 and is projected to reach $12.1 billion by 2035, growing at a CAGR of 12.2% during the forecast period (2026-2035). The market is growing due to the increasing need for secure patient identification and data protection across healthcare systems. Rising digitization of medical records and expansion of electronic health infrastructure are further strengthening demand. Adoption is also supported by regulatory emphasis on minimizing identity fraud and ensuring compliance in clinical workflows. Technological advancements in biometric accuracy and integration capabilities are enhancing operational efficiency within healthcare facilities. In addition, the growing incidence of data breaches is encouraging healthcare providers to invest in advanced authentication solutions.
Blockchain in healthcare Market Size, Share & Trends Analysis by Network Type (Public, Private, and Hybrid), by Application (Clinical Data Exchange & Interoperability, Supply Chain Tracking, Claims and Billing Management, Clinical Trials & Consent Management, and Others), by End-User (Healthcare Providers, Healthcare Payers, and Pharmaceutical & Life Sciences Companies), by Data & Functional Layer (EHR Management, Patient Identity & Access Management, Drug Traceability & Authentication, Secure Health Data Sharing Systems, and Others), and by Deployment Mode (Cloud, On-Premise, and Hybrid), Forecast Period (2026-2035)
Published: May 2026
Blockchain in the healthcare market was valued at $11.1 billion in 2025 and is projected to reach $180.3 billion by 2035, growing at a CAGR of 32.2% from 2026 to 2035. The global market is expanding steadily as organizations increasingly prioritize secure and efficient digital data exchange across complex healthcare ecosystems. Rising demand for improved transparency, traceability, and data integrity is further accelerating adoption across multiple applications. Continuous advancements in digital infrastructure and interoperability frameworks are enabling more seamless integration of distributed systems. In addition, growing regulatory emphasis on data security and compliance is encouraging wider implementation of advanced technologies. Increasing investment in digital transformation initiatives by healthcare stakeholders is also supporting sustained market momentum. Overall, these combined factors are contributing to consistent growth across the global landscape.
Healthcare Analytics Market Size, Share & Trends Analysis By Deployment Mode (Cloud, On-Premise, and Hybrid), and By Component (Hardware, Software, and Services), and By Type (Descriptive Analytics, Predictive Analytics, Prescriptive Analytics, Cognitive/AI-driven Analytics, and Others), and By Application (Clinical Analytics, Financial Analytics, Operational & Administrative Analytics, Population Health Analytics, and Others), and By End-Users (Healthcare Providers, Healthcare Payers, Pharmaceutical & Life Sciences Companies, Government & Public Health Agencies, and Others), Forecast Period (2026-2035)
Published: May 2026
Healthcare analytics market was valued at $51.1 billion in 2025 and is projected to reach $444.7 billion by 2035, growing at a CAGR of 24.2% from 2026 to 2035. The global market is experiencing steady expansion driven by the increasing adoption of data-driven decision-making across industries. Organizations are progressively integrating advanced analytics solutions to enhance operational efficiency and improve strategic outcomes. Rising digital transformation initiatives and the growing volume of healthcare data are further accelerating market development. In addition, the shift toward value-based models is encouraging wider utilization of analytical tools for performance optimization. Technological advancements in artificial intelligence and machine learning are also strengthening analytical capabilities. Collectively, these factors are contributing to sustained growth momentum across the global market landscape.
Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)
Published: Jun 2026
Sleep-wake disorder market was valued at $21.4 billion in 2025 and is projected to reach $38.5 billion by 2035, growing at a CAGR of 6.1% from 2026 to 2035. The global market continues to witness steady expansion, supported by evolving industry requirements, rising investment across developing economies, and the growing focus on operational efficiency. Businesses are increasingly adopting advanced technologies and modernized solutions to strengthen productivity, improve customer engagement, and maintain long-term competitiveness. In addition, supportive regulatory frameworks and ongoing infrastructure development are creating favorable conditions for market progression. The increasing participation of both established enterprises and emerging firms is further contributing to innovation and broader commercial adoption. Market growth is also being reinforced by changing consumer expectations and the continuous shift toward integrated and scalable business models across multiple sectors.
Baby Cleaning Products Market Size, Share & Trends Analysis By Product Type (Baby Wipes, Baby Soaps & Body Washes, Baby Shampoos, Diaper Rash Creams & Lotions, Baby Detergents, Sanitizing & Disinfecting Products, and Other Bath Accessories & Cleaning Tools), By Formulation Type (Organic/Natural Products, Chemical-Based Products, Hypoallergenic Products, and Dermatologically Tested/Sensitive-Skin Variants), By Age Group (Newborn (0–6 Months), Infants (6–12 Months), Toddlers (1–3 Years), and Preschool (3+ Years)), and By Distribution Channel (Online and Offline), Forecast Period (2026-2035)
Published: Jun 2026
Baby cleaning products market was valued at $5.1 billion in 2025 and is projected to reach $8.5 billion by 2035, growing at a CAGR of 5.2% from 2026 to 2035. The global market is expanding steadily due to increasing consumer focus on infant hygiene and safety standards across both developed and emerging economies. Rising awareness among parents regarding skin sensitivity and chemical exposure in baby care products is encouraging the adoption of safer and specialized formulations. Continuous product innovation, particularly in organic, hypoallergenic, and dermatologically tested variants, is further strengthening market demand. Expanding urban populations and changing lifestyles are also contributing to higher usage of convenient and ready-to-use baby cleaning solutions. In addition, the rapid growth of online retail channels is improving product accessibility and driving purchase frequency. Strong involvement of established personal care brands along with their widening distribution networks is further supporting consistent market expansion.
Medical Alert System Market Size, Share & Trends Analysis By Product Type (In-Home Medical Alert Systems, Mobile Medical Alert Systems, Standalone Wearable Devices, and Smartwatch-Based Systems), By Connectivity Type (Landline-Based Systems, Cellular-Based Systems, GPS-Enabled Systems, and Wi-Fi/IoT-Connected Systems), By Service Type (Monitored Systems and Unmonitored Systems), and By End User (Elderly Population, Chronic Disease Patients, Disabled And Mobility-Impaired Individuals, and Others), Forecast Period (2026-2035)
Published: Jun 2026
Medical alert system market was valued at $3.2 billion in 2025 and is projected to reach $7.2 billion by 2035, growing at a CAGR of 8.4% from 2026 to 2035. The global market is witnessing steady expansion driven by a combination of evolving industry dynamics and increasing end-user demand. Continuous advancements in technology and production processes are contributing to improved efficiency and product innovation. Rising adoption across multiple application areas is further supporting market penetration. In addition, growing investment activities by key stakeholders are strengthening overall industry development. Expanding awareness among consumers and organizations is also encouraging broader acceptance. Collectively, these factors are creating a positive growth environment for the global market landscape.
Referral Management Market Size, Share & Trends Analysis Report, By Component (Software, Services), By Deployment Mode (Cloud-Based, On-Premises), By Organization Size (Large Enterprises, SMEs), By Referral Type (Outbound, Inbound, Cross-Specialty, External Network), By End User (Hospitals, Physician Practices, Specialty Clinics, ASCs, ACOs, Health Insurance Companies, Government Healthcare Organizations), Forecast Period (2026–2035)
Published: Jun 2026
Referral management market was valued at approximately $3.1 billion in 2025 and is projected to reach $9.6 billion by 2035, expanding at a CAGR of approximately 12.0% during the forecast period 2026–2035. Referral management systems digitize and automate the process of coordinating patient referrals between primary care providers, specialists, and ancillary service providers, reducing referral leakage, administrative burden, and delays in specialist access. According to the World Health Organization (WHO), fragmented care coordination results in an estimated 27% of patients not completing specialist referrals, contributing to adverse health outcomes and avoidable readmissions. The U.S. Centers for Medicare and Medicaid Services (CMS) reports that care coordination failures cost the U.S. healthcare system over $25 billion annually.
Oncology Information System Market Size, Share & Trends Analysis Report, By Component (Software, Services), By Deployment (Cloud-Based, On-Premises), By Application (Radiation Therapy, Chemotherapy Management, Immunotherapy Management, Clinical Research, Cancer Registry Management), By End User (Hospitals, Cancer Centers, Radiation Therapy Centers, Specialty Oncology Clinics, Research Institutes), Forecast Period (2026–2035)
Published: Jun 2026
Oncology Information System (OIS) Market was valued at approximately $2.7 billion in 2025 and is projected to reach $7.8 billion by 2035, expanding at a CAGR of approximately 11.2% during the forecast period 2026–2035. Oncology information systems are specialized clinical platforms that integrate radiation therapy planning, chemotherapy regimen management, cancer registry documentation, and clinical trial data management within oncology care workflows. According to the World Health Organization (WHO), cancer is the second leading cause of death globally, responsible for approximately 9.7 million deaths in 2022, with incidence projected to rise by 77% by 2050 due to population aging and risk factor prevalence. The WHO's International Agency for Research on Cancer (IARC) estimates that 20 million new cancer cases were diagnosed globally in 2022, generating enormous clinical data volumes that necessitate specialized oncology information management platforms.
Nurse Call Systems Market Size, Share & Trends Analysis Report by Equipment Type (Basic Audio/Visual Nurse Call Systems, Digital Nurse Call Systems, IP-Based Nurse Call System, Nurse Call Intercoms, and Nurse Call Mobile Systems) by Communication (Wired Nurse Call Systems, and Wireless Nurse Call Systems) and by End-Users (Hospitals & Clinics, Ambulatory Care Centers, and Others ) Forecast Period (2025-2035)
Published: Feb 2026
Nurse call systems market was valued at approximately $2.3 billion in 2024 and is projected to reach $6.9 billion by 2035, growing at a CAGR of 10.6% during the forecast period. This growth is primarily attributed to the rising geriatric population, the prevalence of chronic diseases, and the need for enhanced patient safety and operational efficiency in healthcare settings. Technological advancements, such as the integration of wireless and mobile nurse call systems, are further propelling market expansion. North America currently holds the largest market share, accounting for 42% in 2024, due to its advanced healthcare infrastructure and early adoption of digital health technologies. However, the Asia-Pacific region is anticipated to witness the fastest growth, driven by increasing healthcare investments and modernization efforts in countries like China and India.
Ostomy Drainage Bags Market Size, Share & Trends Analysis Report by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, and Others), by Use (Single-Use [Closed-End] and Multi-Use [Drainable]), and by End User (Hospitals and Clinics, and Homecare) Forecast Period (2026-2035)
Published: Mar 2026
Ostomy drainage bags market was valued at $4,869.0 million in 2025 and is projected to reach $7,068.61 million by 2035, growing at a CAGR of 3.9% during the forecast period (2026-2035). The global ostomy drainage bags market is expanding due to the rising prevalence of surgical procedures that require long-term stoma management, particularly in colorectal and urological conditions. Increasing life expectancy has contributed to a larger patient population dependent on ongoing ostomy care products. Continuous product improvements aimed at enhancing comfort, skin protection, and leakage prevention have supported higher adoption across care settings. Growth in home care treatment models has further increased demand for reliable and easy-to-use drainage solutions. Stable reimbursement frameworks in several healthcare systems continue to support consistent product utilization.
Varicose Veins Treatment Market Size, Share & Trends Analysis by Type (Endovenous Ablation, Injection Sclerotherapy, Surgical Ligation & Stripping), By End-User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), Forecast Period (2026-2035)
Published: Mar 2026
Varicose veins treatment market was valued at $1.3 billion in 2025 and is projected to reach $2.5 billion by 2035, growing at a CAGR of 6.5% during the forecast Period (2026-2035). The growth is driven by the rising prevalence of venous diseases due to aging, obesity, and sedentary lifestyles, alongside increasing demand for minimally invasive procedures (like EVLT & RFA) and better awareness. Its key factors include technological advancements, patient preference for outpatient treatments, expanding insurance, and rising healthcare expenditure, with opportunities in emerging markets like the Asia-Pacific region, though high costs and a lack of skilled professionals pose challenges.
Wheelchair Market Size, Share & Trends Analysis By Age Group (Adult Wheelchair and Pediatric Wheelchair), By Operation Mode (Electric Powered Wheelchair and Manual Wheelchair/ Transport Wheelchair), By Type (Standard Wheelchair, Bariatric Wheelchair, Standing Wheelchair, Sports Wheelchair and Other) and By End-User (Homecare and Hospitals), By End-User (Hospitals, Diagnostic Centre, and Research Institute), Forecast Period (2026-2035)
Published: Mar 2026
The wheelchair market was valued at $3.4 billion in 2025 and is projected to reach $6.2 billion by 2035, growing at a CAGR of 6.1% during the forecast Period (2026-2035). The market growth is driven by a growing elderly population, increased chronic diseases, and demand for advanced mobility solutions. Key factors include high rates of spinal injuries, rising obesity, and increased adoption of powered/smart wheelchairs.
Internet of Medical Things (IoMT) Market Size, Share & Trends Analysis By Component (Medical Devices, and Software & Services) By Application (Patient Monitoring, Telemedicine, Connected Imaging, Drug Development, and Others) By End-User (Hospitals and Clinics, Research Institutes and Academics, and Homecare), Forecast Period (2026-2035)
Published: Mar 2026
Internet of medical things (IoMT) market was valued at $36 billion in 2025 and is projected to reach $88.5 billion by 2035, growing at a CAGR of 9.5% during the forecast Period (2026-2035). The market is witnessing rapid growth due to the increasing adoption of connected healthcare devices, wearable sensors, and remote patient monitoring solutions. The market is driven by rising chronic disease prevalence, an aging population, and the need for efficient, data-driven healthcare delivery. Technological advancements in AI, cloud computing, and wireless connectivity are enhancing real-time monitoring and predictive analytics. Hospitals, clinics, and homecare settings are increasingly integrating IoMT solutions to improve patient outcomes and operational efficiency.
Global E-Clinical Solution Market Size, Share & Trends Analysis Report By Deployment (Web-Based, Cloud-Based, and Licensed Enterprise), By End-User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Hospitals, Clinical Research Organizations, and Others), Forecast Period 2025-2035
Published: Feb 2026
The global e-clinical solution market is expected to grow at a CAGR of 12.8% during the forecast period (2021-2027). E-clinical solutions are software or applications used to track, manage, and record data related to clinical trials and clinical research. The e-clinical solutions provide solutions incorporated with advanced technologies expertise to support and accelerate the clinical development process.
E-Prescribing Market Size, Share & Trends Analysis by Component (Software and Hardware), by Type (Standalone and Integrated e-Prescription), by Offering (Cloud, Web-Based, and On-Premises), and by End-User (Hospital and Pharmacy), Forecast Period (2026-2035)
Published: Jun 2026
e-prescribing market was valued at $3.5 billion in 2025 and is projected to reach $18.7 billion by 2035, growing at a CAGR of 18.2% from 2026 to 2035. The global e-prescribing market is expanding as healthcare providers increasingly adopt digital solutions to improve prescription accuracy and patient safety. Growing emphasis on reducing medication errors and enhancing workflow efficiency is driving demand for integrated e-prescribing systems. Regulatory frameworks and government initiatives promoting electronic health records are further encouraging adoption. The need for seamless communication between prescribers, pharmacies, and patients is supporting the deployment of interoperable platforms. Rising healthcare digitization and the shift toward value-based care are also contributing to market growth. Overall, advancements in technology and increasing awareness of safe medication practices are reinforcing the transition to electronic prescribing solutions across the globe.
Aortic Valve Replacement Market Size, Share & Trends Analysis Report by Disease (Aortic Stenosis and Aortic Regurgitation), by Device (Mechanical Heart Valves, Transcatheter Heart Valves, and Tissue Heart Valves), and by End User (Hospitals, Ambulatory Surgical Centers, and Others) Forecast Period, (2026-2035)
Published: Jun 2026
Aortic valve replacement market valued at $10,803.5 million in 2025 and is projected to reach $23,797.7 million by 2035, growing at a CAGR of 8.3% during the forecast period (2026-2035). The global aortic valve replacement market is progressing steadily as healthcare systems prioritize advanced cardiac care solutions for managing structural heart diseases. Growth is being supported by the increasing prevalence of aortic stenosis, particularly among aging populations, alongside rising awareness regarding timely diagnosis and treatment. The shift toward minimally invasive procedures, including transcatheter approaches, is significantly transforming treatment pathways by reducing recovery time and procedural risk. Technological advancements in valve design, imaging guidance, and procedural techniques are further enhancing clinical outcomes. As healthcare providers emphasize improved patient quality of life and long-term durability of implants, aortic valve replacement solutions are becoming an essential component of modern cardiovascular care.
Orthopedic Software Market Size, Share & Trends Analysis Report by Product (Practice Management Software, Electronic Health Record (EHR) Software, Digital Orthopedic Templating Software, Picture Archiving and Communication Systems (PACS), Revenue Cycle Management (RCM) Software, and Patient Engagement Software), by Mode of Deployment (Cloud-Based, and On-Premise), and by Application (Joint Replacement, Fracture Management, Deformity Correction, Sports Medicine, Spine Surgery, Pediatric Orthopedics, and Others), Forecast Period (2026-2035)
Published: Jun 2026
Orthopedic software market was valued at $450.3 million in 2025 and is projected to reach $813.9 million by 2035, growing at a CAGR of 6.1% during the forecast period (2026-2035). The market is growing due to the increasing adoption of digital solutions in orthopedic practices, which enhances clinical efficiency and patient outcomes. Rising demand for advanced electronic health record systems and digital orthopedic templating software is driving healthcare providers to modernize workflows and reduce procedural errors. Additionally, the shift toward cloud-based and on-premise software deployment enables scalable, secure, and cost-effective management of patient data and imaging records. Integration of practice management, revenue cycle management, and patient engagement tools further supports streamlined operations and improved financial performance.
Clinical Decision Support System Market Size, Share & Trends Analysis Report by Component (Software and Services), by Deployment Mode (Cloud-Based (SaaS), On-Premise and Hybrid), and by Application (Drug Allergy Alerts, Drug Interaction Alerts, Clinical Guidelines & Protocols, Diagnostic Support and Others), and End-User (Hospitals, Clinics & Physician Practices, Ambulatory Care Centers, and Diagnostic Centers), Forecast Period, (2026-2035)
Published: May 2026
Clinical decision support system market was valued at $5.9 billion in 2025 and is projected to reach $13.0 billion by 2035, growing at a CAGR of 8.3% during the forecast period (2026-2035). The global clinical decision support system market is experiencing steady growth due to increasing demand for solutions that enhance clinical accuracy and patient safety. Rising adoption of digital healthcare technologies and electronic health records is driving widespread integration of these systems. Healthcare providers are prioritizing tools that reduce medical errors, streamline workflows, and support evidence-based decision-making. Technological advancements in artificial intelligence and machine learning are further expanding system capabilities and predictive accuracy. Additionally, growing awareness among hospitals, clinics, and diagnostic centers about the benefits of data-driven decision support is contributing to adoption. These factors collectively position the market for sustained growth over the forecast period.
Laboratory Information System (LIS) Market Size, Share & Trends Analysis Report By Product (Standalone LIS, Integrated LIS), By Deployment (On-Premise and Cloud-Based), By Components (Hardware, Software & Services), By End-User (Physician Laboratories, Hospital Laboratories, Research Laboratories) Forecast Period (2026-2035)
Published: Mar 2026
LIS market was valued at $2.3 billion in 2025 and is projected to reach $4.6 billion by 2035, growing at a CAGR of 7.2% from 2026 to 2035. The global market is expanding steadily as laboratories face rising pressure to improve diagnostic accuracy, turnaround times, and regulatory compliance. Increasing test volumes driven by chronic disease prevalence and preventive screening programs are accelerating system modernization. Healthcare providers are prioritizing digital traceability to reduce manual errors and support audit readiness across laboratory workflows. Growing consolidation of diagnostic networks is further strengthening demand for standardized, scalable information platforms. Investments in healthcare IT infrastructure across emerging and developed economies are reinforcing long-term adoption. In parallel, workforce shortages are encouraging automation to maintain service quality without proportional increases in staffing.
Assisted Reproductive Technology Market Size, Share & Trends Analysis by Technology (In Vitro Fertilization, Artificial Insemination (AI / IUI), Intracytoplasmic Sperm Injection (ICSI), Surrogacy, Cryopreservation / Embryo Freezing Technologies, Preimplantation Genetic Diagnosis/Screening (PGD/PGT), and Others (Gamete Intrafallopian Transfer), and by Procedure (Frozen Donor, Frozen Non-Donor, Fresh Donor, Fresh Non-Donor, and Embryo Banking), Forecast Period (2026-2035)
Published: Mar 2026
Assisted reproductive technology market was valued at $4.3 billion in 2025 and is projected to reach $8.8 billion by 2035, growing at a CAGR of 7.5% during the forecast Period (2026-2035). The market growth is driven by rising infertility rates (resulting from lifestyle factors and delayed marriage), technological advancements (including IVF, PGT, and cryopreservation), increased awareness, and supportive policies. The Asia-Pacific region is emerging as the fastest-growing region, although high costs, ethical debates, and accessibility issues remain key challenges.
Electronic Health Records (EHR) Market Size, Share & Trends Analysis by Installation (Web-Based, and Client Based), By End-User (Hospitals, Physician Offices, Ambulatory Services, and Laboratory and Diagnosis Centers), Forecast Period (2026-2035)
Published: Mar 2026
Electronic health records (EHR) market was valued at $26.2 billion in 2025 and is projected to reach $64.5 billion by 2035, growing at a CAGR of 9.5% during the forecast Period (2026-2035). The market is witnessing significant growth, driven by increasing adoption of digital healthcare solutions, government initiatives, and the need for streamlined patient data management. EHR systems enable improved clinical decision-making, operational efficiency, and interoperability across healthcare facilities. Hospitals, physician offices, ambulatory services, and diagnostic centers are increasingly implementing EHR platforms to enhance patient care and comply with regulatory standards. Technological advancements, including cloud-based solutions and AI integration, further support market expansion globally.
Pharmacy Information Systems Market Size, Share & Trends Analysis Report By Deployment (On-Premises and Cloud-Based) By Type (Out-Patients, and In-Patients) By Components (Hardware and Software & Services) By End-User (Physician Offices, Hospital & Pharmacy, and Paramedic Services) Forecast, 2026-2035
Published: Feb 2026
Pharmacy information systems market was valued at $11.2 billion in 2025 and is projected to reach $27.6 billion by 2035, growing at a CAGR of 9.5% during the forecast period (2026-2035). The pharmacy information systems market is gaining momentum as healthcare facilities place greater importance on structured medication workflows. Hospitals and pharmacies are investing in digital platforms that simplify prescription handling and improve coordination between clinical and administrative teams. These systems are increasingly viewed as essential tools for maintaining accuracy in dispensing and reducing avoidable errors. Growing adoption of electronic health records has also encouraged facilities to integrate pharmacy modules for smoother data exchange. Vendors are responding with solutions that offer a balance of reliability, ease of use, and compliance features. This collective shift is steadily strengthening the market’s overall growth trajectory.
Hospital Information System Market Size, Share & Trends Analysis Global Hospital Information System Market Size, Share & Trends Analysis Report by Deployment (Web-Based, On-Premises, and Cloud-Based), by Component (Hardware, Software, and Services), and by Product (Electronic Medical Record, Electronic Health Record, Laboratory Information System, Cardiology Information System, Radiology Information System, Material Management System, Clinical data Repository, HR and Payroll, and Others), Forecast Period (2026-2035)
Published: Mar 2026
Hospital Information System market was valued at $28.2 billion in 2025 and is projected to reach $55.1 billion by 2035, growing at a CAGR of 7.0% during the forecast Period (2026-2035). The market growth is driven by digital transformation, demand for efficiency, and patient-centric care, with key factors including AI/Analytics, cloud adoption, EHR growth, telemedicine, government support, interoperability needs, and rising data volumes, while facing challenges like data security concerns. Major players like Epic, Cerner, Oracle, and GE Healthcare lead this expansion, focusing on value-based care and streamlined workflows.
Artificial Intelligence (AI) in Healthcare Market Size, Share & Trends Analysis Report by Product Type (Hardware and Software & Service), By Application (Diagnosis, Biomarkers, Virtual nursing assistance, Drug Discovery, and Others) and By End-User (Hospitals & healthcare facilities, Personal care, and Biotechnology, & pharmaceutical companies) Forecast Period (2026-2035)
Published: Mar 2026
Global AI in healthcare market was valued at $19.8 billion in 2025 and is projected to reach $137.1 billion by 2035, growing at a CAGR of 21.4% from 2026 to 2035. The global market is expanding steadily as healthcare systems increasingly integrate advanced digital solutions to improve clinical accuracy and operational efficiency. Rising pressure to manage growing patient volumes, aging populations, and chronic disease burdens is accelerating the adoption of intelligent technologies across care settings. Continuous improvements in data availability, computing infrastructure, and analytical capabilities are further strengthening the commercial viability of these solutions. In parallel, healthcare providers are prioritizing tools that support faster decision-making and resource optimization. Growing acceptance among clinicians and patients alike is reinforcing long-term market momentum. Together, these factors are supporting sustained growth across both developed and emerging regions.
Medical Simulation Market Size, Share & Trends Analysis Report by Offerings (Simulation Products, Simulation Software, and Simulation Training Services), by Simulation Products (Manikin-Based Simulation Products, Model-Based Simulation Products, VR Hardware & Interfaces, and Accessories & Consumables), by Simulation Software (Web-Based Simulation Software, VR / AR / MR Simulation Software, Manikin Control & Physiology Software, Simulation & Performance Recording Software, and Virtual Tutors & AI Coaching Software), by End User(Academic Institutes & Research Centers, Hospitals, and Military Organizations), Forecast Period (2026-2035)
Published: Mar 2026
Medical simulation market was valued at $1,860.2 million in 2025 and is projected to reach $8,158.4 million by 2035, growing at a CAGR of 16.0% during the forecast period (2026-2035). The market is growing due to factors like the rising emphasis on patient safety, the need to improve healthcare professional skills, and advancements in VR, AR, and AI technologies. These drivers are leading to increased adoption of simulation for training, especially for minimally invasive procedures. Key restraints include the high initial investment and operational costs associated with simulators, such as software updates and maintenance.
Cardiovascular Information System Market By Type, By Applications, By Deployment - Global Industry Share, Growth, Competitive Analysis And Forecast, 2017-2022
Published: Feb 2026
The Global Cardiovascular Information System Market is expected to grow
at a CAGR of 11% during 2017-2022. Cardiovascular Information System is
an approach that provides access and management of patient’s digital
integrated cardiovascular records from a centralized and web-enabled
system. Moreover, Cardiovascular Information System enables patient
management through an approach of built-in report generation and
distribution process and thus increases the speed of reimbursements.
Patient Engagement Solutions Market By Delivery Mode, By Application, By Therapeutic Area, By End Users - Global Industry Share, Growth, Competitive Analysis And Forecast, 2017-2022
Published: Feb 2026
The Global patient engagement solutions market is expected to grow at a
CAGR of 21.70% during 2017-2022. The solution which allows patients to
manage and keep their healthcare related information along with greater
interaction with medical team is patient engagement solution. It is very
important to provide the necessary tools to actively engage in the
management of their own health.
Healthcare BPO Market Size, Share & Trends Analysis by Service Type (Life Science Services, Supply Chain Management & Logistics, and Others), By Payer Services (Claims Management Services, Integrated Front-End & Back-Office Operations, Member Management, Product Development & Business Acquisition (PDBA), Provider Management, Care Management, Billing & Accounts Management, and HR Services), and By Provider Services (Revenue Cycle Management (RCM), Patient Enrollment, Patient Care Services, and Others), Forecast Period (2026-2035)
Published: Jun 2026
Healthcare BPO market was valued at $417.8 billion in 2025 and is projected to reach $1,053.7 billion by 2035, growing at a CAGR of 9.8% during the forecast Period (2026-2035). The market is witnessing steady growth, driven by increasing demand for cost-efficient, technology-enabled outsourcing solutions across healthcare providers, payers, and life sciences organizations. Key services include revenue cycle management, patient care support, medical transcription, and analytics. Factors such as rising administrative complexity, stringent regulatory requirements, and the need for operational efficiency are boosting adoption. Additionally, advancements in AI, automation, and digital health platforms are enhancing service quality and scalability, positioning Healthcare BPO as a critical component of modern healthcare operations.
IoT Healthcare Market Size, Share & Trends Analysis by Component (Hardware and Software & Services), Application (Patient Monitoring, Telemedicine, Connected Imaging, and others), End-user (Healthcare Providers, Healthcare Payers, Research Laboratories), Forecast Period (2026-2035)
Published: Feb 2026
IoT healthcare market was valued at $56.6 billion in 2025 and is projected to reach $425.0 billion by 2035, growing at a CAGR of 22.4% during the forecast Period (2026-2035). The market is growing rapidly, driven by factors like advancements in technology, the expansion of telehealth, and the increasing popularity of wearable devices. Other key drivers include a focus on preventative care, the integration of Artificial Intelligence, government initiatives, and the need for cost-effective and remote patient monitoring. However, challenges such as data privacy, security concerns, and high infrastructure costs could impede market growth.
Biosimulation Market Size, Share & Trends Analysis By Application (Drug Discovery, Drug Development, Preclinical Testing, and Clinical Trials), By Product (Software and Services), and By End User ( Biotechnology and Pharmaceutical Companies, Contract Research Organizations (CROs), Regulatory Authorities, and Others), Forecast Period (2026-2035)
Published: Feb 2026
Biosimulation market was valued at $5.6 billion in 2025 and is projected to reach $37.8 billion by 2035, growing at a CAGR of 21.1% during the forecast period (2026-2035). The industry is growing due to factors like the rise of chronic diseases, increased R&D investments, and the integration of AI and machine learning. Key market drivers include the expansion of cloud-based solutions, the use of virtual clinical trials to reduce costs, and growing regulatory support for model-informed drug development.
Healthcare Cloud Computing Market - Global Industry Share, Growth, Competitive Analysis and Forecast, 2018-2023
Published: Feb 2026
Global healthcare cloud computing market is growing significantly with a CAGR of 22% during 2018-2023. The robust growth of the Market is due to various factors such as rise in adoption of cloud services across the globe and significant reforms in healthcare information technology.
Global Healthcare Information Systems Market Research and Analysis, Forecast to 2022
Published: Feb 2026
The Global Healthcare Information System market is estimated to witness a significant growth rate of 7.2% over the projected period 2016-2022. Growing investment by healthcare IT companies along with supportive government initiatives are the key driving forces attributing towards the growth of the global market.